name,category,terms2'-5'-oligoadenylate synthetase 2, 69/71kDa,INTERPRO[450002588$IPR002934:Nucleotidyltransferase, 450005548$IPR006116:2-5-oligoadenylate synthetase, ubiquitin-like region, 450005549$IPR006117:2-5-oligoadenylate synthetase, conserved site, 450017222$IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000881$lipoprotein, 790000959$microsome, 790000969$mitochondrion, 790001004$myristate, 790001063$nucleotide-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001304$repeat, 790001339$rna-binding, 790001547$transferase]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,UP_SEQ_FEATURE[850001029$chain:2'-5'-oligoadenylate synthetase 2, 850102588$compositionally biased region:Pro-rich (linker), 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850113824$region of interest:OAS domain 1, 850113825$region of interest:OAS domain 2, 850117294$sequence conflict, 850118574$splice variant]
5-hydroxytryptamine (serotonin) receptor 1D,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000431$IPR000505:5-Hydroxytryptamine 1D receptor, 450001978$IPR002231:5-Hydroxytryptamine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
5-hydroxytryptamine (serotonin) receptor 1D,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
5-hydroxytryptamine (serotonin) receptor 1D,PIR_SUPERFAMILY[630005396$PIRSF005474:5-hydroxytryptamine receptor 1, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
5-hydroxytryptamine (serotonin) receptor 1D,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
5-hydroxytryptamine (serotonin) receptor 1D,UP_SEQ_FEATURE[850002194$chain:5-hydroxytryptamine receptor 1D, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,INTERPRO[450001187$IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, 450002719$IPR003094:Fructose-2,6-bisphosphatase, 450011723$IPR013078:Phosphoglycerate mutase, 450011724$IPR013079:6-phosphofructo-2-kinase, 450014584$IPR016260:Bifunctional 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,PIR_SUPERFAMILY[630000821$PIRSF000709:6PFK_2-Ptase, 630000822$PIRSF000709:bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000825$kinase, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000158$active site:Tele-phosphohistidine intermediate, 850000362$binding site:Fructose-6-phosphate, 850002499$chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 2, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110612$region of interest:6-phosphofructo-2-kinase, 850111707$region of interest:Fructose-2,6-bisphosphatase, 850117294$sequence conflict, 850118574$splice variant]
A kinase (PRKA) anchor protein 11,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa]
A kinase (PRKA) anchor protein 11,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 11,UP_SEQ_FEATURE[850002960$chain:A-kinase anchor protein 11, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 3,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa, 450016576$IPR018292:A-kinase anchor 110 kDa, C-terminal, 450016733$IPR018459:RII binding domain]
A kinase (PRKA) anchor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 3,UP_SEQ_FEATURE[850002965$chain:A-kinase anchor protein 3, 850106258$modified residue, 850106259$mutagenesis site, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 7,INTERPRO[450017747$IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain, 450017748$IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain]
A kinase (PRKA) anchor protein 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001212$polymorphism]
A kinase (PRKA) anchor protein 7,UP_SEQ_FEATURE[850002970$chain:A-kinase anchor protein 7 isoform gamma, 850002971$chain:A-kinase anchor protein 7 isoforms alpha and beta, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850114237$region of interest:Required for apical membrane localization, 850114425$region of interest:Required for membrane localization, 850114538$region of interest:RII-binding, 850117295$sequence variant, 850118574$splice variant]
ABI family, member 3,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
ABI family, member 3,SMART[760000295$SM00326:SH3]
ABI family, member 3,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
ABI family, member 3,UP_SEQ_FEATURE[850003171$chain:ABI gene family member 3, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850117295$sequence variant]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,INTERPRO[450001412$IPR001590:Peptidase M12B, ADAM/reprolysin, 450001561$IPR001762:Blood coagulation inhibitor, Disintegrin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002537$IPR002870:Peptidase M12B, propeptide, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450006006$IPR006586:ADAM, cysteine-rich, 450011699$IPR013032:EGF-like region, conserved site, 450016643$IPR018358:Disintegrin, conserved site]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,PIR_SUPERFAMILY[630006703$PIRSF006749:mouse meltrin alpha]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SMART[760000042$SM00050:DISIN, 760000538$SM00608:ACR]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease, 790001405$signal, 790001555$transmembrane, 790001648$zinc, 790001652$zymogen]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,UP_SEQ_FEATURE[850015303$chain:Disintegrin and metalloproteinase domain- containing protein 21, 850102480$compositionally biased region:Cys-rich, 850102585$compositionally biased region:Poly-Val, 850102883$disulfide bond, 850103526$domain:Disintegrin, 850103596$domain:EGF-like, 850104962$domain:Peptidase M12B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850117294$sequence conflict, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ADP-ribosylation factor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
ADP-ribosylation factor 1,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
ADP-ribosylation factor 1,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 1,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 1,UP_SEQ_FEATURE[850004004$chain:ADP-ribosylation factor 1, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
ADP-ribosylation factor-like 2,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor-like 2,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor-like 2,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor-like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790000811$isopeptide bond, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ADP-ribosylation factor-like 2,UP_SEQ_FEATURE[850000387$binding site:GTP; via amide nitrogen, 850004038$chain:ADP-ribosylation factor-like protein 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),SMART[760000240$SM00268:ACTIN]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000950$methylated amino acid, 790000957$microfilament, 790000973$mitosis, 790001063$nucleotide-binding]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),UP_SEQ_FEATURE[850004743$chain:Alpha-centractin, 850106258$modified residue]
AT hook, DNA binding motif, containing 1,INTERPRO[450016267$IPR017956:AT hook, DNA-binding, conserved site]
AT hook, DNA binding motif, containing 1,SMART[760000336$SM00384:AT_hook]
AT hook, DNA binding motif, containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
AT hook, DNA binding motif, containing 1,UP_SEQ_FEATURE[850002980$chain:A.T hook DNA-binding motif-containing protein 1, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ATG2 autophagy related 2 homolog B (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
ATG2 autophagy related 2 homolog B (S. cerevisiae),INTERPRO[450013854$IPR015412:ATG2, C-terminal]
ATG2 autophagy related 2 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
ATG2 autophagy related 2 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850006877$chain:Autophagy-related protein 2 homolog B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ATH1, acid trehalase-like 1 (yeast),INTERPRO[450004658$IPR005195:Glycoside hydrolase family 65, central catalytic, 450011039$IPR012341:Six-hairpin glycosidase]
ATH1, acid trehalase-like 1 (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000617$glycosidase, 790000743$hydrolase]
ATH1, acid trehalase-like 1 (yeast),UP_SEQ_FEATURE[850003437$chain:Acid trehalase-like protein 1, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850118574$splice variant]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,INTERPRO[450007946$IPR008689:ATPase, F0 complex, subunit D, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,PIR_SUPERFAMILY[630005438$PIRSF005514:ATPase_F0_D_mt, 630005439$PIRSF005514:F-type ATP synthase, subunit d, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000281$cf(0), 790000356$complete proteome, 790000445$direct protein sequencing, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001558$transport]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,UP_SEQ_FEATURE[850006509$chain:ATP synthase subunit d, mitochondrial, 850106258$modified residue, 850118574$splice variant]
ATP-grasp domain containing 1,INTERPRO[450003342$IPR003806:ATP-grasp fold, DUF201-type, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450010588$IPR011761:ATP-grasp fold]
ATP-grasp domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000906$manganese, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
ATP-grasp domain containing 1,UP_SEQ_FEATURE[850006752$chain:ATP-grasp domain-containing protein 1, 850103068$domain:ATP-grasp, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATP/GTP binding protein-like 2,INTERPRO[450000726$IPR000834:Peptidase M14, carboxypeptidase A]
ATP/GTP binding protein-like 2,SMART[760000546$SM00631:Zn_pept]
ATP/GTP binding protein-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
ATP/GTP binding protein-like 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014082$chain:Cytosolic carboxypeptidase 2, 850106218$metal ion-binding site:Zinc, 850117295$sequence variant, 850118574$splice variant]
ATPase family, AAA domain containing 1,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
ATPase family, AAA domain containing 1,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000811$isopeptide bond, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ATPase family, AAA domain containing 1,UP_SEQ_FEATURE[850006779$chain:ATPase family AAA domain-containing protein 1, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATPase family, AAA domain containing 3C,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
ATPase family, AAA domain containing 3C,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 3C,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding]
ATPase family, AAA domain containing 3C,UP_SEQ_FEATURE[850006789$chain:ATPase family AAA domain-containing protein 3C, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP]
ATPase, Ca++ transporting, plasma membrane 1,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039438$chain:Plasma membrane calcium-transporting ATPase 1, 850102572$compositionally biased region:Poly-Glu, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,UP_SEQ_FEATURE[850006012$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10, 850006020$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850110004$region of interest:2 X 23 AA tandem repeats of A-L-E-F-N- [LS]-S-A-N-P-E-A-S-T-I-F-Q-R-N-S-Q-T-D, 850115074$repeat:1, 850115273$repeat:2, 850115631$repeat:ANK, 850118762$zinc finger region:C4-type]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,UP_SEQ_FEATURE[850006008$chain:Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850118574$splice variant, 850118762$zinc finger region:C4-type]
B-cell CLL/lymphoma 9,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001642$wnt signaling pathway]
B-cell CLL/lymphoma 9,UP_SEQ_FEATURE[850007049$chain:B-cell CLL/lymphoma 9 protein, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850111365$region of interest:CTNNB1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
B-cell CLL/lymphoma 9-like,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
B-cell CLL/lymphoma 9-like,UP_SEQ_FEATURE[850007050$chain:B-cell CLL/lymphoma 9-like protein, 850102562$compositionally biased region:Met-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113605$region of interest:Necessary for interaction with CTNNB1, 850118574$splice variant]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),OMIM_DISEASE[520000533$Bartter syndrome, type 4]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),SP_PIR_KEYWORDS[790000169$bartter syndrome, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),UP_SEQ_FEATURE[850007325$chain:Barttin, 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),INTERPRO[450008710$IPR009617:Adipose-regulatory protein, Seipin]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),OMIM_DISEASE[520002905$Lipodystrophy, congenital generalized, type 2, 520003610$Neuropathy, distal hereditary motor, type V, 520004483$Silver spastic paraplegia syndrome, 520004539$Spastic paraplegia 17 (autosomal dominant), 520004540$spastic paraplegia 17 (Silver syndrome), 520004549$Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome), 520004595$Spinal muscular atrophy, distal, type V]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),UP_SEQ_FEATURE[850059230$chain:Seipin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
C-type lectin domain family 17, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 17, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 17, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790000919$membrane, 790001555$transmembrane]
C-type lectin domain family 17, member A,UP_SEQ_FEATURE[850008692$chain:C-type lectin and transmembrane domain- containing protein FLJ45910, 850103184$domain:C-type lectin, 850118623$transmembrane region]
C-type lectin domain family 9, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 9, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 9, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 9, member A,UP_SEQ_FEATURE[850008740$chain:C-type lectin domain family 9 member A, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
C1q and tumor necrosis factor related protein 1,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
C1q and tumor necrosis factor related protein 1,SMART[760000097$SM00110:C1Q]
C1q and tumor necrosis factor related protein 1,SP_PIR_KEYWORDS[790000345$collagen, 790000356$complete proteome, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
C1q and tumor necrosis factor related protein 1,UP_SEQ_FEATURE[850012307$chain:Complement C1q tumor necrosis factor- related protein 1, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
C2 calcium-dependent domain containing 3,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting]
C2 calcium-dependent domain containing 3,SMART[760000211$SM00239:C2]
C2 calcium-dependent domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
C2 calcium-dependent domain containing 3,UP_SEQ_FEATURE[850008791$chain:C2 domain-containing protein 3, 850103200$domain:C2 1, 850103201$domain:C2 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
CCR4-NOT transcription complex, subunit 2,INTERPRO[450006648$IPR007282:NOT2/NOT3/NOT5]
CCR4-NOT transcription complex, subunit 2,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
CCR4-NOT transcription complex, subunit 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
CCR4-NOT transcription complex, subunit 2,UP_SEQ_FEATURE[850010112$chain:CCR4-NOT transcription complex subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
CD22 molecule,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
CD22 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage, 470038870$hsa04662:B cell receptor signaling pathway]
CD22 molecule,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
CD22 molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000152$B-cell, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000436$dimer, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
CD22 molecule,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850007061$chain:B-cell receptor CD22, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD247 molecule,BIOCARTA[30000072$h_CSKPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor, 30000075$h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents, 30000284$h_tcapoptosisPathway:HIV Induced T Cell Apoptosis, 30000285$h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation, 30000286$h_tcrmolecule:T Cell Receptor and CD3 Complex, 30000287$h_tcrPathway:T Cell Receptor Signaling Pathway, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
CD247 molecule,INTERPRO[450002734$IPR003110:Phosphorylated immunoreceptor signaling ITAM]
CD247 molecule,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway]
CD247 molecule,OMIM_DISEASE[520002611$Immunodeficiency due to defect in CD3-zeta]
CD247 molecule,PIR_SUPERFAMILY[630021605$PIRSF028738:CD3, zeta type]
CD247 molecule,SMART[760000067$SM00077:ITAM]
CD247 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000733$host-virus interaction, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001481$T-cell receptor, 790001555$transmembrane, 790001556$transmembrane protein]
CD247 molecule,UP_SEQ_FEATURE[850063404$chain:T-cell surface glycoprotein CD3 zeta chain, 850102883$disulfide bond, 850104484$domain:ITAM 1, 850104485$domain:ITAM 2, 850104486$domain:ITAM 3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
COMM domain containing 5,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
COMM domain containing 5,UP_SEQ_FEATURE[850012277$chain:COMM domain-containing protein 5, 850103407$domain:COMM, 850117294$sequence conflict, 850117295$sequence variant]
COMM domain containing 9,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 9,SP_PIR_KEYWORDS[790000356$complete proteome]
COMM domain containing 9,UP_SEQ_FEATURE[850012281$chain:COMM domain-containing protein 9, 850103407$domain:COMM, 850117294$sequence conflict]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),BIOCARTA[30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),PIR_SUPERFAMILY[630013144$PIRSF016373:hypothetical protein, Caenorhabditis elegans B0547.1 type]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),SMART[760000204$SM00232:JAB_MPN]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001065$nucleus, 790001252$Protease, 790001410$signalosome]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),UP_SEQ_FEATURE[850012530$chain:COP9 signalosome complex subunit 5, 850104794$domain:MPN, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117527$short sequence motif:JAMM motif]
COX assembly mitochondrial protein homolog (S. cerevisiae),INTERPRO[450012488$IPR013892:Cytochrome c oxidase biogenesis protein Cmc1-like]
COX assembly mitochondrial protein homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000371$copper, 790000937$metal-binding, 790000969$mitochondrion]
COX assembly mitochondrial protein homolog (S. cerevisiae),UP_SEQ_FEATURE[850012660$chain:COX assembly mitochondrial protein homolog, 850106258$modified residue, 850117294$sequence conflict]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),INTERPRO[450003320$IPR003780:Cytochrome oxidase assembly]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038802$hsa00860:Porphyrin and chlorophyll metabolism]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),OMIM_DISEASE[520000810$Cardiomyopathy, hypertrophic, early-onset fatal, 520002807$Leigh syndrome due to cytochrome c oxidase deficiency]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),UP_SEQ_FEATURE[850013512$chain:Cytochrome c oxidase assembly protein COX15 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
CUB domain containing protein 2,INTERPRO[450000750$IPR000859:CUB]
CUB domain containing protein 2,SMART[760000034$SM00042:CUB]
CUB domain containing protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
CUB domain containing protein 2,UP_SEQ_FEATURE[850012807$chain:CUB domain-containing protein 2, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103453$domain:CUB 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
CUG triplet repeat, RNA binding protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014322$IPR015903:Ribonucleoprotein, BRUNO-like]
CUG triplet repeat, RNA binding protein 1,SMART[760000328$SM00360:RRM]
CUG triplet repeat, RNA binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000988$mrna processing, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
CUG triplet repeat, RNA binding protein 1,UP_SEQ_FEATURE[850012820$chain:CUG-BP- and ETR-3-like factor 1, 850102597$compositionally biased region:Ser-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
D-2-hydroxyglutarate dehydrogenase,COG_ONTOLOGY[90000064$Energy production and conversion]
D-2-hydroxyglutarate dehydrogenase,INTERPRO[450003627$IPR004113:FAD-linked oxidase, C-terminal, 450005528$IPR006094:FAD linked oxidase, N-terminal, 450011734$IPR013090:Phospholipase A2, active site, 450014512$IPR016166:FAD-binding, type 2, 450014513$IPR016167:FAD-binding, type 2, subdomain 1]
D-2-hydroxyglutarate dehydrogenase,OMIM_DISEASE[520001308$D-2-hydroxyglutaric aciduria]
D-2-hydroxyglutarate dehydrogenase,PIR_SUPERFAMILY[630006095$PIRSF006165:glycolate oxidase chain GlcD]
D-2-hydroxyglutarate dehydrogenase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000559$Flavoprotein, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
D-2-hydroxyglutarate dehydrogenase,UP_SEQ_FEATURE[850014158$chain:D-2-hydroxyglutarate dehydrogenase, mitochondrial, 850103738$domain:FAD-binding PCMH-type, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,UP_SEQ_FEATURE[850041113$chain:Probable ATP-dependent RNA helicase DDX47, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118575$strand]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,UP_SEQ_FEATURE[850041114$chain:Probable ATP-dependent RNA helicase DDX49, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001331$ribosome biogenesis, 790001339$rna-binding, 790001345$rrna processing]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,UP_SEQ_FEATURE[850041119$chain:Probable ATP-dependent RNA helicase DDX56, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),INTERPRO[450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450005977$IPR006554:Helicase-like, DEXD box c2 type, 450005978$IPR006555:Helicase, ATP-dependent, c2 type, 450009663$IPR010614:DEAD2, 450011687$IPR013020:DNA helicase (DNA repair), Rad3 type, 450012607$IPR014013:Helicase, superfamily 1 and 2, ATP-binding, DinG/Rad3-type]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),PIR_SUPERFAMILY[630023581$PIRSF031023:PIRSF031023]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),SMART[760000433$SM00488:DEXDc2, 760000435$SM00491:HELICc2]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001339$rna-binding]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),UP_SEQ_FEATURE[850041102$chain:Probable ATP-dependent RNA helicase DDX12, 850102507$compositionally biased region:Glu-rich, 850104106$domain:Helicase ATP-binding, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117386$short sequence motif:DEAH]
DENN/MADD domain containing 2C,INTERPRO[450001049$IPR001194:DENN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 2C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 2C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
DENN/MADD domain containing 2C,UP_SEQ_FEATURE[850014829$chain:DENN domain-containing protein 2C, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DENN/MADD domain containing 4A,INTERPRO[450001049$IPR001194:DENN, 450002551$IPR002885:Pentatricopeptide repeat, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 4A,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 4A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
DENN/MADD domain containing 4A,UP_SEQ_FEATURE[850008638$chain:C-myc promoter-binding protein, 850102572$compositionally biased region:Poly-Glu, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850106258$modified residue, 850116806$repeat:PPR 1, 850116817$repeat:PPR 2, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal]
DENN/MADD domain containing 5B,INTERPRO[450000897$IPR001024:Lipoxygenase, LH2, 450001049$IPR001194:DENN, 450003532$IPR004012:RUN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 5B,SMART[760000278$SM00308:LH2, 760000527$SM00593:RUN, 760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 5B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
DENN/MADD domain containing 5B,UP_SEQ_FEATURE[850014835$chain:DENN domain-containing protein 5B, 850103503$domain:dDENN, 850103514$domain:DENN, 850105029$domain:PLAT, 850105224$domain:RUN 1, 850105225$domain:RUN 2, 850105606$domain:uDENN, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DIP2 disco-interacting protein 2 homolog B (Drosophila),COG_ONTOLOGY[90000086$Lipid metabolism / Secondary metabolites biosynthesis, transport, and catabolism]
DIP2 disco-interacting protein 2 homolog B (Drosophila),INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase, 450009560$IPR010506:DMAP1-binding]
DIP2 disco-interacting protein 2 homolog B (Drosophila),OMIM_DISEASE[520003170$Mental retardation, FRA12A type]
DIP2 disco-interacting protein 2 homolog B (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
DIP2 disco-interacting protein 2 homolog B (Drosophila),UP_SEQ_FEATURE[850015260$chain:Disco-interacting protein 2 homolog B, 850102565$compositionally biased region:Poly-Ala, 850102585$compositionally biased region:Poly-Val, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DIS3 mitotic control homolog (S. cerevisiae),COG_ONTOLOGY[90000115$Transcription]
DIS3 mitotic control homolog (S. cerevisiae),INTERPRO[450001682$IPR001900:Ribonuclease II and R, 450006016$IPR006596:Nucleotide binding protein, PINc]
DIS3 mitotic control homolog (S. cerevisiae),KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
DIS3 mitotic control homolog (S. cerevisiae),PIR_SUPERFAMILY[630006771$PIRSF006825:mitotic control protein Dis3]
DIS3 mitotic control homolog (S. cerevisiae),SMART[760000582$SM00670:PINc]
DIS3 mitotic control homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
DIS3 mitotic control homolog (S. cerevisiae),UP_SEQ_FEATURE[850018279$chain:Exosome complex exonuclease RRP44, 850104997$domain:PINc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DIS3 mitotic control homolog (S. cerevisiae)-like,INTERPRO[450001682$IPR001900:Ribonuclease II and R]
DIS3 mitotic control homolog (S. cerevisiae)-like,PIR_SUPERFAMILY[630006771$PIRSF006825:mitotic control protein Dis3]
DIS3 mitotic control homolog (S. cerevisiae)-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001339$rna-binding]
DIS3 mitotic control homolog (S. cerevisiae)-like,UP_SEQ_FEATURE[850015252$chain:DIS3-like exonuclease 1, 850117295$sequence variant, 850118574$splice variant]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),INTERPRO[450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015509$chain:DNA cross-link repair 1A protein, 850106258$modified residue, 850106259$mutagenesis site, 850113804$region of interest:Nuclear focus formation, 850113808$region of interest:Nuclear localization region, 850117295$sequence variant]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),INTERPRO[450001128$IPR001279:Beta-lactamase-like, 450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015510$chain:DNA cross-link repair 1B protein, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013753$IPR015311:Apoptosis, DNA fragmentation factor 40 kDa]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),UP_SEQ_FEATURE[850015551$chain:DNA fragmentation factor subunit beta, 850103367$domain:CIDE-N, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
DPH2 homolog (S. cerevisiae),INTERPRO[450002419$IPR002728:Diphthamide synthesis, DPH1/DHP2, 450009098$IPR010014:Diphthamide synthesis, DHP2]
DPH2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
DPH2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850015237$chain:Diphthamide biosynthesis protein 2, 850106258$modified residue, 850117294$sequence conflict]
DnaJ (Hsp40) homolog, subfamily C, member 16,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450011036$IPR012335:Thioredoxin fold, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016249$IPR017936:Thioredoxin-like, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 16,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 16,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
DnaJ (Hsp40) homolog, subfamily C, member 16,UP_SEQ_FEATURE[850016166$chain:DnaJ homolog subfamily C member 16, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850104487$domain:J, 850105478$domain:Thioredoxin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
E74-like factor 4 (ets domain transcription factor),INTERPRO[450000358$IPR000418:Ets, 450010816$IPR011991:Winged helix repressor DNA-binding]
E74-like factor 4 (ets domain transcription factor),SMART[760000360$SM00413:ETS]
E74-like factor 4 (ets domain transcription factor),SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
E74-like factor 4 (ets domain transcription factor),UP_SEQ_FEATURE[850018052$chain:ETS-related transcription factor Elf-4, 850102913$DNA-binding region:ETS, 850106258$modified residue, 850114563$region of interest:RUNX1-binding, 850117294$sequence conflict]
EF-hand calcium binding domain 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 2,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
EF-hand calcium binding domain 2,UP_SEQ_FEATURE[850016943$chain:EF-hand calcium-binding domain-containing protein 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117294$sequence conflict, 850118574$splice variant]
EF-hand calcium binding domain 4A,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 4A,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 4A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
EF-hand calcium binding domain 4A,UP_SEQ_FEATURE[850016945$chain:EF-hand calcium-binding domain-containing protein 4A, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117295$sequence variant, 850118574$splice variant]
EGF, latrophilin and seven transmembrane domain containing 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016532$IPR018247:EF-HAND 1]
EGF, latrophilin and seven transmembrane domain containing 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000273$SM00303:GPS]
EGF, latrophilin and seven transmembrane domain containing 1,SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
EGF, latrophilin and seven transmembrane domain containing 1,UP_SEQ_FEATURE[850016985$chain:EGF, latrophilin and seven transmembrane domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ER degradation enhancer, mannosidase alpha-like 2,INTERPRO[450001227$IPR001382:Glycoside hydrolase, family 47]
ER degradation enhancer, mannosidase alpha-like 2,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
ER degradation enhancer, mannosidase alpha-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001595$unfolded protein response]
ER degradation enhancer, mannosidase alpha-like 2,UP_SEQ_FEATURE[850017746$chain:ER degradation-enhancing alpha- mannosidase-like 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
F-box protein 9,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box protein 9,SMART[760000228$SM00256:FBOX]
F-box protein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
F-box protein 9,UP_SEQ_FEATURE[850018511$chain:F-box only protein 9, 850103725$domain:F-box, 850117118$repeat:TPR, 850118574$splice variant]
FERM domain containing 6,INTERPRO[450000257$IPR000299:FERM domain, 450010818$IPR011993:Pleckstrin homology-type, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
FERM domain containing 6,SMART[760000266$SM00295:B41]
FERM domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein]
FERM domain containing 6,UP_SEQ_FEATURE[850019182$chain:FERM domain-containing protein 6, 850102581$compositionally biased region:Poly-Ser, 850102584$compositionally biased region:Poly-Tyr, 850103760$domain:FERM, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
FGFR1 oncogene partner 2,INTERPRO[450007825$IPR008555:Protein of unknown function DUF837]
FGFR1 oncogene partner 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm]
FGFR1 oncogene partner 2,UP_SEQ_FEATURE[850019347$chain:FGFR1 oncogene partner 2, 850106258$modified residue, 850117294$sequence conflict, 850117881$site:Breakpoint for translocation to form FGFR1OP2-FGFR1, 850118574$splice variant]
FIG4 homolog (S. cerevisiae),INTERPRO[450001784$IPR002013:Synaptojanin, N-terminal]
FIG4 homolog (S. cerevisiae),OMIM_DISEASE[520000280$Amyotrophic lateral sclerosis 11, 520000969$Charcot-Marie-Tooth disease, type 4J]
FIG4 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000080$amyotrophic lateral sclerosis, 790000289$charcot-marie-tooth disease, 790000356$complete proteome, 790000446$disease mutation, 790000501$endosome, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001020$neuropathy, 790001212$polymorphism]
FIG4 homolog (S. cerevisiae),UP_SEQ_FEATURE[850039945$chain:Polyphosphoinositide phosphatase, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850105248$domain:SAC, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
FK506 binding protein 2, 13kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type]
FK506 binding protein 2, 13kDa,PIR_SUPERFAMILY[630001631$PIRSF001468:FK506-binding protein 1]
FK506 binding protein 2, 13kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000810$Isomerase, 790000919$membrane, 790001212$polymorphism, 790001343$Rotamase, 790001405$signal]
FK506 binding protein 2, 13kDa,UP_SEQ_FEATURE[850019525$chain:FK506-binding protein 2, 850105058$domain:PPIase FKBP-type, 850105852$helix, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118575$strand, 850118624$turn]
FK506 binding protein 4, 59kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, 450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
FK506 binding protein 4, 59kDa,SMART[760000020$SM00028:TPR]
FK506 binding protein 4, 59kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000394$cyclosporin A binding, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000810$Isomerase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001343$Rotamase, 790001537$tpr repeat]
FK506 binding protein 4, 59kDa,UP_SEQ_FEATURE[850019530$chain:FK506-binding protein 4, 850019531$chain:FK506-binding protein 4, N-terminally processed, 850105059$domain:PPIase FKBP-type 1, 850105060$domain:PPIase FKBP-type 2, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117295$sequence variant, 850118575$strand, 850118624$turn]
FXYD domain containing ion transport regulator 2,BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
FXYD domain containing ion transport regulator 2,INTERPRO[450000237$IPR000272:Ion-transport regulator, FXYD region]
FXYD domain containing ion transport regulator 2,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction]
FXYD domain containing ion transport regulator 2,OMIM_DISEASE[520002525$Hypomagnesemia-2, renal]
FXYD domain containing ion transport regulator 2,PIR_SUPERFAMILY[630021015$PIRSF027828:PIRSF027828]
FXYD domain containing ion transport regulator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000798$ion transport, 790000919$membrane, 790001226$potassium, 790001229$potassium transport, 790001240$primary hypomagnesemia, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001558$transport]
FXYD domain containing ion transport regulator 2,UP_SEQ_FEATURE[850061295$chain:Sodium/potassium-transporting ATPase subunit gamma, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
FYN binding protein (FYB-120/130),INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3, 450016415$IPR018115:Xylose isomerase, active site]
FYN binding protein (FYB-120/130),SMART[760000295$SM00326:SH3]
FYN binding protein (FYB-120/130),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
FYN binding protein (FYB-120/130),UP_SEQ_FEATURE[850020201$chain:FYN-binding protein, 850102580$compositionally biased region:Poly-Pro, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850112832$region of interest:Interaction with SKAP1, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117706$short sequence motif:SH2-binding, 850117709$short sequence motif:SH2-binding; to FYN, 850117710$short sequence motif:SH2-binding; to LCP2, 850118575$strand, 850118624$turn]
Fas apoptotic inhibitory molecule 2,INTERPRO[450005640$IPR006214:Uncharacterised protein family UPF0005]
Fas apoptotic inhibitory molecule 2,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
Fas apoptotic inhibitory molecule 2,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 2,UP_SEQ_FEATURE[850018981$chain:Fas apoptotic inhibitory molecule 2, 850102581$compositionally biased region:Poly-Ser, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
Fas apoptotic inhibitory molecule 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fas apoptotic inhibitory molecule 3,SMART[760000357$SM00409:IG]
Fas apoptotic inhibitory molecule 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 3,UP_SEQ_FEATURE[850018982$chain:Fas apoptotic inhibitory molecule 3, 850102404$compositionally biased region:Arg-rich, 850102883$disulfide bond, 850104199$domain:Ig-like, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc receptor-like 2,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 2,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 2,UP_SEQ_FEATURE[850019114$chain:Fc receptor-like protein 2, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc receptor-like 5,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 5,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 5,UP_SEQ_FEATURE[850019117$chain:Fc receptor-like protein 5, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850104404$domain:Ig-like C2-type 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 61,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 61,PIR_SUPERFAMILY[630030082$PIRSF038578:probable G protein-coupled receptor 61, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 61,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 61,UP_SEQ_FEATURE[850042074$chain:Probable G-protein coupled receptor 61, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 68,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450004847$IPR005389:OGR1 sphingosylphosphorylcholine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 68,PIR_SUPERFAMILY[630005778$PIRSF005853:GPR4-like G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 68,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001580$tumor suppressor]
G protein-coupled receptor 68,UP_SEQ_FEATURE[850036439$chain:Ovarian cancer G-protein coupled receptor 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,INTERPRO[450014108$IPR015672:G-protein coupled receptor 89-related]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,PIR_SUPERFAMILY[630011150$PIRSF013287:uncharacterized conserved protein]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,UP_SEQ_FEATURE[850046312$chain:Protein GPR89, 850053876$chain:Putative protein GPR89C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
GA binding protein transcription factor, beta subunit 1,INTERPRO[450001870$IPR002110:Ankyrin]
GA binding protein transcription factor, beta subunit 1,PIR_SUPERFAMILY[630027779$PIRSF036345:nuclear respiratory factor-2 beta-1 chain]
GA binding protein transcription factor, beta subunit 1,SMART[760000220$SM00248:ANK]
GA binding protein transcription factor, beta subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
GA binding protein transcription factor, beta subunit 1,UP_SEQ_FEATURE[850020362$chain:GA-binding protein subunit beta-1, 850106259$mutagenesis site, 850114911$region of interest:Transcription activation and HCFC1 interaction, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GATA binding protein 3,BBID[10000099$78.B_Cell_Development, 10000102$80.T_cell_Activation, 10000111$89.CD4_T_Cell_Differentiation]
GATA binding protein 3,BIOCARTA[30000123$h_GATA3pathway:GATA3 participate in activating the Th2 cytokine genes expression]
GATA binding protein 3,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450014695$IPR016374:Transcription factor, GATA-1/2/3]
GATA binding protein 3,OMIM_DISEASE[520002530$Hypoparathyroidism, sensorineural deafness, and renal dysplasia]
GATA binding protein 3,PIR_SUPERFAMILY[630003115$PIRSF003027:TF_GATA-1/2/3]
GATA binding protein 3,SMART[760000352$SM00401:ZnF_GATA]
GATA binding protein 3,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
GATA binding protein 3,UP_SEQ_FEATURE[850064903$chain:Trans-acting T-cell-specific transcription factor GATA-3, 850102581$compositionally biased region:Poly-Ser, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118823$zinc finger region:GATA-type 1, 850118824$zinc finger region:GATA-type 2]
GDP dissociation inhibitor 2,INTERPRO[450000699$IPR000806:Rab GDI protein, 450001776$IPR002005:Rab GTPase activator, 450016490$IPR018203:GDP dissociation inhibitor]
GDP dissociation inhibitor 2,PIR_SUPERFAMILY[630016226$PIRSF019647:GDP dissociation inhibitor XAP-4]
GDP dissociation inhibitor 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein]
GDP dissociation inhibitor 2,UP_SEQ_FEATURE[850056509$chain:Rab GDP dissociation inhibitor beta, 850106258$modified residue, 850117294$sequence conflict]
GRB2-associated binding protein 2,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
GRB2-associated binding protein 2,KEGG_PATHWAY[470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038910$hsa05220:Chronic myeloid leukemia]
GRB2-associated binding protein 2,OMIM_DISEASE[520001954$GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers]
GRB2-associated binding protein 2,SMART[760000205$SM00233:PH]
GRB2-associated binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
GRB2-associated binding protein 2,UP_SEQ_FEATURE[850022390$chain:GRB2-associated-binding protein 2, 850104979$domain:PH, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
GTP cyclohydrolase I feedback regulator,INTERPRO[450008232$IPR009112:GTP cyclohydrolase I, feedback regulatory protein]
GTP cyclohydrolase I feedback regulator,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000919$membrane, 790001065$nucleus]
GTP cyclohydrolase I feedback regulator,UP_SEQ_FEATURE[850022514$chain:GTP cyclohydrolase 1 feedback regulatory protein]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,INTERPRO[450000140$IPR000164:Histone H3, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,PIR_SUPERFAMILY[630002185$PIRSF002051:histone H3]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,SMART[760000374$SM00428:H3]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000015$acetyllysine, 790000315$chromosomal protein, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000950$methylated amino acid, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,UP_SEQ_FEATURE[850024091$chain:Histone H3.3, 850106258$modified residue, 850117294$sequence conflict]
IKAROS family zinc finger 1 (Ikaros),COG_ONTOLOGY[90000073$General function prediction only]
IKAROS family zinc finger 1 (Ikaros),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
IKAROS family zinc finger 1 (Ikaros),OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic]
IKAROS family zinc finger 1 (Ikaros),SMART[760000323$SM00355:ZnF_C2H2]
IKAROS family zinc finger 1 (Ikaros),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
IKAROS family zinc finger 1 (Ikaros),UP_SEQ_FEATURE[850015926$chain:DNA-binding protein Ikaros, 850102576$compositionally biased region:Poly-Leu, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114251$region of interest:Required for binding PP1CC, 850114261$region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization, 850117294$sequence conflict, 850118520$site:Required for both pericentromeric heterochromatin localization and complete DNA binding, 850118521$site:Required for both pericentromeric heterochromatin localization and DNA binding, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),INTERPRO[450000192$IPR000223:Peptidase S26A, signal peptidase I, 450010014$IPR011056:Peptidase S24, S26A, S26B and S26C, beta-ribbon domain, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site, 450017992$IPR019757:Peptidase S26A, signal peptidase I, lysine active site, 450017993$IPR019758:Peptidase S26A, signal peptidase I, conserved site, 450017994$IPR019759:Peptidase S24, S26A and S26B, conserved region]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),PIR_SUPERFAMILY[630001348$PIRSF001208:signal peptidase I]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001252$Protease]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),UP_SEQ_FEATURE[850031973$chain:Mitochondrial inner membrane protease subunit 1]
IQ motif and Sec7 domain 2,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology]
IQ motif and Sec7 domain 2,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
IQ motif and Sec7 domain 2,SMART[760000009$SM00015:IQ, 760000194$SM00222:Sec7, 760000205$SM00233:PH]
IQ motif and Sec7 domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
IQ motif and Sec7 domain 2,UP_SEQ_FEATURE[850026751$chain:IQ motif and SEC7 domain-containing protein 2, 850102540$compositionally biased region:His-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850104439$domain:IQ, 850104979$domain:PH, 850105336$domain:SEC7, 850106258$modified residue, 850118574$splice variant]
KIAA0090,COG_ONTOLOGY[90000070$Function unknown]
KIAA0090,INTERPRO[450010506$IPR011678:Protein of unknown function DUF1620]
KIAA0090,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
KIAA0090,UP_SEQ_FEATURE[850075488$chain:Uncharacterized protein KIAA0090, 850103554$domain:DUF1620, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KIAA0284,INTERPRO[450000219$IPR000253:Forkhead-associated]
KIAA0284,SMART[760000212$SM00240:FHA]
KIAA0284,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000811$isopeptide bond, 790000960$microtubule, 790001162$phosphoprotein, 790001592$ubl conjugation]
KIAA0284,UP_SEQ_FEATURE[850046544$chain:Protein KIAA0284, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
KIAA1128,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like]
KIAA1128,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1128,UP_SEQ_FEATURE[850045936$chain:Protein FAM190B, 850102540$compositionally biased region:His-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1274,SP_PIR_KEYWORDS[790000356$complete proteome, 790000881$lipoprotein, 790001004$myristate, 790001212$polymorphism]
KIAA1274,UP_SEQ_FEATURE[850036738$chain:Paladin, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117295$sequence variant]
KIAA1409,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
KIAA1409,UP_SEQ_FEATURE[850048300$chain:Protein unc-79 homolog, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
KIAA1683,COG_ONTOLOGY[90000053$Cytoskeleton]
KIAA1683,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
KIAA1683,SMART[760000009$SM00015:IQ]
KIAA1683,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
KIAA1683,UP_SEQ_FEATURE[850075562$chain:Uncharacterized protein KIAA1683, 850102605$compositionally biased region:Thr-rich, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850104473$domain:IQ 4, 850104477$domain:IQ 5, 850104478$domain:IQ 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Kruppel-like factor 6,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Kruppel-like factor 6,OMIM_DISEASE[520001968$Gastric cancer, somatic, 520004116$Prostate adenocarcinoma-1, 520004129$Prostate cancer, somatic]
Kruppel-like factor 6,SMART[760000323$SM00355:ZnF_C2H2]
Kruppel-like factor 6,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 6,UP_SEQ_FEATURE[850027611$chain:Krueppel-like factor 6, 850117294$sequence conflict, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
LBXCOR1 homolog (mouse),INTERPRO[450002951$IPR003380:Transforming protein Ski, 450009947$IPR010919:SAND-like, 450013339$IPR014890:c-SKI Smad4 binding]
LBXCOR1 homolog (mouse),OMIM_DISEASE[520002018$Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions]
LBXCOR1 homolog (mouse),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
LBXCOR1 homolog (mouse),UP_SEQ_FEATURE[850027897$chain:Ladybird homeobox corepressor 1, 850118574$splice variant]
LEM domain containing 1,INTERPRO[450003412$IPR003887:Lamino-associated polypeptide 2/emerin]
LEM domain containing 1,SMART[760000480$SM00540:LEM]
LEM domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
LEM domain containing 1,UP_SEQ_FEATURE[850028239$chain:LEM domain-containing protein 1, 850104709$domain:LEM, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
LLP homolog, long-term synaptic facilitation (Aplysia); similar to LLP homolog; similar to hCG2013595,INTERPRO[450017056$IPR018784:Learning associated protein 18-like]
LLP homolog, long-term synaptic facilitation (Aplysia); similar to LLP homolog; similar to hCG2013595,SP_PIR_KEYWORDS[790000356$complete proteome]
LLP homolog, long-term synaptic facilitation (Aplysia); similar to LLP homolog; similar to hCG2013595,UP_SEQ_FEATURE[850046721$chain:Protein LLP homolog, 850102554$compositionally biased region:Lys-rich, 850117294$sequence conflict]
Ly6/neurotoxin 1,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
Ly6/neurotoxin 1,PIR_SUPERFAMILY[630002157$PIRSF002021:Ly-6-like protein]
Ly6/neurotoxin 1,SMART[760000116$SM00134:LU]
Ly6/neurotoxin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal]
Ly6/neurotoxin 1,UP_SEQ_FEATURE[850029207$chain:Ly-6/neurotoxin-like protein 1, 850059126$chain:Secreted Ly-6/uPAR-related protein 2, 850102883$disulfide bond, 850105609$domain:UPAR/Ly6, 850105852$helix, 850105860$lipid moiety-binding region:GPI-anchor amidated glycine, 850109701$propeptide:Removed in mature form, 850117814$signal peptide, 850118575$strand, 850118624$turn]
M-phase phosphoprotein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
M-phase phosphoprotein 9,UP_SEQ_FEATURE[850029453$chain:M-phase phosphoprotein 9, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MACRO domain containing 1,INTERPRO[450002300$IPR002589:Appr-1-p processing]
MACRO domain containing 1,SMART[760000449$SM00506:A1pp]
MACRO domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome]
MACRO domain containing 1,UP_SEQ_FEATURE[850029466$chain:MACRO domain-containing protein 1, 850104739$domain:Macro, 850106258$modified residue, 850117936$site:Breakpoint for translocation to form RUNX1-MACROD1]
MAP7 domain containing 1,INTERPRO[450007865$IPR008604:E-MAP-115]
MAP7 domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
MAP7 domain containing 1,UP_SEQ_FEATURE[850030508$chain:MAP7 domain-containing protein 1, 850102586$compositionally biased region:Pro-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MAS-related GPR, member F,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member F,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member F,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member F,UP_SEQ_FEATURE[850030541$chain:Mas-related G-protein coupled receptor member F, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MLX interacting protein,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
MLX interacting protein,SMART[760000321$SM00353:HLH]
MLX interacting protein,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
MLX interacting protein,UP_SEQ_FEATURE[850032243$chain:MLX-interacting protein, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850113353$region of interest:Mediates heterotypic interactions between MLXIP and MLX and is required for cytoplasmic localization, 850114279$region of interest:Required for cytoplasmic localization, 850114898$region of interest:Transactivation domain, 850117295$sequence variant, 850118574$splice variant]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),COG_ONTOLOGY[90000008$Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),INTERPRO[450001969$IPR002220:Dihydrodipicolinate synthetase, 450012397$IPR013785:Aldolase-type TIM barrel]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase, 790001357$Schiff base]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),UP_SEQ_FEATURE[850000152$active site:Schiff-base intermediate with substrate, 850033220$chain:N-acetylneuraminate lyase, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118380$site:Involved in proton transfer during cleavage, 850118574$splice variant]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,INTERPRO[450006227$IPR006823:Neutral/alkaline nonlysosomal ceramidase]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,KEGG_PATHWAY[470038783$hsa00600:Sphingolipid metabolism]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,PIR_SUPERFAMILY[630007339$PIRSF007540:neutral/alkaline ceramidase]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000873$lipid metabolism, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001428$sphingolipid metabolism, 790001555$transmembrane, 790001592$ubl conjugation]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850034152$chain:Neutral ceramidase, 850034153$chain:Neutral ceramidase soluble form, 850051630$chain:Putative inactive neutral ceramidase B, 850052910$chain:Putative neutral ceramidase C, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106259$mutagenesis site, 850114274$region of interest:Required for correct folding and localization, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
N-terminal asparagine amidase,PIR_SUPERFAMILY[630019060$PIRSF023959:N-terminal asparagine amidohydrolase]
N-terminal asparagine amidase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001212$polymorphism]
N-terminal asparagine amidase,UP_SEQ_FEATURE[850046976$chain:Protein N-terminal asparagine amidohydrolase, 850117295$sequence variant]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,INTERPRO[450008527$IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,PIR_SUPERFAMILY[630014491$PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2, 630014492$PIRSF017834:NADH-UbQ_OxRdtase_b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001555$transmembrane, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,UP_SEQ_FEATURE[850033542$chain:NADH dehydrogenase [ubiquinone] 1 subunit C2, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
NADPH oxidase activator 1,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000235$IPR000270:Octicosapeptide/Phox/Bem1p, 450001282$IPR001440:Tetratricopeptide TPR-1, 450001294$IPR001452:Src homology-3 domain, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
NADPH oxidase activator 1,SMART[760000020$SM00028:TPR, 760000295$SM00326:SH3, 760000579$SM00666:PB1]
NADPH oxidase activator 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001537$tpr repeat]
NADPH oxidase activator 1,UP_SEQ_FEATURE[850033705$chain:NADPH oxidase activator 1, 850104868$domain:OPR, 850105350$domain:SH3, 850106258$modified residue, 850106259$mutagenesis site, 850113380$region of interest:Mediates interaction with RAC1, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NIMA (never in mitosis gene a)-related kinase 4,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
NIMA (never in mitosis gene a)-related kinase 4,SMART[760000193$SM00220:S_TKc]
NIMA (never in mitosis gene a)-related kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
NIMA (never in mitosis gene a)-related kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059871$chain:Serine/threonine-protein kinase Nek4, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NmrA-like family domain containing 1,INTERPRO[450007368$IPR008030:NmrA-like, 450014426$IPR016040:NAD(P)-binding domain]
NmrA-like family domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790001065$nucleus, 790001212$polymorphism]
NmrA-like family domain containing 1,UP_SEQ_FEATURE[850000461$binding site:NADP, 850000462$binding site:NADP; shared with dimeric partner, 850034468$chain:NmrA-like family domain-containing protein 1, 850102883$disulfide bond, 850105852$helix, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850112101$region of interest:Interaction with ASS1, 850117295$sequence variant, 850118575$strand, 850118624$turn]
OTU domain containing 3,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain]
OTU domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
OTU domain containing 3,UP_SEQ_FEATURE[850036298$chain:OTU domain-containing protein 3, 850104870$domain:OTU, 850106258$modified residue, 850117295$sequence variant]
OTU domain containing 7B,INTERPRO[450002353$IPR002653:Zinc finger, A20-type, 450002899$IPR003323:Ovarian tumour, otubain]
OTU domain containing 7B,SMART[760000231$SM00259:ZnF_A20]
OTU domain containing 7B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
OTU domain containing 7B,UP_SEQ_FEATURE[850036306$chain:OTU domain-containing protein 7B, 850104870$domain:OTU, 850106258$modified residue, 850106259$mutagenesis site, 850111190$region of interest:Catalytic, 850114894$region of interest:TRAF-binding, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118625$zinc finger region:A20-type]
OTU domain, ubiquitin aldehyde binding 2,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450014937$IPR016615:Ubiquitin thioesterase Otubain, 450017638$IPR019400:Peptidase C65, otubain]
OTU domain, ubiquitin aldehyde binding 2,PIR_SUPERFAMILY[630011258$PIRSF013503:ubiquitin thioesterase Otubain, 630011259$PIRSF013503:Ubiquitin_thioesterase_Otubain]
OTU domain, ubiquitin aldehyde binding 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
OTU domain, ubiquitin aldehyde binding 2,UP_SEQ_FEATURE[850068042$chain:Ubiquitin thioesterase OTUB2, 850104870$domain:OTU, 850105852$helix, 850106259$mutagenesis site, 850118547$site:Required to orient and stabilize the active site H-224, 850118574$splice variant, 850118575$strand]
PCTAIRE protein kinase 3,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450009944$IPR010916:TonB box, conserved site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
PCTAIRE protein kinase 3,SMART[760000193$SM00220:S_TKc]
PCTAIRE protein kinase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
PCTAIRE protein kinase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010438$chain:Cell division protein kinase 18, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PDZ domain containing 7,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
PDZ domain containing 7,SMART[760000200$SM00228:PDZ]
PDZ domain containing 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
PDZ domain containing 7,UP_SEQ_FEATURE[850036987$chain:PDZ domain-containing protein 7, 850102597$compositionally biased region:Ser-rich, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
PDZ domain containing 8,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding]
PDZ domain containing 8,SMART[760000096$SM00109:C1, 760000200$SM00228:PDZ]
PDZ domain containing 8,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
PDZ domain containing 8,UP_SEQ_FEATURE[850036988$chain:PDZ domain-containing protein 8, 850102586$compositionally biased region:Pro-rich, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
POU class 3 homeobox 1,INTERPRO[450000280$IPR000327:POU-specific, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450016278$IPR017970:Homeobox, conserved site]
POU class 3 homeobox 1,PIR_SUPERFAMILY[630002737$PIRSF002629:POU domain class 3 transcription factor, brain type]
POU class 3 homeobox 1,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 3 homeobox 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
POU class 3 homeobox 1,UP_SEQ_FEATURE[850040239$chain:POU domain, class 3, transcription factor 1, 850102378$compositionally biased region:Ala-rich, 850102517$compositionally biased region:Gly-rich, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850117294$sequence conflict]
POU class 5 homeobox 1B,INTERPRO[450000280$IPR000327:POU-specific, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450014024$IPR015585:POU domain class 5, 450016278$IPR017970:Homeobox, conserved site]
POU class 5 homeobox 1B,PIR_SUPERFAMILY[630002736$PIRSF002628:transcription factor Oct-3]
POU class 5 homeobox 1B,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 5 homeobox 1B,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
POU class 5 homeobox 1B,UP_SEQ_FEATURE[850053794$chain:Putative POU domain, class 5, transcription factor 1B, 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850117294$sequence conflict]
PQ loop repeat containing 2,INTERPRO[450006023$IPR006603:Cystinosin/ERS1p repeat]
PQ loop repeat containing 2,SMART[760000590$SM00679:CTNS]
PQ loop repeat containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
PQ loop repeat containing 2,UP_SEQ_FEATURE[850040281$chain:PQ-loop repeat-containing protein 2, 850105069$domain:PQ-loop 1, 850105070$domain:PQ-loop 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
PR domain containing 11,INTERPRO[450001068$IPR001214:SET]
PR domain containing 11,SMART[760000286$SM00317:SET]
PR domain containing 11,SP_PIR_KEYWORDS[790000356$complete proteome]
PR domain containing 11,UP_SEQ_FEATURE[850040296$chain:PR domain-containing protein 11, 850105340$domain:SET]
PR domain containing 2, with ZNF domain,INTERPRO[450001068$IPR001214:SET, 450006475$IPR007087:Zinc finger, C2H2-type, 450008289$IPR009170:Predicted retinoblastoma binding protein (RIZ), 450014303$IPR015880:Zinc finger, C2H2-like]
PR domain containing 2, with ZNF domain,PIR_SUPERFAMILY[630002513$PIRSF002395:retinoblastoma binding protein (RIZ), 630002514$PIRSF002395:RIZ_SET]
PR domain containing 2, with ZNF domain,SMART[760000286$SM00317:SET, 760000323$SM00355:ZnF_C2H2]
PR domain containing 2, with ZNF domain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
PR domain containing 2, with ZNF domain,UP_SEQ_FEATURE[850040292$chain:PR domain zinc finger protein 2, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850105340$domain:SET, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114517$region of interest:Retinoblastoma protein binding, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118732$zinc finger region:C2H2-type 7; atypical, 850118735$zinc finger region:C2H2-type 8; atypical]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),INTERPRO[450002202$IPR002483:Splicing factor PWI, 450012478$IPR013881:Pre-mRNA-splicing factor 3]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),OMIM_DISEASE[520004290$Retinitis pigmentosa-18]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),SMART[760000281$SM00311:PWI]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001316$retinitis pigmentosa, 790001377$sensory transduction, 790001433$Spliceosome, 790001622$vision]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),UP_SEQ_FEATURE[850067859$chain:U4/U6 small nuclear ribonucleoprotein PRP3, 850102585$compositionally biased region:Poly-Val, 850105125$domain:PWI, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
PTK2B protein tyrosine kinase 2 beta,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis, 30000027$h_At1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling, 30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000052$h_Ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage, 30000077$h_cxcr4Pathway:CXCR4 Signaling Pathway, 30000133$h_HBxPathway:Calcium Signaling by HBx of Hepatitis B virus, 30000161$h_il7Pathway:IL-7 Signal Transduction, 30000166$h_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway, 30000186$h_metPathway:Signaling of Hepatocyte Growth Factor Receptor, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity, 30000218$h_Par1Pathway:Thrombin signaling and protease-activated receptors, 30000244$h_pyk2Pathway:Links between Pyk2 and Map Kinases]
PTK2B protein tyrosine kinase 2 beta,INTERPRO[450000257$IPR000299:FERM domain, 450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450004653$IPR005189:Focal adhesion targeting region, 450007559$IPR008266:Tyrosine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
PTK2B protein tyrosine kinase 2 beta,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038873$hsa04670:Leukocyte transendothelial migration, 470038883$hsa04912:GnRH signaling pathway]
PTK2B protein tyrosine kinase 2 beta,SMART[760000192$SM00219:TyrKc, 760000266$SM00295:B41]
PTK2B protein tyrosine kinase 2 beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase, 790001586$tyrosine-protein kinase]
PTK2B protein tyrosine kinase 2 beta,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850048623$chain:Protein-tyrosine kinase 2-beta, 850102586$compositionally biased region:Pro-rich, 850103760$domain:FERM, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850111692$region of interest:Focal adhesion targeting (FAT), 850112919$region of interest:Interaction with TGFB1I1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
Purkinje cell protein 2,INTERPRO[450002733$IPR003109:GoLoco motif]
Purkinje cell protein 2,SMART[760000342$SM00390:GoLoco]
Purkinje cell protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001304$repeat]
Purkinje cell protein 2,UP_SEQ_FEATURE[850048972$chain:Purkinje cell protein 2 homolog, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2]
Putative PRAME family member 24; PRAME family member 8,PIR_SUPERFAMILY[630029880$PIRSF038286:preferentially expressed antigen of melanoma (PRAME) family protein]
Putative PRAME family member 24; PRAME family member 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat]
Putative PRAME family member 24; PRAME family member 8,UP_SEQ_FEATURE[850040344$chain:PRAME family member 8, 850053795$chain:Putative PRAME family member 24, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3]
RAB25, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014034$IPR015595:Rab11-related]
RAB25, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB25, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB25, member RAS oncogene family,UP_SEQ_FEATURE[850056775$chain:Ras-related protein Rab-25, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB40C, member RAS oncogene family,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB40C, member RAS oncogene family,OMIM_DISEASE[520002597$Identification of ten loci associated with height highlights new biological pathways in human growth]
RAB40C, member RAS oncogene family,PIR_SUPERFAMILY[630029084$PIRSF037502:Ras-related protein Rab-40]
RAB40C, member RAS oncogene family,SMART[760000149$SM00175:RAB, 760000225$SM00253:SOCS]
RAB40C, member RAS oncogene family,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001100$palmitate, 790001236$prenylation, 790001593$ubl conjugation pathway]
RAB40C, member RAS oncogene family,UP_SEQ_FEATURE[850056803$chain:Ras-related protein Rab-40C, 850105375$domain:SOCS box, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP]
RAB42, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450012373$IPR013753:Ras]
RAB42, member RAS oncogene family,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
RAB42, member RAS oncogene family,UP_SEQ_FEATURE[850054008$chain:Putative Ras-related protein Rab-42, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP]
RAS-like, family 12,INTERPRO[450001599$IPR001806:Ras GTPase, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAS-like, family 12,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding]
RAS-like, family 12,UP_SEQ_FEATURE[850056732$chain:Ras-like protein family member 12, 850105852$helix, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand]
REST corepressor 1,INTERPRO[450000828$IPR000949:ELM2, 450000876$IPR001005:SANT, DNA-binding, 450013228$IPR014778:Myb, DNA-binding, 450016201$IPR017884:SANT, eukarya]
REST corepressor 1,KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
REST corepressor 1,SMART[760000623$SM00717:SANT]
REST corepressor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
REST corepressor 1,UP_SEQ_FEATURE[850057312$chain:REST corepressor 1, 850102378$compositionally biased region:Ala-rich, 850103712$domain:ELM2, 850105255$domain:SANT 1, 850105256$domain:SANT 2, 850105852$helix, 850106258$modified residue, 850112389$region of interest:Interaction with HDAC1, 850112495$region of interest:Interaction with LSD1, 850118624$turn]
RNA binding motif protein 17,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450003478$IPR003954:RNA recognition, region 1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450015287$IPR016967:Splicing factor, SPF45]
RNA binding motif protein 17,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
RNA binding motif protein 17,PIR_SUPERFAMILY[630023617$PIRSF031066:splicing factor, SPF45 type, 630023618$PIRSF031066:Splicing_factor_SPF45]
RNA binding motif protein 17,SMART[760000328$SM00360:RRM, 760000329$SM00361:RRM_1, 760000389$SM00443:G_patch]
RNA binding motif protein 17,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001433$Spliceosome]
RNA binding motif protein 17,UP_SEQ_FEATURE[850062049$chain:Splicing factor 45, 850104022$domain:G-patch, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
RNA binding motif protein 19,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
RNA binding motif protein 19,SMART[760000328$SM00360:RRM]
RNA binding motif protein 19,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
RNA binding motif protein 19,UP_SEQ_FEATURE[850043647$chain:Probable RNA-binding protein 19, 850102572$compositionally biased region:Poly-Glu, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105216$domain:RRM 4, 850105217$domain:RRM 5, 850105218$domain:RRM 6, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
RNA binding motif protein 34,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
RNA binding motif protein 34,SMART[760000328$SM00360:RRM]
RNA binding motif protein 34,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
RNA binding motif protein 34,UP_SEQ_FEATURE[850058486$chain:RNA-binding protein 34, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
RNA binding motif protein 6,COG_ONTOLOGY[90000070$Function unknown]
RNA binding motif protein 6,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014303$IPR015880:Zinc finger, C2H2-like]
RNA binding motif protein 6,SMART[760000323$SM00355:ZnF_C2H2, 760000328$SM00360:RRM, 760000389$SM00443:G_patch]
RNA binding motif protein 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
RNA binding motif protein 6,UP_SEQ_FEATURE[850058503$chain:RNA-binding protein 6, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850104022$domain:G-patch, 850105211$domain:RRM, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
Rab interacting lysosomal protein-like 1,INTERPRO[450017389$IPR019143:JNK/Rab-associated protein-1]
Rab interacting lysosomal protein-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
Rab interacting lysosomal protein-like 1,UP_SEQ_FEATURE[850058153$chain:RILP-like protein 1, 850105198$domain:RILP-like, 850106258$modified residue, 850118574$splice variant]
Rh blood group, CcEe antigens,INTERPRO[450001687$IPR001905:Ammonium transporter, 450001976$IPR002229:Blood group Rhesus C/E and D polypeptide]
Rh blood group, CcEe antigens,OMIM_DISEASE[520000615$Blood group, Rhesus, 520004327$Rh-null disease, amorph type]
Rh blood group, CcEe antigens,PIR_SUPERFAMILY[630014625$PIRSF017968:erythrocyte membrane protein RhD]
Rh blood group, CcEe antigens,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000194$blood group antigen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000512$erythrocyte, 790000919$membrane, 790001212$polymorphism, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
Rh blood group, CcEe antigens,UP_SEQ_FEATURE[850008177$chain:Blood group Rh(CE) polypeptide, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
Rho-related BTB domain containing 1,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450012373$IPR013753:Ras]
Rho-related BTB domain containing 1,PIR_SUPERFAMILY[630030010$PIRSF038482:Rho-related BTB domain-containing protein]
Rho-related BTB domain containing 1,SMART[760000148$SM00174:RHO, 760000197$SM00225:BTB]
Rho-related BTB domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001304$repeat]
Rho-related BTB domain containing 1,UP_SEQ_FEATURE[850057593$chain:Rho-related BTB domain-containing protein 1, 850103178$domain:BTB 1, 850103179$domain:BTB 2, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850114526$region of interest:Rho-like]
S100 calcium binding protein A16,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A16,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
S100 calcium binding protein A16,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047559$chain:Protein S100-A16, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue]
S100 calcium binding protein A6,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A6,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000480$EF hand, 790000635$growth regulation, 790000919$membrane, 790000937$metal-binding, 790000972$mitogen, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat]
S100 calcium binding protein A6,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850047564$chain:Protein S100-A6, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SAFB-like, transcription modulator,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450002665$IPR003034:DNA-binding SAP, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
SAFB-like, transcription modulator,SMART[760000328$SM00360:RRM, 760000456$SM00513:SAP]
SAFB-like, transcription modulator,SP_PIR_KEYWORDS[790000012$acetylation, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation]
SAFB-like, transcription modulator,UP_SEQ_FEATURE[850058821$chain:SAFB-like transcription modulator, 850102415$compositionally biased region:Arg/Glu-rich, 850102507$compositionally biased region:Glu-rich, 850105211$domain:RRM, 850105257$domain:SAP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
SCAN domain containing 2 pseudogene,INTERPRO[450002887$IPR003309:Transcriptional regulator SCAN]
SCAN domain containing 2 pseudogene,SMART[760000377$SM00431:SCAN]
SCAN domain containing 2 pseudogene,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
SCAN domain containing 2 pseudogene,UP_SEQ_FEATURE[850058938$chain:SCAN domain-containing protein 2, 850102378$compositionally biased region:Ala-rich, 850102404$compositionally biased region:Arg-rich, 850105271$domain:SCAN box, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SEC11 homolog A (S. cerevisiae),INTERPRO[450001536$IPR001733:Peptidase S26B, eukaryotic signal peptidase, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site, 450017993$IPR019758:Peptidase S26A, signal peptidase I, conserved site, 450017994$IPR019759:Peptidase S24, S26A and S26B, conserved region]
SEC11 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630001349$PIRSF001209:signal peptidase SEC11]
SEC11 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790000959$microsome, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane]
SEC11 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850060748$chain:Signal peptidase complex catalytic subunit SEC11A, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
SEC14-like 3 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 3 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
SEC14-like 3 (S. cerevisiae),UP_SEQ_FEATURE[850059083$chain:SEC14-like protein 3, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850117295$sequence variant]
SEC23 interacting protein,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450003687$IPR004177:DDHD]
SEC23 interacting protein,SMART[760000399$SM00454:SAM]
SEC23 interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
SEC23 interacting protein,UP_SEQ_FEATURE[850059086$chain:SEC23-interacting protein, 850102586$compositionally biased region:Pro-rich, 850103504$domain:DDHD, 850105249$domain:SAM, 850106258$modified residue, 850112814$region of interest:Interaction with SEC23A, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SEC24 family, member C (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
SEC24 family, member C (S. cerevisiae),INTERPRO[450006295$IPR006895:Zinc finger, Sec23/Sec24-type, 450006296$IPR006896:Sec23/Sec24 trunk region, 450006300$IPR006900:Sec23/Sec24 helical region, 450006497$IPR007123:Gelsolin region, 450011666$IPR012990:Sec23/Sec24 beta-sandwich]
SEC24 family, member C (S. cerevisiae),PIR_SUPERFAMILY[630013991$PIRSF017225:vesicle coat complex COPII, subunit SEC24]
SEC24 family, member C (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
SEC24 family, member C (S. cerevisiae),UP_SEQ_FEATURE[850048117$chain:Protein transport protein Sec24C, 850105852$helix, 850106258$modified residue, 850115067$region of interest:Zinc finger-like, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SET domain containing 2,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450001068$IPR001214:SET, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450013566$IPR015119:Set2-Rpb1 interacting]
SET domain containing 2,KEGG_PATHWAY[470038751$hsa00310:Lysine degradation]
SET domain containing 2,SMART[760000286$SM00317:SET, 760000401$SM00456:WW, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
SET domain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000953$methylation, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
SET domain containing 2,UP_SEQ_FEATURE[850024164$chain:Histone-lysine N-methyltransferase SETD2, 850102404$compositionally biased region:Arg-rich, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850103074$domain:AWS, 850105053$domain:Post-SET, 850105340$domain:SET, 850105731$domain:WW, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112689$region of interest:Interaction with POLR2A, 850113304$region of interest:Low charge region, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450006446$IPR007052:CS domain, 450007054$IPR007699:SGS, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450015774$IPR017447:CS, 450017972$IPR019734:Tetratricopeptide repeat]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),PIR_SUPERFAMILY[630028306$PIRSF036827:PIRSF036827]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SMART[760000020$SM00028:TPR]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),UP_SEQ_FEATURE[850062991$chain:Suppressor of G2 allele of SKP1 homolog, 850103417$domain:CS, 850105345$domain:SGS, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
SH2 domain containing 1B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 1B,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
SH2 domain containing 1B,PIR_SUPERFAMILY[630029284$PIRSF037711:SH2 domain protein 1B]
SH2 domain containing 1B,SMART[760000224$SM00252:SH2]
SH2 domain containing 1B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 1B,UP_SEQ_FEATURE[850060510$chain:SH2 domain-containing protein 1B, 850105346$domain:SH2, 850117295$sequence variant, 850118574$splice variant]
SH2 domain containing 4B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 4B,SMART[760000224$SM00252:SH2]
SH2 domain containing 4B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 4B,UP_SEQ_FEATURE[850060515$chain:SH2 domain-containing protein 4B, 850102507$compositionally biased region:Glu-rich, 850105346$domain:SH2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SH2B adaptor protein 3,INTERPRO[450000852$IPR000980:SH2 motif, 450001635$IPR001849:Pleckstrin homology, 450013461$IPR015012:Phenylalanine zipper]
SH2B adaptor protein 3,KEGG_PATHWAY[470038877$hsa04722:Neurotrophin signaling pathway]
SH2B adaptor protein 3,OMIM_DISEASE[520000886$Celiac disease, susceptiblity to, 13, 520001490$Diabetes mellitus, insulin-dependent, susceptibility to, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
SH2B adaptor protein 3,SMART[760000205$SM00233:PH, 760000224$SM00252:SH2]
SH2B adaptor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000430$diabetes mellitus, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain]
SH2B adaptor protein 3,UP_SEQ_FEATURE[850060521$chain:SH2B adapter protein 3, 850104979$domain:PH, 850105346$domain:SH2, 850117294$sequence conflict, 850117295$sequence variant]
SLIT-ROBO Rho GTPase activating protein 1,INTERPRO[450000169$IPR000198:RhoGAP, 450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain]
SLIT-ROBO Rho GTPase activating protein 1,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
SLIT-ROBO Rho GTPase activating protein 1,SMART[760000047$SM00055:FCH, 760000293$SM00324:RhoGAP, 760000295$SM00326:SH3]
SLIT-ROBO Rho GTPase activating protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001398$sh3 domain]
SLIT-ROBO Rho GTPase activating protein 1,UP_SEQ_FEATURE[850060966$chain:SLIT-ROBO Rho GTPase-activating protein 1, 850102566$compositionally biased region:Poly-Arg, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850103755$domain:FCH, 850105183$domain:Rho-GAP, 850105350$domain:SH3, 850106258$modified residue, 850118574$splice variant]
SNW domain containing 1,BIOCARTA[30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SNW domain containing 1,INTERPRO[450003535$IPR004015:SKI-interacting protein SKIP, SNW domain, 450016181$IPR017862:SKI-interacting protein, SKIP]
SNW domain containing 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome, 470038848$hsa04330:Notch signaling pathway]
SNW domain containing 1,PIR_SUPERFAMILY[630012767$PIRSF015989:Caenorhabditis elegans hypothetical protein T27F2.1]
SNW domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001433$Spliceosome]
SNW domain containing 1,UP_SEQ_FEATURE[850061161$chain:SNW domain-containing protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850114680$region of interest:SNW]
SP140 nuclear body protein,INTERPRO[450000665$IPR000770:SAND, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450004339$IPR004865:Sp100, 450009947$IPR010919:SAND-like, 450016644$IPR018359:Bromodomain, conserved site, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
SP140 nuclear body protein,OMIM_DISEASE[520000061$A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia]
SP140 nuclear body protein,SMART[760000221$SM00249:PHD, 760000230$SM00258:SAND, 760000267$SM00297:BROMO]
SP140 nuclear body protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000206$bromodomain, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
SP140 nuclear body protein,UP_SEQ_FEATURE[850034810$chain:Nuclear body protein SP140, 850102584$compositionally biased region:Poly-Tyr, 850103166$domain:Bromo, 850104153$domain:HSR, 850105253$domain:SAND, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118877$zinc finger region:PHD-type]
SPARC related modular calcium binding 2,INTERPRO[450000615$IPR000716:Thyroglobulin type-1, 450001814$IPR002048:Calcium-binding EF-hand, 450002091$IPR002350:Proteinase inhibitor I1, Kazal, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2, 450017814$IPR019577:SPARC/Testican, calcium-binding domain]
SPARC related modular calcium binding 2,SMART[760000046$SM00054:EFh, 760000184$SM00211:TY, 760000251$SM00280:KAZAL]
SPARC related modular calcium binding 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790001304$repeat, 790001363$Secreted, 790001405$signal]
SPARC related modular calcium binding 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850061581$chain:SPARC-related modular calcium-binding protein 2, 850102883$disulfide bond, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850104500$domain:Kazal-like, 850105486$domain:Thyroglobulin type-1 1, 850105489$domain:Thyroglobulin type-1 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
SRY (sex determining region Y)-box 9,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 9,OMIM_DISEASE[520000092$Acampomelic campomelic dysplasia, 520000736$Campomelic dysplasia, 520000737$Campomelic dysplasia with autosomal sex reversal]
SRY (sex determining region Y)-box 9,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 9,UP_SEQ_FEATURE[850065337$chain:Transcription factor SOX-9, 850102501$compositionally biased region:Gln/Pro-rich, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box, 850105852$helix, 850117295$sequence variant, 850118575$strand]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),INTERPRO[450005562$IPR006130:Aspartate/ornithine carbamoyltransferase, 450006215$IPR006811:RNA polymerase II subunit A]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),PIR_SUPERFAMILY[630014444$PIRSF017782:RNA polymerase II subunit A C-terminal domain phosphatase SSU72]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000988$mrna processing, 790001065$nucleus, 790001261$protein phosphatase]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),UP_SEQ_FEATURE[850058370$chain:RNA polymerase II subunit A C-terminal domain phosphatase SSU72, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
STE20-like kinase (yeast),INTERPRO[450000618$IPR000719:Protein kinase, core, 450001719$IPR001943:UvrB/UvrC protein, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
STE20-like kinase (yeast),KEGG_PATHWAY[470038835$hsa04114:Oocyte meiosis]
STE20-like kinase (yeast),SMART[760000193$SM00220:S_TKc]
STE20-like kinase (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
STE20-like kinase (yeast),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850062406$chain:STE20-like serine/threonine-protein kinase, 850102507$compositionally biased region:Glu-rich, 850102577$compositionally biased region:Poly-Lys, 850105086$domain:Protein kinase, 850105615$domain:UVR, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118020$site:Cleavage; by caspase-3, 850118574$splice variant, 850118575$strand, 850118624$turn]
SUMO1/sentrin specific peptidase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
SUMO1/sentrin specific peptidase 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850059421$chain:Sentrin-specific protease 1, 850102540$compositionally biased region:His-rich, 850102597$compositionally biased region:Ser-rich, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114140$region of interest:Protease, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
SWAP switching B-cell complex 70kDa subunit,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
SWAP switching B-cell complex 70kDa subunit,SMART[760000205$SM00233:PH]
SWAP switching B-cell complex 70kDa subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
SWAP switching B-cell complex 70kDa subunit,UP_SEQ_FEATURE[850063139$chain:Switch-associated protein 70, 850102577$compositionally biased region:Poly-Lys, 850104979$domain:PH, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
Sec61 alpha 2 subunit (S. cerevisiae),INTERPRO[450001958$IPR002208:SecY protein, 450017798$IPR019561:Translocon Sec61/SecY, plug domain]
Sec61 alpha 2 subunit (S. cerevisiae),KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
Sec61 alpha 2 subunit (S. cerevisiae),PIR_SUPERFAMILY[630004530$PIRSF004557:preprotein translocase Sec, SecY/Sec61-alpha subunit, 630004531$PIRSF004557:SecY]
Sec61 alpha 2 subunit (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001266$protein transport, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
Sec61 alpha 2 subunit (S. cerevisiae),UP_SEQ_FEATURE[850048128$chain:Protein transport protein Sec61 subunit alpha isoform 2, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
StAR-related lipid transfer (START) domain containing 6,INTERPRO[450002572$IPR002913:Lipid-binding START]
StAR-related lipid transfer (START) domain containing 6,SMART[760000206$SM00234:START]
StAR-related lipid transfer (START) domain containing 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000875$lipid transport, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
StAR-related lipid transfer (START) domain containing 6,UP_SEQ_FEATURE[850062384$chain:StAR-related lipid transfer protein 6, 850105403$domain:START, 850117295$sequence variant]
StAR-related lipid transfer (START) domain containing 9,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450002572$IPR002913:Lipid-binding START, 450018052$IPR019821:Kinesin, motor region, conserved site]
StAR-related lipid transfer (START) domain containing 9,SMART[760000111$SM00129:KISc, 760000206$SM00234:START]
StAR-related lipid transfer (START) domain containing 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000986$motor protein, 790001063$nucleotide-binding, 790001212$polymorphism]
StAR-related lipid transfer (START) domain containing 9,UP_SEQ_FEATURE[850062387$chain:StAR-related lipid transfer protein 9, 850102485$compositionally biased region:Gln-rich, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850103775$domain:FHA, 850104543$domain:Kinesin-motor, 850105403$domain:START, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,INTERPRO[450002837$IPR003228:Transcription initiation factor TFIID, 450008207$IPR009072:Histone-fold]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,UP_SEQ_FEATURE[850065451$chain:Transcription initiation factor TFIID subunit 12, 850105852$helix, 850106258$modified residue, 850118574$splice variant]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450005985$IPR006565:Bromodomain transcription factor, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,SMART[760000221$SM00249:PHD, 760000513$SM00576:BTP]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,UP_SEQ_FEATURE[850065455$chain:Transcription initiation factor TFIID subunit 3, 850102554$compositionally biased region:Lys-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118877$zinc finger region:PHD-type]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,COG_ONTOLOGY[90000115$Transcription]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,INTERPRO[450004306$IPR004823:TATA box binding protein associated factor (TAF), 450008207$IPR009072:Histone-fold, 450010308$IPR011442:Protein of unknown function DUF1546]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,SMART[760000706$SM00803:TAF]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,UP_SEQ_FEATURE[850063463$chain:TAF6-like RNA polymerase II p300/CBP- associated factor-associated factor 65 kDa subunit 6L, 850106258$modified residue]
TAP binding protein-like,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450007393$IPR008056:Tapasin, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
TAP binding protein-like,SMART[760000355$SM00407:IGc1, 760000357$SM00409:IG]
TAP binding protein-like,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000768$Immunoglobulin domain, 790000919$membrane, 790000959$microsome, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
TAP binding protein-like,UP_SEQ_FEATURE[850063523$chain:Tapasin-related protein, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850104407$domain:Ig-like V-type, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001271$Proto-oncogene]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,UP_SEQ_FEATURE[850063671$chain:TBC1 domain family member 3, 850063672$chain:TBC1 domain family member 3-like protein LOC729837, 850063674$chain:TBC1 domain family member 3B/I, 850063675$chain:TBC1 domain family member 3C/3D, 850063676$chain:TBC1 domain family member 3G, 850105135$domain:Rab-GAP TBC, 850117294$sequence conflict]
TBC1 domain family, member 4,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
TBC1 domain family, member 4,SMART[760000143$SM00164:TBC, 760000407$SM00462:PTB]
TBC1 domain family, member 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
TBC1 domain family, member 4,UP_SEQ_FEATURE[850063677$chain:TBC1 domain family member 4, 850102597$compositionally biased region:Ser-rich, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TBC1 domain family, member 7,COG_ONTOLOGY[90000073$General function prediction only]
TBC1 domain family, member 7,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 7,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
TBC1 domain family, member 7,UP_SEQ_FEATURE[850063679$chain:TBC1 domain family member 7, 850105135$domain:Rab-GAP TBC, 850117295$sequence variant]
TERF1 (TRF1)-interacting nuclear factor 2,OMIM_DISEASE[520001589$Dyskeratosis congenita, autosomal dominant, 520004324$Revesz syndrome]
TERF1 (TRF1)-interacting nuclear factor 2,PIR_SUPERFAMILY[630030271$PIRSF038821:TERF1-interacting nuclear factor 2 (TINF2)]
TERF1 (TRF1)-interacting nuclear factor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000315$chromosomal protein, 790000356$complete proteome, 790000446$disease mutation, 790000476$dyskeratosis congenita, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere]
TERF1 (TRF1)-interacting nuclear factor 2,UP_SEQ_FEATURE[850063842$chain:TERF1-interacting nuclear factor 2, 850106258$modified residue, 850114863$region of interest:TERF1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
THO complex 5,INTERPRO[450017409$IPR019163:THO complex,  subunit 5]
THO complex 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001558$transport]
THO complex 5,UP_SEQ_FEATURE[850064317$chain:THO complex subunit 5 homolog, 850106258$modified residue, 850112220$region of interest:Interaction with CSF1R, 850112946$region of interest:Interaction with THOC7, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,BIOCARTA[30000314$h_WNVpathway:West Nile Virus]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,COG_ONTOLOGY[90000073$General function prediction only]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SMART[760000328$SM00360:RRM]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,UP_SEQ_FEATURE[850035207$chain:Nucleolysin TIAR, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
TIMELESS interacting protein,INTERPRO[450011599$IPR012923:Replication fork protection component Swi3]
TIMELESS interacting protein,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
TIMELESS interacting protein,UP_SEQ_FEATURE[850064497$chain:TIMELESS-interacting protein, 850106258$modified residue, 850112949$region of interest:Interaction with TIMELESS, 850117294$sequence conflict, 850117295$sequence variant]
TRAF-type zinc finger domain containing 1,INTERPRO[450014303$IPR015880:Zinc finger, C2H2-like]
TRAF-type zinc finger domain containing 1,OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
TRAF-type zinc finger domain containing 1,SMART[760000323$SM00355:ZnF_C2H2]
TRAF-type zinc finger domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
TRAF-type zinc finger domain containing 1,UP_SEQ_FEATURE[850064872$chain:TRAF-type zinc finger domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118936$zinc finger region:TRAF-type]
TRAF3 interacting protein 2,INTERPRO[450012192$IPR013568:SEFIR]
TRAF3 interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
TRAF3 interacting protein 2,UP_SEQ_FEATURE[850003830$chain:Adapter protein CIKS, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),COG_ONTOLOGY[90000073$General function prediction only]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),INTERPRO[450002972$IPR003402:Protein of unknown function Met10]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000954$methyltransferase, 790001212$polymorphism, 790001547$transferase, 790001572$trna processing]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),UP_SEQ_FEATURE[850066727$chain:tRNA (guanine-N(1)-)-methyltransferase, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
TatD DNase domain containing 1,INTERPRO[450000991$IPR001130:Deoxyribonuclease, TatD-related, 450010991$IPR012278:Deoxyribonuclease, TatD Mg-dependent, 450014394$IPR015992:Deoxyribonuclease, TatD, 450016513$IPR018228:Deoxyribonuclease, TatD-related, conserved site]
TatD DNase domain containing 1,PIR_SUPERFAMILY[630005834$PIRSF005902:DNase_TatD, 630005835$PIRSF005902:Mg-dependent DNase, TatD type]
TatD DNase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus]
TatD DNase domain containing 1,UP_SEQ_FEATURE[850050480$chain:Putative deoxyribonuclease TATDN1, 850117294$sequence conflict, 850118574$splice variant]
Tctex1 domain containing 2,INTERPRO[450004797$IPR005334:Tctex-1]
Tctex1 domain containing 2,PIR_SUPERFAMILY[630012582$PIRSF015816:dynein light chain, Tctex-type]
Tctex1 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome]
Tctex1 domain containing 2,UP_SEQ_FEATURE[850063698$chain:Tctex1 domain-containing protein 2, 850117294$sequence conflict]
Thy-1 cell surface antigen,BIOCARTA[30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules]
Thy-1 cell surface antigen,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin]
Thy-1 cell surface antigen,KEGG_PATHWAY[470038873$hsa04670:Leukocyte transendothelial migration]
Thy-1 cell surface antigen,PIR_SUPERFAMILY[630030239$PIRSF038777:Thy-1 membrane glycoprotein]
Thy-1 cell surface antigen,SMART[760000357$SM00409:IG]
Thy-1 cell surface antigen,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001291$Pyrrolidone carboxylic acid, 790001405$signal, 790001520$thymocyte, 790001556$transmembrane protein]
Thy-1 cell surface antigen,UP_SEQ_FEATURE[850064408$chain:Thy-1 membrane glycoprotein, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105859$lipid moiety-binding region:GPI-anchor amidated cysteine, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117814$signal peptide]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),PIR_SUPERFAMILY[630005598$PIRSF005670:polypeptide N-acetylgalactosaminyltransferase]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),UP_SEQ_FEATURE[850039925$chain:Polypeptide N- acetylgalactosaminyltransferase 2, 850039926$chain:Polypeptide N- acetylgalactosaminyltransferase 2 soluble form, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105852$helix, 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118450$site:Not glycosylated, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),COG_ONTOLOGY[90000032$Cell envelope biogenesis, outer membrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),PIR_SUPERFAMILY[630005598$PIRSF005670:polypeptide N-acetylgalactosaminyltransferase]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),UP_SEQ_FEATURE[850039931$chain:Polypeptide N- acetylgalactosaminyltransferase 6, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),UP_SEQ_FEATURE[850043291$chain:Probable polypeptide N- acetylgalactosaminyltransferase 8, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UEV and lactate/malate dehyrogenase domains,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450001087$IPR001236:Lactate/malate dehydrogenase, 450001383$IPR001557:L-lactate/malate dehydrogenase, 450008125$IPR008883:Tumour susceptibility gene 101, 450014366$IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal, 450014426$IPR016040:NAD(P)-binding domain, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
UEV and lactate/malate dehyrogenase domains,PIR_SUPERFAMILY[630000119$PIRSF000102:Lac_mal_DH]
UEV and lactate/malate dehyrogenase domains,SMART[760000185$SM00212:UBCc]
UEV and lactate/malate dehyrogenase domains,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001006$nad, 790001593$ubl conjugation pathway]
UEV and lactate/malate dehyrogenase domains,UP_SEQ_FEATURE[850068113$chain:Ubiquitin-conjugating enzyme E2 variant 3, 850105607$domain:UEV, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
URB2 ribosome biogenesis 2 homolog (S. cerevisiae),INTERPRO[450017121$IPR018849:Nucleolar 27S pre-rRNA processing, Urb2/Npa2]
URB2 ribosome biogenesis 2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
URB2 ribosome biogenesis 2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850083009$chain:Unhealthy ribosome biogenesis protein 2 homolog, 850117295$sequence variant]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,INTERPRO[450000458$IPR000535:Major sperm protein, 450008175$IPR008962:PapD-like, 450015083$IPR016763:Vesicle-associated membrane protein]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,KEGG_PATHWAY[470038857$hsa04530:Tight junction]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,PIR_SUPERFAMILY[630016271$PIRSF019693:VAMP-associated]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,UP_SEQ_FEATURE[850100248$chain:Vesicle-associated membrane protein- associated protein A, 850104795$domain:MSP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
WAP four-disulfide core domain 2,INTERPRO[450007512$IPR008197:Whey acidic protein, 4-disulphide core, 450014297$IPR015874:4-disulphide core, 450016370$IPR018069:Whey acidic protein, 4-disulphide core, conserved site]
WAP four-disulfide core domain 2,SMART[760000190$SM00217:WAP]
WAP four-disulfide core domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001253$protease inhibitor, 790001304$repeat, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal]
WAP four-disulfide core domain 2,UP_SEQ_FEATURE[850100661$chain:WAP four-disulfide core domain protein 2, 850102883$disulfide bond, 850105689$domain:WAP 1, 850105691$domain:WAP 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
WAS protein family, member 2,BIOCARTA[30000006$h_actinYPathway:Y branching of actin filaments]
WAS protein family, member 2,INTERPRO[450002748$IPR003124:Actin-binding WH2, 450003503$IPR003980:Histamine H3 receptor]
WAS protein family, member 2,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton]
WAS protein family, member 2,PIR_SUPERFAMILY[630030009$PIRSF038481:Wiskott-Aldrich syndrome proteins]
WAS protein family, member 2,SMART[760000218$SM00246:WH2]
WAS protein family, member 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein]
WAS protein family, member 2,UP_SEQ_FEATURE[850100902$chain:Wiskott-Aldrich syndrome protein family member 2, 850102580$compositionally biased region:Poly-Pro, 850105698$domain:WH2, 850105852$helix, 850106258$modified residue]
WAS protein homolog associated with actin, golgi membranes and microtubules,INTERPRO[450002748$IPR003124:Actin-binding WH2]
WAS protein homolog associated with actin, golgi membranes and microtubules,SMART[760000218$SM00246:WH2]
WAS protein homolog associated with actin, golgi membranes and microtubules,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
WAS protein homolog associated with actin, golgi membranes and microtubules,UP_SEQ_FEATURE[850100706$chain:WASP homolog-associated protein with actin, membranes and microtubules, 850102586$compositionally biased region:Pro-rich, 850105699$domain:WH2 1, 850105700$domain:WH2 2, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant]
WD repeat domain 26,INTERPRO[450001490$IPR001680:WD40 repeat, 450006014$IPR006594:LisH dimerisation motif, 450006015$IPR006595:CTLH, C-terminal to LisH motif, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 26,SMART[760000289$SM00320:WD40, 760000580$SM00667:LisH, 760000581$SM00668:CTLH]
WD repeat domain 26,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 26,UP_SEQ_FEATURE[850100732$chain:WD repeat-containing protein 26, 850103431$domain:CTLH, 850104733$domain:LisH, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850118574$splice variant]
WD repeat domain 37,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 37,SMART[760000289$SM00320:WD40]
WD repeat domain 37,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 37,UP_SEQ_FEATURE[850100741$chain:WD repeat-containing protein 37, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant]
WD repeat domain 62,INTERPRO[450001490$IPR001680:WD40 repeat, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 62,SMART[760000289$SM00320:WD40]
WD repeat domain 62,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 62,UP_SEQ_FEATURE[850100765$chain:WD repeat-containing protein 62, 850106258$modified residue, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117174$repeat:WD 12, 850117175$repeat:WD 13, 850117176$repeat:WD 14, 850117177$repeat:WD 15, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,OMIM_DISEASE[520003613$Neuropathy, hereditary sensory and autonomic, type II, 520004158$Pseudohypoaldosteronism, type IIC]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,SP_PIR_KEYWORDS[790000052$alternative promoter usage, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001388$serine/threonine-protein kinase, 790001547$transferase]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850060062$chain:Serine/threonine-protein kinase WNK1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,INTERPRO[450000500$IPR000587:Creatinase, 450000865$IPR000994:Peptidase M24, structural domain, 450000992$IPR001131:Peptidase M24B, X-Pro dipeptidase/aminopeptidase P, conserved site]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,PIR_SUPERFAMILY[630006687$PIRSF006732:pig X-Pro aminopeptidase]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000069$Aminopeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000906$manganese, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,UP_SEQ_FEATURE[850100987$chain:Xaa-Pro aminopeptidase 1, 850105852$helix, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
XRCC6 binding protein 1,INTERPRO[450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450017411$IPR019165:Peptidase M76, ATP23]
XRCC6 binding protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease]
XRCC6 binding protein 1,UP_SEQ_FEATURE[850031972$chain:Mitochondrial inner membrane protease ATP23 homolog, 850105995$metal ion-binding site:Divalent metal cation; catalytic, 850117295$sequence variant]
YEATS domain containing 4,INTERPRO[450004502$IPR005033:YEATS]
YEATS domain containing 4,OMIM_DISEASE[520002069$Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic, 520002110$Glioma, 520003072$Many sequence variants affecting diversity of adult human height]
YEATS domain containing 4,PIR_SUPERFAMILY[630013109$PIRSF016332:PIRSF016332]
YEATS domain containing 4,SP_PIR_KEYWORDS[790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000635$growth regulation, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
YEATS domain containing 4,UP_SEQ_FEATURE[850101127$chain:YEATS domain-containing protein 4, 850105744$domain:YEATS, 850112548$region of interest:Interaction with MLLT10, 850112897$region of interest:Interaction with TACC1, 850117294$sequence conflict]
YME1-like 1 (S. cerevisiae),INTERPRO[450000549$IPR000642:Peptidase M41, 450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005380$IPR005936:Peptidase M41, FtsH]
YME1-like 1 (S. cerevisiae),SMART[760000335$SM00382:AAA]
YME1-like 1 (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001252$Protease, 790001648$zinc]
YME1-like 1 (S. cerevisiae),UP_SEQ_FEATURE[850006648$chain:ATP-dependent metalloprotease YME1L1, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118574$splice variant]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),KEGG_PATHWAY[470038804$hsa00903:Limonene and pinene degradation, 470038811$hsa01040:Biosynthesis of unsaturated fatty acids]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),SMART[760000323$SM00355:ZnF_C2H2]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway, 790001595$unfolded protein response, 790001648$zinc, 790001651$zinc-finger]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850068040$chain:Ubiquitin thioesterase OTU1, 850104870$domain:OTU, 850106259$mutagenesis site, 850114999$region of interest:UBX-like, 850117294$sequence conflict, 850118574$splice variant, 850118655$zinc finger region:C2H2-type]
abl-interactor 1,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000626$IPR000727:Target SNARE coiled-coil region, 450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
abl-interactor 1,SMART[760000295$SM00326:SH3, 760000348$SM00397:t_SNARE]
abl-interactor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000263$cell junction, 790000267$cell projection, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001475$synapse, 790001477$Synaptosome]
abl-interactor 1,UP_SEQ_FEATURE[850003175$chain:Abl interactor 1, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850114260$region of interest:Required for binding to WASF1, 850117294$sequence conflict, 850117295$sequence variant, 850117890$site:Breakpoint for translocation to form MLL- ABI1, 850118574$splice variant]
acid phosphatase 6, lysophosphatidic,INTERPRO[450000480$IPR000560:Histidine acid phosphatase]
acid phosphatase 6, lysophosphatidic,KEGG_PATHWAY[470038794$hsa00740:Riboflavin metabolism]
acid phosphatase 6, lysophosphatidic,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
acid phosphatase 6, lysophosphatidic,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850029336$chain:Lysophosphatidic acid phosphatase type 6, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
actin related protein 2/3 complex, subunit 5-like,INTERPRO[450006195$IPR006789:ARP2/3 complex 16 kDa subunit (p16-Arc)]
actin related protein 2/3 complex, subunit 5-like,KEGG_PATHWAY[470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038898$hsa05130:Pathogenic Escherichia coli infection]
actin related protein 2/3 complex, subunit 5-like,PIR_SUPERFAMILY[630013130$PIRSF016358:Caenorhabditis elegans hypothetical protein M01B12.3]
actin related protein 2/3 complex, subunit 5-like,SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein]
actin related protein 2/3 complex, subunit 5-like,UP_SEQ_FEATURE[850003632$chain:Actin-related protein 2/3 complex subunit 5-like protein, 850106258$modified residue, 850117294$sequence conflict]
actin, alpha, cardiac muscle 1,INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
actin, alpha, cardiac muscle 1,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038922$hsa05414:Dilated cardiomyopathy]
actin, alpha, cardiac muscle 1,OMIM_DISEASE[520000450$Atrial septal defect 5, 520000780$Cardiomyopathy, dilated, 1R, 520000794$Cardiomyopathy, familial hypertrophic, 520000798$Cardiomyopathy, familial hypertrophic, 11]
actin, alpha, cardiac muscle 1,PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
actin, alpha, cardiac muscle 1,SMART[760000240$SM00268:ACTIN]
actin, alpha, cardiac muscle 1,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000138$atp-binding, 790000141$atrial septal defect, 790000244$cardiac muscle, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790000646$heart, 790000950$methylated amino acid, 790000953$methylation, 790000996$muscle contraction, 790000997$muscle protein, 790001063$nucleotide-binding]
actin, alpha, cardiac muscle 1,UP_SEQ_FEATURE[850003516$chain:Actin, alpha cardiac muscle 1, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117295$sequence variant]
activating signal cointegrator 1 complex subunit 1,INTERPRO[450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450008322$IPR009210:Predicted eukaryotic LigT, 450016411$IPR018111:K Homology, type 1, subgroup]
activating signal cointegrator 1 complex subunit 1,PIR_SUPERFAMILY[630020619$PIRSF027019:Euk_LigT, 630020620$PIRSF027019:phosphoesterase, eukaryotic LigT type]
activating signal cointegrator 1 complex subunit 1,SMART[760000291$SM00322:KH]
activating signal cointegrator 1 complex subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
activating signal cointegrator 1 complex subunit 1,UP_SEQ_FEATURE[850003662$chain:Activating signal cointegrator 1 complex subunit 1, 850104520$domain:KH, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
acyl-CoA synthetase short-chain family member 1,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase, 450010730$IPR011904:Acetate--CoA ligase]
acyl-CoA synthetase short-chain family member 1,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038787$hsa00620:Pyruvate metabolism, 470038789$hsa00640:Propanoate metabolism]
acyl-CoA synthetase short-chain family member 1,PIR_SUPERFAMILY[630001720$PIRSF001552:4-coumarate-CoA ligase]
acyl-CoA synthetase short-chain family member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001550$transit peptide]
acyl-CoA synthetase short-chain family member 1,UP_SEQ_FEATURE[850003329$chain:Acetyl-coenzyme A synthetase 2-like, mitochondrial, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
acylphosphatase 1, erythrocyte (common) type,INTERPRO[450001585$IPR001792:Acylphosphatase, 450001586$IPR001792:Acylphosphatase-like, 450016276$IPR017968:Acylphosphatase, conserved site]
acylphosphatase 1, erythrocyte (common) type,KEGG_PATHWAY[470038787$hsa00620:Pyruvate metabolism]
acylphosphatase 1, erythrocyte (common) type,PIR_SUPERFAMILY[630001412$PIRSF001266:acylphosphatase]
acylphosphatase 1, erythrocyte (common) type,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000356$complete proteome, 790000411$cytosol, 790000445$direct protein sequencing, 790000512$erythrocyte, 790000743$hydrolase]
acylphosphatase 1, erythrocyte (common) type,UP_SEQ_FEATURE[850003803$chain:Acylphosphatase-1, 850103019$domain:Acylphosphatase-like, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
adaptor-related protein complex 4, beta 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450010814$IPR011989:Armadillo-like helical, 450013598$IPR015151:Clathrin adaptor, beta-adaptin, appendage, C-terminal subdomain, 450014665$IPR016342:Adaptor protein complex, beta subunit]
adaptor-related protein complex 4, beta 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 4, beta 1 subunit,PIR_SUPERFAMILY[630002416$PIRSF002291:adaptor protein complex, beta subunit, 630002417$PIRSF002291:AP_complex_beta]
adaptor-related protein complex 4, beta 1 subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 4, beta 1 subunit,UP_SEQ_FEATURE[850005738$chain:AP-4 complex subunit beta-1, 850117294$sequence conflict, 850117295$sequence variant]
adducin 3 (gamma),INTERPRO[450001148$IPR001303:Class II aldolase/adducin, N-terminal]
adducin 3 (gamma),SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000195$blood pressure control, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000679$heterodimer, 790000919$membrane, 790001162$phosphoprotein, 790001483$tail protein, 790001592$ubl conjugation]
adducin 3 (gamma),UP_SEQ_FEATURE[850020475$chain:Gamma-adducin, 850106258$modified residue, 850112141$region of interest:Interaction with calmodulin, 850117294$sequence conflict, 850118574$splice variant]
adenine phosphoribosyltransferase,INTERPRO[450000728$IPR000836:Phosphoribosyltransferase, 450002113$IPR002375:Purine/pyrimidine phosphoribosyl transferase, conserved site, 450005218$IPR005764:Adenine phosphoribosyl transferase]
adenine phosphoribosyltransferase,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenine phosphoribosyltransferase,OMIM_DISEASE[520004988$Urolithiasis, 2,8-dihydroxyadenine]
adenine phosphoribosyltransferase,PIR_SUPERFAMILY[630000566$PIRSF000479:adenine phosphoribosyltransferase]
adenine phosphoribosyltransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000619$glycosyltransferase, 790000701$homodimer, 790001116$pentosyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001280$purine salvage, 790001354$salvage pathway, 790001547$transferase]
adenine phosphoribosyltransferase,UP_SEQ_FEATURE[850003848$chain:Adenine phosphoribosyltransferase, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
adenylate kinase 2,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 2,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenylate kinase 2,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001097$P-loop, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase]
adenylate kinase 2,UP_SEQ_FEATURE[850000229$binding site:AMP, 850003913$chain:Adenylate kinase 2, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
adenylate kinase 7,COG_ONTOLOGY[90000033$Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism]
adenylate kinase 7,INTERPRO[450000742$IPR000850:Adenylate kinase, 450007206$IPR007858:Dpy-30, conserved site]
adenylate kinase 7,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenylate kinase 7,SP_PIR_KEYWORDS[790000138$atp-binding, 790000322$cilium biogenesis/degradation, 790000344$coiled coil, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001547$transferase]
adenylate kinase 7,UP_SEQ_FEATURE[850049315$chain:Putative adenylate kinase 7, 850102507$compositionally biased region:Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850106263$nucleotide phosphate-binding region:ATP, 850110876$region of interest:Adenylate kinase, 850111538$region of interest:DPY-30, 850117294$sequence conflict, 850117295$sequence variant]
adherens junctions associated protein 1,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
adherens junctions associated protein 1,UP_SEQ_FEATURE[850003944$chain:Adherens junction-associated protein 1, 850102605$compositionally biased region:Thr-rich, 850106258$modified residue, 850106259$mutagenesis site, 850114851$region of interest:Targeting signals, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
adhesion molecule with Ig-like domain 1,COG_ONTOLOGY[90000070$Function unknown]
adhesion molecule with Ig-like domain 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin]
adhesion molecule with Ig-like domain 1,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000357$SM00409:IG]
adhesion molecule with Ig-like domain 1,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000267$cell projection, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001016$neurogenesis, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
adhesion molecule with Ig-like domain 1,UP_SEQ_FEATURE[850005152$chain:Amphoterin-induced protein 1, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
aldehyde dehydrogenase 18 family, member A1,INTERPRO[450000838$IPR000965:Gamma-glutamyl phosphate reductase GPR, 450000919$IPR001048:Aspartate/glutamate/uridylate kinase, 450000926$IPR001057:Glutamate 5-kinase, 450005170$IPR005715:Glutamate 5-kinase, ProB-related, 450005220$IPR005766:Delta l-pyrroline-5-carboxylate synthetase, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal, 450014511$IPR016163:Aldehyde dehydrogenase, C-terminal, 450018029$IPR019797:Glutamate 5-kinase, conserved site]
aldehyde dehydrogenase 18 family, member A1,KEGG_PATHWAY[470038752$hsa00330:Arginine and proline metabolism]
aldehyde dehydrogenase 18 family, member A1,OMIM_DISEASE[520002405$Hyperammonemia with hypoornithinemia, hypocitrullinemia, hypoargininemia, and hypoprolinemia, 520003171$Mental retardation, joint hypermobility and skin laxity, with or without metabolic abnormalities]
aldehyde dehydrogenase 18 family, member A1,PIR_SUPERFAMILY[630027876$PIRSF036429:Delta-1-pyrroline-5-carboxylate synthetase, 630027877$PIRSF036429:P5C_syn]
aldehyde dehydrogenase 18 family, member A1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000064$amino-acid biosynthesis, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000825$kinase, 790000919$membrane, 790000930$mental retardation, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790000993$multifunctional enzyme, 790001008$nadp, 790001063$nucleotide-binding, 790001092$oxidoreductase, 790001212$polymorphism, 790001246$proline biosynthesis, 790001547$transferase]
aldehyde dehydrogenase 18 family, member A1,UP_SEQ_FEATURE[850014775$chain:Delta-1-pyrroline-5-carboxylate synthetase, 850105852$helix, 850111736$region of interest:Gamma-glutamyl phosphate reductase, 850111775$region of interest:Glutamate 5-kinase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
aldehyde dehydrogenase 3 family, member B2,INTERPRO[450011082$IPR012394:Aldehyde dehydrogenase NAD(P)-dependent, 450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal, 450014511$IPR016163:Aldehyde dehydrogenase, C-terminal]
aldehyde dehydrogenase 3 family, member B2,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038753$hsa00340:Histidine metabolism, 470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
aldehyde dehydrogenase 3 family, member B2,PIR_SUPERFAMILY[630027949$PIRSF036492:ALDH]
aldehyde dehydrogenase 3 family, member B2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
aldehyde dehydrogenase 3 family, member B2,UP_SEQ_FEATURE[850004333$chain:Aldehyde dehydrogenase family 3 member B2, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant]
aldehyde dehydrogenase 6 family, member A1,INTERPRO[450009142$IPR010061:Methylmalonate-semialdehyde dehydrogenase, 450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal]
aldehyde dehydrogenase 6 family, member A1,KEGG_PATHWAY[470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038776$hsa00562:Inositol phosphate metabolism, 470038789$hsa00640:Propanoate metabolism]
aldehyde dehydrogenase 6 family, member A1,OMIM_DISEASE[520003265$Methylmalonate semialdehyde dehydrogenase deficiency]
aldehyde dehydrogenase 6 family, member A1,PIR_SUPERFAMILY[630000172$PIRSF000147:NAD-dependent aldehyde dehydrogenase]
aldehyde dehydrogenase 6 family, member A1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000969$mitochondrion, 790001006$nad, 790001092$oxidoreductase, 790001550$transit peptide]
aldehyde dehydrogenase 6 family, member A1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000454$binding site:NAD, 850031529$chain:Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
aldo-keto reductase family 1, member A1 (aldehyde reductase),INTERPRO[450001240$IPR001395:Aldo/keto reductase, 450016460$IPR018170:Aldo/keto reductase, conserved site]
aldo-keto reductase family 1, member A1 (aldehyde reductase),KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038775$hsa00561:Glycerolipid metabolism]
aldo-keto reductase family 1, member A1 (aldehyde reductase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
aldo-keto reductase family 1, member A1 (aldehyde reductase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000555$binding site:Substrate, 850004303$chain:Alcohol dehydrogenase [NADP+], 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),INTERPRO[450001240$IPR001395:Aldo/keto reductase]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),PIR_SUPERFAMILY[630000111$PIRSF000097:aldo-keto reductase]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000624$golgi apparatus, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000461$binding site:NADP, 850000555$binding site:Substrate, 850004119$chain:Aflatoxin B1 aldehyde reductase member 2, 850105852$helix, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand, 850118624$turn]
aldo-keto reductase family 7-like,INTERPRO[450001240$IPR001395:Aldo/keto reductase]
aldo-keto reductase family 7-like,PIR_SUPERFAMILY[630000111$PIRSF000097:aldo-keto reductase]
aldo-keto reductase family 7-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001368$selenium, 790001370$selenocysteine]
aldo-keto reductase family 7-like,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000461$binding site:NADP, 850000555$binding site:Substrate, 850004121$chain:Aflatoxin B1 aldehyde reductase member 4, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118574$splice variant]
alpha- and gamma-adaptin-binding protein p34,INTERPRO[450017579$IPR019341:Alpha- and gamma-adaptin-binding protein p34]
alpha- and gamma-adaptin-binding protein p34,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
alpha- and gamma-adaptin-binding protein p34,UP_SEQ_FEATURE[850004580$chain:Alpha- and gamma-adaptin-binding protein p34, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),INTERPRO[450005485$IPR006046:Glycoside hydrolase family 13, 450005486$IPR006047:Glycosyl hydrolase, family 13, catalytic region, 450005487$IPR006048:Alpha-amylase, C-terminal all beta, 450006009$IPR006589:Glycosyl hydrolase, family 13, subfamily, catalytic region, 450012394$IPR013780:Glycosyl hydrolase, family 13, all-beta, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),KEGG_PATHWAY[470038765$hsa00500:Starch and sucrose metabolism]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),SMART[760000547$SM00632:Aamy_C, 760000557$SM00642:Aamy]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000232$carbohydrate metabolism, 790000295$chloride, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000937$metal-binding, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850000281$binding site:Chloride, 850004698$chain:Alpha-amylase 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand, 850118624$turn]
angiomotin like 1,INTERPRO[450008234$IPR009114:Angiomotin]
angiomotin like 1,KEGG_PATHWAY[470038857$hsa04530:Tight junction]
angiomotin like 1,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
angiomotin like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
angiomotin like 1,UP_SEQ_FEATURE[850005272$chain:Angiomotin-like protein 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117634$short sequence motif:PDZ-binding, 850118574$splice variant]
ankyrin repeat and SOCS box-containing 2,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001870$IPR002110:Ankyrin]
ankyrin repeat and SOCS box-containing 2,SMART[760000220$SM00248:ANK, 760000225$SM00253:SOCS]
ankyrin repeat and SOCS box-containing 2,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
ankyrin repeat and SOCS box-containing 2,UP_SEQ_FEATURE[850005349$chain:Ankyrin repeat and SOCS box protein 2, 850105375$domain:SOCS box, 850106259$mutagenesis site, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850117295$sequence variant]
ankyrin repeat domain 12,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 12,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 12,UP_SEQ_FEATURE[850005362$chain:Ankyrin repeat domain-containing protein 12, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 28,COG_ONTOLOGY[90000073$General function prediction only]
ankyrin repeat domain 28,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 28,PIR_SUPERFAMILY[630002426$PIRSF002300:syphilis spirochete probable ankyrin]
ankyrin repeat domain 28,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 28,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
ankyrin repeat domain 28,UP_SEQ_FEATURE[850060140$chain:Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, 850106258$modified residue, 850106259$mutagenesis site, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115636$repeat:ANK 13, 850115637$repeat:ANK 14, 850115638$repeat:ANK 15, 850115639$repeat:ANK 16, 850115640$repeat:ANK 17, 850115641$repeat:ANK 18, 850115642$repeat:ANK 19, 850115644$repeat:ANK 2, 850115645$repeat:ANK 20, 850115646$repeat:ANK 21, 850115647$repeat:ANK 22, 850115648$repeat:ANK 23, 850115649$repeat:ANK 24, 850115650$repeat:ANK 25, 850115651$repeat:ANK 26, 850115652$repeat:ANK 27, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850118574$splice variant]
ankyrin repeat domain 34A,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 34A,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 34A,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001304$repeat]
ankyrin repeat domain 34A,UP_SEQ_FEATURE[850005392$chain:Ankyrin repeat domain-containing protein 34A, 850102586$compositionally biased region:Pro-rich, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4]
annexin A11,INTERPRO[450001304$IPR001464:Annexin, 450007488$IPR008157:Annexin, type XI, N-terminal, 450013917$IPR015475:Annexin XI, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A11,PIR_SUPERFAMILY[630002478$PIRSF002360:annexin VII]
annexin A11,SMART[760000303$SM00335:ANX]
annexin A11,SP_PIR_KEYWORDS[790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000473$duplication, 790000497$endonexin fold, 790000616$glycoprotein, 790001065$nucleus, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
annexin A11,UP_SEQ_FEATURE[850005451$chain:Annexin A11, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850117295$sequence variant]
apolipoprotein M,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000643$hdl, 790000875$lipid transport, 790000881$lipoprotein, 790001363$Secreted, 790001405$signal, 790001558$transport]
apolipoprotein M,UP_SEQ_FEATURE[850005829$chain:Apolipoprotein M, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand]
arginine vasopressin receptor 1B,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000536$IPR000628:Vasopressin VIB receptor, 450001610$IPR001817:Vasopressin receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
arginine vasopressin receptor 1B,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038845$hsa04270:Vascular smooth muscle contraction]
arginine vasopressin receptor 1B,PIR_SUPERFAMILY[630001980$PIRSF001841:vasopressin/oxytocin receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
arginine vasopressin receptor 1B,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
arginine vasopressin receptor 1B,UP_SEQ_FEATURE[850100090$chain:Vasopressin V1b receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
arginine vasopressin-induced 1,SP_PIR_KEYWORDS[790000258$cell cycle, 790000356$complete proteome, 790001212$polymorphism]
arginine vasopressin-induced 1,UP_SEQ_FEATURE[850006076$chain:Arginine vasopressin-induced protein 1, 850117294$sequence conflict, 850117295$sequence variant]
armadillo repeat containing 5,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
armadillo repeat containing 5,SMART[760000159$SM00185:ARM, 760000197$SM00225:BTB]
armadillo repeat containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
armadillo repeat containing 5,UP_SEQ_FEATURE[850006121$chain:Armadillo repeat-containing protein 5, 850103177$domain:BTB, 850115674$repeat:ARM 1, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850117295$sequence variant, 850118574$splice variant]
arsenic (+3 oxidation state) methyltransferase,INTERPRO[450011853$IPR013216:Methyltransferase type 11]
arsenic (+3 oxidation state) methyltransferase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000954$methyltransferase, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
arsenic (+3 oxidation state) methyltransferase,UP_SEQ_FEATURE[850006173$chain:Arsenite methyltransferase, 850117294$sequence conflict, 850117295$sequence variant]
aryl hydrocarbon receptor nuclear translocator-like 2,INTERPRO[450000012$IPR000014:PAS, 450000935$IPR001067:Nuclear translocator, 450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450001428$IPR001610:PAC motif, 450010429$IPR011598:Helix-loop-helix DNA-binding, 450012276$IPR013655:PAS fold-3, 450012386$IPR013767:PAS fold]
aryl hydrocarbon receptor nuclear translocator-like 2,SMART[760000074$SM00086:PAC, 760000079$SM00091:PAS, 760000321$SM00353:HLH]
aryl hydrocarbon receptor nuclear translocator-like 2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000182$biological rhythms, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
aryl hydrocarbon receptor nuclear translocator-like 2,UP_SEQ_FEATURE[850006189$chain:Aryl hydrocarbon receptor nuclear translocator-like protein 2, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104880$domain:PAC, 850104897$domain:PAS 1, 850104898$domain:PAS 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
aryl-hydrocarbon receptor nuclear translocator 2,INTERPRO[450000012$IPR000014:PAS, 450000935$IPR001067:Nuclear translocator, 450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450001428$IPR001610:PAC motif, 450010429$IPR011598:Helix-loop-helix DNA-binding, 450012276$IPR013655:PAS fold-3, 450012386$IPR013767:PAS fold]
aryl-hydrocarbon receptor nuclear translocator 2,KEGG_PATHWAY[470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
aryl-hydrocarbon receptor nuclear translocator 2,PIR_SUPERFAMILY[630013920$PIRSF017155:aryl hydrocarbon receptor nuclear translocator]
aryl-hydrocarbon receptor nuclear translocator 2,SMART[760000074$SM00086:PAC, 760000079$SM00091:PAS, 760000321$SM00353:HLH]
aryl-hydrocarbon receptor nuclear translocator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
aryl-hydrocarbon receptor nuclear translocator 2,UP_SEQ_FEATURE[850006186$chain:Aryl hydrocarbon receptor nuclear translocator 2, 850102566$compositionally biased region:Poly-Arg, 850102570$compositionally biased region:Poly-Gln, 850102581$compositionally biased region:Poly-Ser, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104880$domain:PAC, 850104897$domain:PAS 1, 850104898$domain:PAS 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ash1 (absent, small, or homeotic)-like (Drosophila),INTERPRO[450000898$IPR001025:Bromo adjacent region, 450001068$IPR001214:SET, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450016267$IPR017956:AT hook, DNA-binding, conserved site, 450016644$IPR018359:Bromodomain, conserved site, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
ash1 (absent, small, or homeotic)-like (Drosophila),KEGG_PATHWAY[470038751$hsa00310:Lysine degradation, 470038857$hsa04530:Tight junction]
ash1 (absent, small, or homeotic)-like (Drosophila),SMART[760000221$SM00249:PHD, 760000267$SM00297:BROMO, 760000286$SM00317:SET, 760000336$SM00384:AT_hook, 760000385$SM00439:BAH, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
ash1 (absent, small, or homeotic)-like (Drosophila),SP_PIR_KEYWORDS[790000020$activator, 790000206$bromodomain, 790000263$cell junction, 790000311$chromatin regulator, 790000356$complete proteome, 790000811$isopeptide bond, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001528$Tight junction, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
ash1 (absent, small, or homeotic)-like (Drosophila),UP_SEQ_FEATURE[850042338$chain:Probable histone-lysine N- methyltransferase ASH1L, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850102889$DNA-binding region:A.T hook 3, 850103074$domain:AWS, 850103089$domain:BAH, 850103166$domain:Bromo, 850105053$domain:Post-SET, 850105340$domain:SET, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118877$zinc finger region:PHD-type]
asialoglycoprotein receptor 2,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450005088$IPR005640:Hepatic lectin, N-terminal, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
asialoglycoprotein receptor 2,PIR_SUPERFAMILY[630002543$PIRSF002424:hepatic lectin]
asialoglycoprotein receptor 2,SMART[760000026$SM00034:CLECT]
asialoglycoprotein receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000881$lipoprotein, 790000885$liver, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
asialoglycoprotein receptor 2,UP_SEQ_FEATURE[850006245$chain:Asialoglycoprotein receptor 2, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850117294$sequence conflict, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
aurora kinase B,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
aurora kinase B,SMART[760000193$SM00220:S_TKc]
aurora kinase B,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000276$centromere, 790000315$chromosomal protein, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
aurora kinase B,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059727$chain:Serine/threonine-protein kinase 12, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
basic leucine zipper transcription factor, ATF-like,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
basic leucine zipper transcription factor, ATF-like,SMART[760000306$SM00338:BRLZ]
basic leucine zipper transcription factor, ATF-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
basic leucine zipper transcription factor, ATF-like,UP_SEQ_FEATURE[850007377$chain:Basic leucine zipper transcriptional factor ATF-like, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper]
beta-1,4-N-acetyl-galactosaminyl transferase 3,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase, 450010486$IPR011658:PA14]
beta-1,4-N-acetyl-galactosaminyl transferase 3,SMART[760000664$SM00758:PA14]
beta-1,4-N-acetyl-galactosaminyl transferase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
beta-1,4-N-acetyl-galactosaminyl transferase 3,UP_SEQ_FEATURE[850033163$chain:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
beta-carotene oxygenase 2,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
beta-carotene oxygenase 2,INTERPRO[450003805$IPR004294:Carotenoid oxygenase]
beta-carotene oxygenase 2,PIR_SUPERFAMILY[630012792$PIRSF016018:carotenoid oxygenase, 630030702$PIRSF500488:beta,beta-carotene 9',10'-dioxygenase]
beta-carotene oxygenase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001212$polymorphism]
beta-carotene oxygenase 2,UP_SEQ_FEATURE[850007512$chain:Beta,beta-carotene 9',10'-oxygenase, 850106003$metal ion-binding site:Iron, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
beta-transducin repeat containing,BIOCARTA[30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
beta-transducin repeat containing,INTERPRO[450001490$IPR001680:WD40 repeat, 450001603$IPR001810:Cyclin-like F-box, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
beta-transducin repeat containing,KEGG_PATHWAY[470038835$hsa04114:Oocyte meiosis, 470038837$hsa04120:Ubiquitin mediated proteolysis, 470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway]
beta-transducin repeat containing,SMART[760000228$SM00256:FBOX, 760000289$SM00320:WD40]
beta-transducin repeat containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000859$ligase, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001642$wnt signaling pathway]
beta-transducin repeat containing,UP_SEQ_FEATURE[850018848$chain:F-box/WD repeat-containing protein 1A, 850103725$domain:F-box, 850105852$helix, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
biogenesis of lysosomal organelles complex-1, subunit 2,INTERPRO[450017509$IPR019269:Biogenesis of lysosome-related organelles complex-1, subunit 2]
biogenesis of lysosomal organelles complex-1, subunit 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
biogenesis of lysosomal organelles complex-1, subunit 2,UP_SEQ_FEATURE[850008108$chain:Biogenesis of lysosome-related organelles complex 1 subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
blocked early in transport 1 homolog (S. cerevisiae)-like,INTERPRO[450000626$IPR000727:Target SNARE coiled-coil region]
blocked early in transport 1 homolog (S. cerevisiae)-like,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
blocked early in transport 1 homolog (S. cerevisiae)-like,SMART[760000348$SM00397:t_SNARE]
blocked early in transport 1 homolog (S. cerevisiae)-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
blocked early in transport 1 homolog (S. cerevisiae)-like,UP_SEQ_FEATURE[850007497$chain:BET1-like protein, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
brain and reproductive organ-expressed (TNFRSF1A modulator),INTERPRO[450009421$IPR010358:Brain and reproductive organ-expressed]
brain and reproductive organ-expressed (TNFRSF1A modulator),PIR_SUPERFAMILY[630007027$PIRSF007150:anti-apoptotic protein BRE]
brain and reproductive organ-expressed (TNFRSF1A modulator),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001304$repeat]
brain and reproductive organ-expressed (TNFRSF1A modulator),UP_SEQ_FEATURE[850008344$chain:BRCA1-A complex subunit BRE, 850106258$modified residue, 850115008$region of interest:UEV-like 1, 850115009$region of interest:UEV-like 2, 850117294$sequence conflict, 850118574$splice variant]
breast cancer metastasis-suppressor 1-like,INTERPRO[450012503$IPR013907:Sds3-like]
breast cancer metastasis-suppressor 1-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000635$growth regulation, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
breast cancer metastasis-suppressor 1-like,UP_SEQ_FEATURE[850008358$chain:Breast cancer metastasis-suppressor 1- like protein, 850117294$sequence conflict]
calcium binding protein 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014189$IPR015754:Calcium binding protein, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calcium binding protein 2,SMART[760000046$SM00054:EFh]
calcium binding protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001304$repeat]
calcium binding protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850008971$chain:Calcium-binding protein 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850118574$splice variant]
calcium binding protein 39,INTERPRO[450012475$IPR013878:Mo25-like]
calcium binding protein 39,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway]
calcium binding protein 39,PIR_SUPERFAMILY[630008467$PIRSF009316:hypothetical protein, Saccharomyces cerevisiae YKL189w type]
calcium binding protein 39,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm]
calcium binding protein 39,UP_SEQ_FEATURE[850008973$chain:Calcium-binding protein 39, 850105852$helix, 850106258$modified residue, 850118624$turn]
calcium channel, voltage-dependent, beta 3 subunit,INTERPRO[450000497$IPR000584:Voltage-dependent calcium channel, L-type, beta subunit, 450001294$IPR001452:Src homology-3 domain, 450007416$IPR008079:Voltage-dependent calcium channel, L-type, beta-3 subunit, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region]
calcium channel, voltage-dependent, beta 3 subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, beta 3 subunit,PIR_SUPERFAMILY[630012355$PIRSF015600:human voltage-dependent calcium channel beta chain]
calcium channel, voltage-dependent, beta 3 subunit,SMART[760000063$SM00072:GuKc, 760000295$SM00326:SH3]
calcium channel, voltage-dependent, beta 3 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, beta 3 subunit,UP_SEQ_FEATURE[850100538$chain:Voltage-dependent L-type calcium channel subunit beta-3, 850105350$domain:SH3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase II gamma,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000070$h_crebPathway:Transcription factor CREB and its extracellular signals, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase II gamma,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012167$IPR013543:Calcium/calmodulin dependent protein kinase II, association-domain, 450014177$IPR015742:Calcium/calmodulin-dependent protein kinase II isoform, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase II gamma,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038846$hsa04310:Wnt signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038904$hsa05214:Glioma]
calcium/calmodulin-dependent protein kinase II gamma,PIR_SUPERFAMILY[630000701$PIRSF000594:calcium/calmodulin-dependent protein kinase II]
calcium/calmodulin-dependent protein kinase II gamma,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase II gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase II gamma,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009093$chain:Calcium/calmodulin-dependent protein kinase type II subunit gamma, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cannabinoid receptor 2 (macrophage),BIOCARTA[30000049$h_cb1rPathway:Metabolism of Anandamide, an Endogenous Cannabinoid]
cannabinoid receptor 2 (macrophage),INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001378$IPR001551:Cannabinoid receptor, type 2, 450001977$IPR002230:Cannabinoid receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cannabinoid receptor 2 (macrophage),KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
cannabinoid receptor 2 (macrophage),PIR_SUPERFAMILY[630030135$PIRSF038633:cannabinoid receptor 2, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cannabinoid receptor 2 (macrophage),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000775$inflammatory response, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
cannabinoid receptor 2 (macrophage),UP_SEQ_FEATURE[850009290$chain:Cannabinoid receptor 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
capping protein (actin filament) muscle Z-line, alpha 1,INTERPRO[450001942$IPR002189:F-actin capping protein, alpha subunit, 450016184$IPR017865:F-actin capping protein, alpha subunit, conserved site, 450016599$IPR018315:F-actin capping protein, alpha subunit, actin binding]
capping protein (actin filament) muscle Z-line, alpha 1,PIR_SUPERFAMILY[630005921$PIRSF005982:actin-capping protein alpha chain]
capping protein (actin filament) muscle Z-line, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000018$actin capping, 790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing]
capping protein (actin filament) muscle Z-line, alpha 1,UP_SEQ_FEATURE[850018460$chain:F-actin-capping protein subunit alpha-1, 850106258$modified residue, 850117294$sequence conflict]
capping protein (actin filament) muscle Z-line, beta,INTERPRO[450001504$IPR001698:F-actin capping protein, beta subunit, 450018006$IPR019771:F-actin capping protein, beta subunit conserved site]
capping protein (actin filament) muscle Z-line, beta,PIR_SUPERFAMILY[630002456$PIRSF002336:actin-capping protein beta chain]
capping protein (actin filament) muscle Z-line, beta,SP_PIR_KEYWORDS[790000012$acetylation, 790000018$actin capping, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein]
capping protein (actin filament) muscle Z-line, beta,UP_SEQ_FEATURE[850018463$chain:F-actin-capping protein subunit beta, 850106258$modified residue, 850118574$splice variant]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,INTERPRO[450000753$IPR000863:Sulfotransferase]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,UP_SEQ_FEATURE[850009410$chain:Carbohydrate sulfotransferase 15, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
carbohydrate (chondroitin 6) sulfotransferase 3,INTERPRO[450000753$IPR000863:Sulfotransferase, 450014790$IPR016469:Carbohydrate sulfotransferase]
carbohydrate (chondroitin 6) sulfotransferase 3,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (chondroitin 6) sulfotransferase 3,OMIM_DISEASE[520002383$Humerospinal dysostosis, 520004661$Spondyloepiphyseal dysplasia, Omani type]
carbohydrate (chondroitin 6) sulfotransferase 3,PIR_SUPERFAMILY[630005810$PIRSF005883:carbohydrate sulfotransferase, 630005811$PIRSF005883:Carbohydrate_sulfotransferase]
carbohydrate (chondroitin 6) sulfotransferase 3,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (chondroitin 6) sulfotransferase 3,UP_SEQ_FEATURE[850009412$chain:Carbohydrate sulfotransferase 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
cardiotrophin-like cytokine factor 1,INTERPRO[450009726$IPR010681:Plethodontid receptivity factor PRF]
cardiotrophin-like cytokine factor 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
cardiotrophin-like cytokine factor 1,OMIM_DISEASE[520001076$Cold-induced sweating syndrome 1]
cardiotrophin-like cytokine factor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000446$disease mutation, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
cardiotrophin-like cytokine factor 1,UP_SEQ_FEATURE[850009721$chain:Cardiotrophin-like cytokine factor 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
catenin (cadherin-associated protein), delta 1,INTERPRO[450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
catenin (cadherin-associated protein), delta 1,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038873$hsa04670:Leukocyte transendothelial migration]
catenin (cadherin-associated protein), delta 1,SMART[760000159$SM00185:ARM]
catenin (cadherin-associated protein), delta 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001642$wnt signaling pathway]
catenin (cadherin-associated protein), delta 1,UP_SEQ_FEATURE[850009899$chain:Catenin delta-1, 850106258$modified residue, 850115674$repeat:ARM 1, 850115675$repeat:ARM 10, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850115690$repeat:ARM 8, 850115691$repeat:ARM 9, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
cation channel, sperm associated 1,INTERPRO[450005268$IPR005821:Ion transport]
cation channel, sperm associated 1,SP_PIR_KEYWORDS[790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000264$cell membrane, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000557$flagellum, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001426$spermatogenesis, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
cation channel, sperm associated 1,UP_SEQ_FEATURE[850009956$chain:Cation channel sperm-associated protein 1, 850102540$compositionally biased region:His-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118603$topological domain:Pore forming, 850118623$transmembrane region]
cell cycle exit and neuronal differentiation 1,PIR_SUPERFAMILY[630008836$PIRSF009834:pig BM88 antigen]
cell cycle exit and neuronal differentiation 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
cell cycle exit and neuronal differentiation 1,UP_SEQ_FEATURE[850010267$chain:Cell cycle exit and neuronal differentiation protein 1, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
centrosomal protein 164kDa,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP]
centrosomal protein 164kDa,SMART[760000401$SM00456:WW]
centrosomal protein 164kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000452$DNA damage, 790000459$dna repair, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
centrosomal protein 164kDa,UP_SEQ_FEATURE[850010692$chain:Centrosomal protein of 164 kDa, 850102507$compositionally biased region:Glu-rich, 850102554$compositionally biased region:Lys-rich, 850105731$domain:WW, 850106258$modified residue, 850106259$mutagenesis site, 850112110$region of interest:Interaction with ATRIP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chaperonin containing TCP1, subunit 3 (gamma),INTERPRO[450001946$IPR002194:Chaperonin TCP-1, conserved site, 450002152$IPR002423:Chaperonin Cpn60/TCP-1, 450011398$IPR012719:T-complex protein 1, gamma subunit, 450016306$IPR017998:Chaperone, tailless complex polypeptide 1]
chaperonin containing TCP1, subunit 3 (gamma),PIR_SUPERFAMILY[630002698$PIRSF002584:molecular chaperone t-complex-type]
chaperonin containing TCP1, subunit 3 (gamma),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000976$molecular chaperone, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
chaperonin containing TCP1, subunit 3 (gamma),UP_SEQ_FEATURE[850063420$chain:T-complex protein 1 subunit gamma, 850102883$disulfide bond, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chemokine (C motif) ligand 1,INTERPRO[450001604$IPR001811:Small chemokine, interleukin-8-like, 450007440$IPR008105:Lymphotactin precursor]
chemokine (C motif) ligand 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C motif) ligand 1,SMART[760000172$SM00199:SCY]
chemokine (C motif) ligand 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790001363$Secreted, 790001405$signal]
chemokine (C motif) ligand 1,UP_SEQ_FEATURE[850029252$chain:Lymphotactin, 850102883$disulfide bond, 850105852$helix, 850117814$signal peptide, 850118575$strand]
chemokine (C-X-C motif) ligand 2,INTERPRO[450000954$IPR001089:Small chemokine, C-X-C, 450001604$IPR001811:Small chemokine, interleukin-8-like, 450002193$IPR002473:Small chemokine, C-X-C/Interleukin 8, 450016352$IPR018048:Small chemokine, C-X-C, conserved site]
chemokine (C-X-C motif) ligand 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-X-C motif) ligand 2,PIR_SUPERFAMILY[630002641$PIRSF002522:CXC chemokine, 630030765$PIRSF500568:growth regulated protein, alpha/beta/gamma types]
chemokine (C-X-C motif) ligand 2,SMART[760000172$SM00199:SCY]
chemokine (C-X-C motif) ligand 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000774$inflammation, 790000775$inflammatory response, 790001137$pharmaceutical, 790001363$Secreted, 790001405$signal]
chemokine (C-X-C motif) ligand 2,UP_SEQ_FEATURE[850008778$chain:C-X-C motif chemokine 2, 850022424$chain:GRO-beta(5-73), 850102883$disulfide bond, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chitinase 1 (chitotriosidase),INTERPRO[450001076$IPR001223:Glycoside hydrolase, family 18, catalytic domain, 450001403$IPR001579:Glycoside hydrolase, chitinase active site, 450002273$IPR002557:Chitin binding protein, peritrophin-A, 450010425$IPR011583:Chitinase II, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core]
chitinase 1 (chitotriosidase),KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
chitinase 1 (chitotriosidase),OMIM_DISEASE[520000982$Chitotriosidase deficiency]
chitinase 1 (chitotriosidase),PIR_SUPERFAMILY[630001210$PIRSF001061:chitinase-like protein]
chitinase 1 (chitotriosidase),SMART[760000437$SM00494:ChtBD2, 760000551$SM00636:Glyco_18]
chitinase 1 (chitotriosidase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000293$Chitin degradation, 790000294$Chitin-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001216$polysaccharide degradation, 790001363$Secreted, 790001405$signal]
chitinase 1 (chitotriosidase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850011055$chain:Chitotriosidase-1, 850102883$disulfide bond, 850103339$domain:Chitin-binding type-2, 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
chloride channel 6,INTERPRO[450000551$IPR000644:Cystathionine beta-synthase, core, 450001600$IPR001807:Chloride channel, voltage gated, 450001994$IPR002248:Chloride channel CLC-6, 450013194$IPR014743:Chloride channel, core]
chloride channel 6,PIR_SUPERFAMILY[630012791$PIRSF016017:PIRSF016017]
chloride channel 6,SMART[760000103$SM00116:CBS]
chloride channel 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000102$antiport, 790000138$atp-binding, 790000255$CBS domain, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000501$endosome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
chloride channel 6,UP_SEQ_FEATURE[850000281$binding site:Chloride, 850000287$binding site:Chloride; via amide nitrogen, 850011091$chain:Chloride transport protein 6, 850102480$compositionally biased region:Cys-rich, 850103311$domain:CBS 1, 850103312$domain:CBS 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112009$region of interest:In-membrane helix, 850112010$region of interest:In-membrane loop between two helices, 850117295$sequence variant, 850117701$short sequence motif:Selectivity filter part_1, 850117702$short sequence motif:Selectivity filter part_2, 850117703$short sequence motif:Selectivity filter part_3, 850118429$site:Mediates proton transfer from the outer aqueous phase to the interior of the protein; involved in linking H(+) and Cl(-) transport, 850118430$site:Mediates proton transfer from the protein to the inner aqueous phase, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
cholinergic receptor, muscarinic 1,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000041$h_botulinPathway:Blockade of Neurotransmitter Relase by Botulinum Toxin, 30000204$h_no1Pathway:Actions of Nitric Oxide in the Heart, 30000304$h_tubbyPathway:G-Protein Signaling Through Tubby Proteins]
cholinergic receptor, muscarinic 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000866$IPR000995:Muscarinic acetylcholine receptor, 450001975$IPR002228:Muscarinic acetylcholine receptor M1, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cholinergic receptor, muscarinic 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038881$hsa04810:Regulation of actin cytoskeleton]
cholinergic receptor, muscarinic 1,PIR_SUPERFAMILY[630030053$PIRSF038548:muscarinic acetylcholine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cholinergic receptor, muscarinic 1,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001475$synapse, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
cholinergic receptor, muscarinic 1,UP_SEQ_FEATURE[850032812$chain:Muscarinic acetylcholine receptor M1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,UP_SEQ_FEATURE[850011240$chain:Chondroitin sulfate N- acetylgalactosaminyltransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105986$metal ion-binding site:Divalent metal cation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromodomain helicase DNA binding protein 4,INTERPRO[450000283$IPR000330:SNF2-related, 450000831$IPR000953:Chromo domain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450008565$IPR009462:Protein of unknown function DUF1086, 450008566$IPR009463:Protein of unknown function DUF1087, 450011633$IPR012957:CHD, C-terminal 2, 450011634$IPR012958:CHD, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
chromodomain helicase DNA binding protein 4,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000268$SM00298:CHROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
chromodomain helicase DNA binding protein 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
chromodomain helicase DNA binding protein 4,UP_SEQ_FEATURE[850011385$chain:Chromodomain-helicase-DNA-binding protein 4, 850102565$compositionally biased region:Poly-Ala, 850102568$compositionally biased region:Poly-Asp, 850102572$compositionally biased region:Poly-Glu, 850102576$compositionally biased region:Poly-Leu, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103362$domain:Chromo 1, 850103363$domain:Chromo 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
chromosome 1 open reading frame 103,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 1 open reading frame 103,UP_SEQ_FEATURE[850073567$chain:Uncharacterized protein C1orf103, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 110,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
chromosome 1 open reading frame 110,UP_SEQ_FEATURE[850012083$chain:Coiled-coil domain-containing protein C1orf110, 850117294$sequence conflict, 850118574$splice variant]
chromosome 1 open reading frame 116,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001301$receptor]
chromosome 1 open reading frame 116,UP_SEQ_FEATURE[850061756$chain:Specifically androgen-regulated gene protein, 850102378$compositionally biased region:Ala-rich, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 122,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
chromosome 1 open reading frame 122,UP_SEQ_FEATURE[850073586$chain:Uncharacterized protein C1orf122]
chromosome 1 open reading frame 130,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 1 open reading frame 130,UP_SEQ_FEATURE[850073591$chain:Uncharacterized protein C1orf130, 850102585$compositionally biased region:Poly-Val, 850118623$transmembrane region]
chromosome 1 open reading frame 159,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 1 open reading frame 159,UP_SEQ_FEATURE[850073608$chain:Uncharacterized protein C1orf159, 850102586$compositionally biased region:Pro-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
chromosome 1 open reading frame 168,INTERPRO[450001294$IPR001452:Src homology-3 domain]
chromosome 1 open reading frame 168,SMART[760000295$SM00326:SH3]
chromosome 1 open reading frame 168,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 168,UP_SEQ_FEATURE[850073612$chain:Uncharacterized protein C1orf168, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 182,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 182,UP_SEQ_FEATURE[850073623$chain:Uncharacterized protein C1orf182, 850117295$sequence variant]
chromosome 1 open reading frame 223,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 1 open reading frame 223,UP_SEQ_FEATURE[850073644$chain:Uncharacterized protein C1orf223, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 1 open reading frame 38,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 38,UP_SEQ_FEATURE[850047978$chain:Protein THEMIS2, 850102462$compositionally biased region:Asp/Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 56,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001363$Secreted, 790001405$signal]
chromosome 1 open reading frame 56,UP_SEQ_FEATURE[850073664$chain:Uncharacterized protein C1orf56, 850106258$modified residue, 850117814$signal peptide, 850118574$splice variant]
chromosome 1 open reading frame 85,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 1 open reading frame 85,UP_SEQ_FEATURE[850029379$chain:Lysosomal protein NCU-G1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromosome 1 open reading frame 86,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 86,UP_SEQ_FEATURE[850073673$chain:Uncharacterized protein C1orf86, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 88,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 88,UP_SEQ_FEATURE[850073677$chain:Uncharacterized protein C1orf88, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 10 open reading frame 118,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 10 open reading frame 118,UP_SEQ_FEATURE[850072893$chain:Uncharacterized protein C10orf118, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 10 open reading frame 137,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001539$Transcription, 790001543$transcription regulation]
chromosome 10 open reading frame 137,UP_SEQ_FEATURE[850017806$chain:Erythroid differentiation-related factor 1, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 10 open reading frame 140,INTERPRO[450002951$IPR003380:Transforming protein Ski]
chromosome 10 open reading frame 140,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 10 open reading frame 140,UP_SEQ_FEATURE[850045618$chain:Protein DLN-1, 850102378$compositionally biased region:Ala-rich, 850102507$compositionally biased region:Glu-rich, 850102540$compositionally biased region:His-rich, 850102565$compositionally biased region:Poly-Ala, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict]
chromosome 10 open reading frame 2,INTERPRO[450007050$IPR007694:DNA helicase, DnaB-like, C-terminal]
chromosome 10 open reading frame 2,OMIM_DISEASE[520003344$Mitochondrial DNA depletion syndrome, hepatocerebral form, 520004102$Progressive external ophthalmoplegia with mitochondrial DNA deletions, 520004106$progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3, 520004435$Sensory ataxia neuropathy, dysarthria, and ophthalmoparesis, 520004616$Spinocerebellar ataxia 8, 520004627$Spinocerebellar ataxia, infantile-onset, 520004628$Spinocerebellar ataxia, infantile-onset, with sensory neuropathy]
chromosome 10 open reading frame 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000460$dna replication, 790000649$helicase, 790000743$hydrolase, 790000969$mitochondrion, 790001015$neurodegeneration, 790001020$neuropathy, 790001063$nucleotide-binding, 790001212$polymorphism, 790001244$progressive external ophthalmoplegia, 790001550$transit peptide]
chromosome 10 open reading frame 2,UP_SEQ_FEATURE[850067297$chain:Twinkle protein, mitochondrial, 850105342$domain:SF4 helicase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
chromosome 10 open reading frame 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 10 open reading frame 26,UP_SEQ_FEATURE[850036312$chain:Outcome predictor in acute leukemia 1, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 10 open reading frame 32,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 10 open reading frame 32,UP_SEQ_FEATURE[850098220$chain:UPF0693 protein C10orf32, 850106258$modified residue]
chromosome 10 open reading frame 46,INTERPRO[450001217$IPR001373:Cullin, N-terminal, 450001218$IPR001373:Cullin, N-terminal region, 450014507$IPR016157:Cullin, conserved site]
chromosome 10 open reading frame 46,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 10 open reading frame 46,UP_SEQ_FEATURE[850072903$chain:Uncharacterized protein C10orf46, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,PIR_SUPERFAMILY[630009558$PIRSF011010:Caenorhabditis elegans hypothetical protein R53.5]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,UP_SEQ_FEATURE[850066251$chain:Transmembrane protein C10orf57, 850072908$chain:Uncharacterized protein C10orf58, 850117294$sequence conflict, 850117814$signal peptide, 850118623$transmembrane region]
chromosome 10 open reading frame 72,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450012396$IPR013783:Immunoglobulin-like fold]
chromosome 10 open reading frame 72,SMART[760000357$SM00409:IG]
chromosome 10 open reading frame 72,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 10 open reading frame 72,UP_SEQ_FEATURE[850069979$chain:Uncharacterized Ig-like domain-containing protein C10orf72, 850102883$disulfide bond, 850104199$domain:Ig-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 11 open reading frame 24,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 11 open reading frame 24,UP_SEQ_FEATURE[850072958$chain:Uncharacterized protein C11orf24, 850102586$compositionally biased region:Pro-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 11 open reading frame 30,INTERPRO[450004946$IPR005491:ENT]
chromosome 11 open reading frame 30,OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease]
chromosome 11 open reading frame 30,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000616$glycoprotein, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
chromosome 11 open reading frame 30,UP_SEQ_FEATURE[850045742$chain:Protein EMSY, 850102485$compositionally biased region:Gln-rich, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850102605$compositionally biased region:Thr-rich, 850103716$domain:ENT, 850105829$glycosylation site:O-linked (GlcNAc), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112132$region of interest:Interaction with BRCA2, 850113057$region of interest:Interaction with ZMYND11, 850118574$splice variant, 850118575$strand]
chromosome 11 open reading frame 80,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 11 open reading frame 80,UP_SEQ_FEATURE[850055199$chain:Putative uncharacterized protein C11orf80, 850118574$splice variant]
chromosome 11 open reading frame 84,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 11 open reading frame 84,UP_SEQ_FEATURE[850072993$chain:Uncharacterized protein C11orf84, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant]
chromosome 11 open reading frame 87,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 11 open reading frame 87,UP_SEQ_FEATURE[850072999$chain:Uncharacterized protein C11orf87, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 12 open reading frame 30,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017429$IPR019183:N-acetyltransferase B complex, non-catalytic subunit]
chromosome 12 open reading frame 30,OMIM_DISEASE[520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, 520004355$Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes]
chromosome 12 open reading frame 30,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
chromosome 12 open reading frame 30,UP_SEQ_FEATURE[850033292$chain:N-terminal acetyltransferase B complex subunit MDM20, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 35,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 12 open reading frame 35,UP_SEQ_FEATURE[850073042$chain:Uncharacterized protein C12orf35, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 12 open reading frame 42,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 42,UP_SEQ_FEATURE[850073049$chain:Uncharacterized protein C12orf42, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 51,INTERPRO[450000485$IPR000569:HECT]
chromosome 12 open reading frame 51,SMART[760000104$SM00119:HECTc]
chromosome 12 open reading frame 51,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790000859$ligase, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane, 790001593$ubl conjugation pathway]
chromosome 12 open reading frame 51,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041861$chain:Probable E3 ubiquitin-protein ligase KIAA0614, 850066253$chain:Transmembrane protein C12orf51, 850102565$compositionally biased region:Poly-Ala, 850102568$compositionally biased region:Poly-Asp, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850104105$domain:HECT, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
chromosome 12 open reading frame 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 52,UP_SEQ_FEATURE[850073056$chain:Uncharacterized protein C12orf52, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 57,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
chromosome 12 open reading frame 57,UP_SEQ_FEATURE[850045288$chain:Protein C10, 850106258$modified residue]
chromosome 14 open reading frame 102,INTERPRO[450012256$IPR013633:Protein of unknown function DUF1740]
chromosome 14 open reading frame 102,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
chromosome 14 open reading frame 102,UP_SEQ_FEATURE[850097951$chain:UPF0614 protein C14orf102, 850102554$compositionally biased region:Lys-rich, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850116114$repeat:HAT 1, 850116123$repeat:HAT 2, 850116124$repeat:HAT 3, 850116125$repeat:HAT 4, 850116126$repeat:HAT 5, 850117295$sequence variant]
chromosome 14 open reading frame 129,INTERPRO[450007310$IPR007967:Protein of unknown function DUF727]
chromosome 14 open reading frame 129,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm]
chromosome 14 open reading frame 129,UP_SEQ_FEATURE[850022508$chain:GSK3-beta interaction protein, 850105852$helix, 850106259$mutagenesis site, 850112379$region of interest:Interaction with GSK3B, 850117294$sequence conflict, 850118575$strand]
chromosome 14 open reading frame 159,INTERPRO[450008991$IPR009906:Protein of unknown function DUF1445, 450015455$IPR017135:Uncharacterised protein family UPF0317, mitochondria]
chromosome 14 open reading frame 159,PIR_SUPERFAMILY[630028722$PIRSF037204:UCP037204, 630028723$PIRSF037204:uncharacterized conserved protein]
chromosome 14 open reading frame 159,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 14 open reading frame 159,UP_SEQ_FEATURE[850094009$chain:UPF0317 protein C14orf159, mitochondrial, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
chromosome 14 open reading frame 37,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 14 open reading frame 37,UP_SEQ_FEATURE[850073183$chain:Uncharacterized protein C14orf37, 850102507$compositionally biased region:Glu-rich, 850102566$compositionally biased region:Poly-Arg, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 14 open reading frame 38,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 14 open reading frame 38,UP_SEQ_FEATURE[850073185$chain:Uncharacterized protein C14orf38, 850117295$sequence variant]
chromosome 14 open reading frame 45,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 14 open reading frame 45,UP_SEQ_FEATURE[850073188$chain:Uncharacterized protein C14orf45, 850106258$modified residue, 850117295$sequence variant]
chromosome 14 open reading frame 68,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
chromosome 14 open reading frame 68,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
chromosome 14 open reading frame 68,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
chromosome 14 open reading frame 68,UP_SEQ_FEATURE[850023492$chain:Hepatocellular carcinoma down-regulated mitochondrial carrier protein, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850118574$splice variant, 850118623$transmembrane region]
chromosome 15 open reading frame 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001212$polymorphism, 790001426$spermatogenesis]
chromosome 15 open reading frame 2,UP_SEQ_FEATURE[850045290$chain:Protein C15orf2, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
chromosome 15 open reading frame 27,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 15 open reading frame 27,UP_SEQ_FEATURE[850066259$chain:Transmembrane protein C15orf27, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 15 open reading frame 60,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 15 open reading frame 60,UP_SEQ_FEATURE[850073239$chain:Uncharacterized protein C15orf60, 850117295$sequence variant]
chromosome 16 open reading frame 5,INTERPRO[450006048$IPR006629:LPS-induced tumor necrosis factor alpha factor, 450017821$IPR019584:Zinc finger region, LITAF-like]
chromosome 16 open reading frame 5,SMART[760000621$SM00714:LITAF]
chromosome 16 open reading frame 5,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 16 open reading frame 5,UP_SEQ_FEATURE[850028907$chain:LITAF-like protein, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict]
chromosome 16 open reading frame 92,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 16 open reading frame 92,UP_SEQ_FEATURE[850073325$chain:Uncharacterized protein C16orf92, 850118574$splice variant, 850118623$transmembrane region]
chromosome 17 open reading frame 45,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 17 open reading frame 45,UP_SEQ_FEATURE[850055486$chain:Putative uncharacterized protein NCRNA00188, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
chromosome 19 open reading frame 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 19 open reading frame 12,UP_SEQ_FEATURE[850073499$chain:Uncharacterized protein C19orf12, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 2,INTERPRO[450003641$IPR004127:Prefoldin alpha-like]
chromosome 19 open reading frame 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 19 open reading frame 2,UP_SEQ_FEATURE[850082989$chain:Unconventional prefoldin RPB5 interactor, 850102568$compositionally biased region:Poly-Asp, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 19 open reading frame 47,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 19 open reading frame 47,UP_SEQ_FEATURE[850073519$chain:Uncharacterized protein C19orf47, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850118574$splice variant]
chromosome 19 open reading frame 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 19 open reading frame 62,UP_SEQ_FEATURE[850008345$chain:BRCA1-A complex subunit MERIT40, 850106258$modified residue, 850115054$region of interest:VWFA-like, 850117294$sequence conflict, 850118574$splice variant]
chromosome 19 open reading frame 71,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 71,UP_SEQ_FEATURE[850073534$chain:Uncharacterized protein C19orf71, 850117295$sequence variant]
chromosome 2 open reading frame 14; Uncharacterized protein C2orf14-like 2; Uncharacterized protein C2orf14-like 1,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 2 open reading frame 14; Uncharacterized protein C2orf14-like 2; Uncharacterized protein C2orf14-like 1,UP_SEQ_FEATURE[850073927$chain:Uncharacterized protein C2orf14, 850073928$chain:Uncharacterized protein C2orf14-like 1, 850073929$chain:Uncharacterized protein C2orf14-like 2]
chromosome 7 open reading frame 49,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
chromosome 7 open reading frame 49,UP_SEQ_FEATURE[850032329$chain:Modulator of retrovirus infection homolog, 850117295$sequence variant, 850118574$splice variant]
chromosome 8 open reading frame 83,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 8 open reading frame 83,UP_SEQ_FEATURE[850097920$chain:UPF0599 protein C8orf83, 850118623$transmembrane region]
chromosome 9 open reading frame 16,INTERPRO[450004832$IPR005374:Uncharacterised protein family UPF0184]
chromosome 9 open reading frame 16,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 9 open reading frame 16,UP_SEQ_FEATURE[850088886$chain:UPF0184 protein C9orf16, 850106258$modified residue, 850117294$sequence conflict]
chromosome 9 open reading frame 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 24,UP_SEQ_FEATURE[850074539$chain:Uncharacterized protein C9orf24, 850117295$sequence variant, 850118574$splice variant]
citron (rho-interacting, serine/threonine kinase 21),COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
citron (rho-interacting, serine/threonine kinase 21),INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001035$IPR001180:Citron-like, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450015732$IPR017405:Citron Rho-interacting kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
citron (rho-interacting, serine/threonine kinase 21),PIR_SUPERFAMILY[630029748$PIRSF038145:citron Rho-interacting kinase, 630029749$PIRSF038145:Citron_Rho-interacting_kinase]
citron (rho-interacting, serine/threonine kinase 21),SMART[760000028$SM00036:CNH, 760000096$SM00109:C1, 760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000205$SM00233:PH]
citron (rho-interacting, serine/threonine kinase 21),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000825$kinase, 790000937$metal-binding, 790000973$mitosis, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001399$sh3-binding, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
citron (rho-interacting, serine/threonine kinase 21),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850011548$chain:Citron Rho-interacting kinase, 850103028$domain:AGC-kinase C-terminal, 850103376$domain:CNH, 850104979$domain:PH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112777$region of interest:Interaction with Rho/Rac, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
claspin homolog (Xenopus laevis),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
claspin homolog (Xenopus laevis),UP_SEQ_FEATURE[850011562$chain:Claspin, 850106258$modified residue, 850106259$mutagenesis site, 850115775$repeat:CKB motif 1, 850115776$repeat:CKB motif 2, 850115777$repeat:CKB motif 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
clathrin, light chain (Lcb),INTERPRO[450000867$IPR000996:Clathrin light chain]
clathrin, light chain (Lcb),KEGG_PATHWAY[470038840$hsa04142:Lysosome, 470038841$hsa04144:Endocytosis, 470038894$hsa05016:Huntington's disease]
clathrin, light chain (Lcb),PIR_SUPERFAMILY[630002413$PIRSF002289:clathrin light chain]
clathrin, light chain (Lcb),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000334$coated pit, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein]
clathrin, light chain (Lcb),UP_SEQ_FEATURE[850011634$chain:Clathrin light chain B, 850102883$disulfide bond, 850106258$modified residue, 850113150$region of interest:Involved in binding clathrin heavy chain, 850117294$sequence conflict, 850118574$splice variant]
coagulation factor II (thrombin) receptor,BIOCARTA[30000018$h_amiPathway:Acute Myocardial Infarction, 30000109$h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway, 30000113$h_fibrinolysisPathway:Fibrinolysis Pathway, 30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
coagulation factor II (thrombin) receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000816$IPR000935:Thrombin receptor, 450003437$IPR003912:Protease-activated receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
coagulation factor II (thrombin) receptor,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038841$hsa04144:Endocytosis, 470038859$hsa04610:Complement and coagulation cascades, 470038881$hsa04810:Regulation of actin cytoskeleton]
coagulation factor II (thrombin) receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000192$blood coagulation, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
coagulation factor II (thrombin) receptor,UP_SEQ_FEATURE[850048651$chain:Proteinase-activated receptor 1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850109698$propeptide:Removed for receptor activation, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118124$site:Cleavage; by thrombin, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
coenzyme Q10 homolog A (S. cerevisiae),INTERPRO[450004501$IPR005031:Streptomyces cyclase/dehydrase]
coenzyme Q10 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630012786$PIRSF016012:uncharacterized protein with polyketide synthase domain]
coenzyme Q10 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001550$transit peptide]
coenzyme Q10 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850011898$chain:Coenzyme Q-binding protein COQ10 homolog A, mitochondrial, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
coiled-coil domain containing 38,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 38,UP_SEQ_FEATURE[850012007$chain:Coiled-coil domain-containing protein 38, 850117294$sequence conflict, 850117295$sequence variant]
coiled-coil domain containing 41,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 41,UP_SEQ_FEATURE[850012010$chain:Coiled-coil domain-containing protein 41, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 82,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 82,UP_SEQ_FEATURE[850012059$chain:Coiled-coil domain-containing protein 82, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 85B,INTERPRO[450017597$IPR019359:Protein of unknown function DUF2216]
coiled-coil domain containing 85B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000434$differentiation, 790000635$growth regulation, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
coiled-coil domain containing 85B,UP_SEQ_FEATURE[850012063$chain:Coiled-coil domain-containing protein 85B, 850106259$mutagenesis site, 850117294$sequence conflict]
coiled-coil domain containing 92,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 92,UP_SEQ_FEATURE[850012075$chain:Coiled-coil domain-containing protein 92, 850106258$modified residue, 850117295$sequence variant]
colipase, pancreatic,INTERPRO[450001754$IPR001981:Colipase, 450016227$IPR017913:Colipase, N-terminal, 450016228$IPR017914:Colipase, C-terminal, 450016229$IPR017915:Colipase, conserved site, 450016400$IPR018100:Colipase subgroup]
colipase, pancreatic,PIR_SUPERFAMILY[630002535$PIRSF002415:colipase]
colipase, pancreatic,SMART[760000016$SM00023:COLIPASE]
colipase, pancreatic,SP_PIR_KEYWORDS[790000356$complete proteome, 790000430$diabetes mellitus, 790000435$digestion, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000869$lipid degradation, 790000870$lipid digestion, 790000872$lipid hydrolysis, 790001102$pancreas, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
colipase, pancreatic,UP_SEQ_FEATURE[850012167$chain:Colipase, 850102883$disulfide bond, 850109658$propeptide:Enterostatin, activation peptide, 850117295$sequence variant, 850117814$signal peptide]
collagen, type II, alpha 1,INTERPRO[450000772$IPR000885:Fibrillar collagen, C-terminal, 450000878$IPR001007:von Willebrand factor, type C, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type II, alpha 1,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type II, alpha 1,OMIM_DISEASE[520000101$Achondrogenesis-hypochondrogenesis, type II, 520000393$Arthroophthalmopathy, progressive, 520000493$Avascular necrosis of the femoral head, 520001782$Epiphyseal dysplasia, multiple, with, 520001784$Epiphyseal dysplasia, multiple, with myopia and deafness, 520002747$Kniest dysplasia, 520002804$Legg-Calve-Perthes disease, 520003803$Osteoarthritis with mild chondrodysplasia, 520003852$Otospondylomegaepiphyseal dysplasia, 520004030$Platyspondylic skeletal dysplasia, Torrance type, 520004421$SED congenita, 520004422$SED, Namaqualand type, 520004517$SMD, 520004518$SMED Strudwick type, 520004663$Spondyloperipheral dysplasia, 520004695$Stickler sydrome, type I, nonsyndromic ocular, 520004696$Stickler syndrome, type I, 520005045$Vitreoretinopathy with phalangeal epiphyseal dysplasia]
collagen, type II, alpha 1,PIR_SUPERFAMILY[630002384$PIRSF002255:collagen alpha 1(I) chain]
collagen, type II, alpha 1,SMART[760000030$SM00038:COLFI, 760000187$SM00214:VWC]
collagen, type II, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000250$cartilage, 790000252$cataract, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000415$deafness, 790000445$direct protein sequencing, 790000446$disease mutation, 790000474$dwarfism, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001446$stickler syndrome, 790001565$trimer, 790001568$triple helix]
collagen, type II, alpha 1,UP_SEQ_FEATURE[850011231$chain:Chondrocalcin, 850012176$chain:Collagen alpha-1(II) chain, 850103779$domain:Fibrillar collagen NC1, 850105643$domain:VWFC, 850105770$glycosylation site:N-linked (GlcNAc...), 850105818$glycosylation site:O-linked (Gal...), 850106258$modified residue, 850109670$propeptide:N-terminal propeptide, 850113762$region of interest:Nonhelical region (C-terminal), 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118098$site:Cleavage; by procollagen C-endopeptidase, 850118099$site:Cleavage; by procollagen N-endopeptidase, 850118574$splice variant, 850118575$strand]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450002572$IPR002913:Lipid-binding START, 450010818$IPR011993:Pleckstrin homology-type]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,SMART[760000205$SM00233:PH, 760000206$SM00234:START]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000875$lipid transport, 790001162$phosphoprotein, 790001212$polymorphism, 790001558$transport]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,UP_SEQ_FEATURE[850012222$chain:Collagen type IV alpha-3-binding protein, 850104979$domain:PH, 850105403$domain:START, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117459$short sequence motif:FFAT, 850118574$splice variant, 850118575$strand]
collagen, type IX, alpha 2,INTERPRO[450007490$IPR008160:Collagen triple helix repeat]
collagen, type IX, alpha 2,OMIM_DISEASE[520001776$Epiphyseal dysplasia, multiple, 2, 520002663$Intervertebral disc disease, susceptibility to]
collagen, type IX, alpha 2,PIR_SUPERFAMILY[630003587$PIRSF003543:human herpesvirus 4 BHLF1 protein]
collagen, type IX, alpha 2,SP_PIR_KEYWORDS[790000308$chondroitin sulfate proteoglycan, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000474$dwarfism, 790000530$extracellular matrix, 790000616$glycoprotein, 790000687$heterotrimer, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001568$triple helix]
collagen, type IX, alpha 2,UP_SEQ_FEATURE[850012205$chain:Collagen alpha-2(IX) chain, 850102883$disulfide bond, 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850113771$region of interest:Nonhelical region 1 (NC1), 850113774$region of interest:Nonhelical region 2 (NC2), 850113775$region of interest:Nonhelical region 3 (NC3), 850113776$region of interest:Nonhelical region 4 (NC4), 850114944$region of interest:Triple-helical region 1 (COL1), 850114949$region of interest:Triple-helical region 2 (COL2), 850114951$region of interest:Triple-helical region 3 (COL3), 850114952$region of interest:Triple-helical region 4 (COL4), 850117295$sequence variant, 850117814$signal peptide]
collectin sub-family member 11,INTERPRO[450001149$IPR001304:C-type lectin, 450007490$IPR008160:Collagen triple helix repeat, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
collectin sub-family member 11,SMART[760000026$SM00034:CLECT]
collectin sub-family member 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000447$disulfide bond, 790000848$Lectin, 790000907$mannose-binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
collectin sub-family member 11,UP_SEQ_FEATURE[850012246$chain:Collectin-11, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850103389$domain:Collagen-like, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),INTERPRO[450003099$IPR003532:Short hematopoietin receptor, family 2, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),OMIM_DISEASE[520001195$Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia, 520002838$Leukemia, acute myeloid, M2 type, 520004183$Pulmonary alveolar proteinosis]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SMART[760000051$SM00060:FN3]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000634$growth factor receptor, 790000919$membrane, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),UP_SEQ_FEATURE[850022370$chain:Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
complement component 1, s subcomponent,BIOCARTA[30000066$h_classicPathway:Classical Complement Pathway, 30000067$h_compPathway:Complement Pathway]
complement component 1, s subcomponent,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000750$IPR000859:CUB, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450011699$IPR013032:EGF-like region, conserved site, 450014444$IPR016060:Complement control module, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
complement component 1, s subcomponent,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 1, s subcomponent,OMIM_DISEASE[520000719$C1r/C1s deficiency, combined, 520000720$C1s deficiency, isolated]
complement component 1, s subcomponent,PIR_SUPERFAMILY[630001305$PIRSF001155:complement-activating serine proteases C1r/C1s/MASP]
complement component 1, s subcomponent,SMART[760000013$SM00020:Tryp_SPc, 760000024$SM00032:CCP, 760000034$SM00042:CUB, 760000153$SM00179:EGF_CA]
complement component 1, s subcomponent,SP_PIR_KEYWORDS[790000002$3d-structure, 790000022$acute phase, 790000176$beta-hydroxyasparagine, 790000211$calcium, 790000212$calcium binding, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000481$egf-like domain, 790000616$glycoprotein, 790000701$homodimer, 790000743$hydrolase, 790000745$hydroxylation, 790000763$immune response, 790000777$innate immunity, 790000937$metal-binding, 790001191$plasma, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001471$sushi]
complement component 1, s subcomponent,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850012330$chain:Complement C1s subcomponent, 850012331$chain:Complement C1s subcomponent heavy chain, 850012332$chain:Complement C1s subcomponent light chain, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103705$domain:EGF-like; calcium-binding, 850104964$domain:Peptidase S1, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
congenital dyserythropoietic anemia, type I,OMIM_DISEASE[520000060$A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs), 520000305$Anemia, congenital dyserythropoietic, type I]
congenital dyserythropoietic anemia, type I,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000360$congenital dyserythropoietic anemia, 790000446$disease mutation, 790000672$hereditary hemolytic anemia, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
congenital dyserythropoietic anemia, type I,UP_SEQ_FEATURE[850011884$chain:Codanin-1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
connector enhancer of kinase suppressor of Ras 2,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001470$IPR001660:Sterile alpha motif SAM, 450001635$IPR001849:Pleckstrin homology, 450009649$IPR010599:Connector enhancer of kinase suppressor of ras 2, 450010818$IPR011993:Pleckstrin homology-type, 450012380$IPR013761:Sterile alpha motif-type, 450016193$IPR017874:CRIC domain, 450017792$IPR019555:CRIC domain, Chordata]
connector enhancer of kinase suppressor of Ras 2,SMART[760000200$SM00228:PDZ, 760000205$SM00233:PH, 760000399$SM00454:SAM]
connector enhancer of kinase suppressor of Ras 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
connector enhancer of kinase suppressor of Ras 2,UP_SEQ_FEATURE[850012467$chain:Connector enhancer of kinase suppressor of ras 2, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850103412$domain:CRIC, 850103552$domain:DUF1170, 850104918$domain:PDZ, 850104979$domain:PH, 850105249$domain:SAM, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
coronin, actin binding protein, 2B,INTERPRO[450001490$IPR001680:WD40 repeat, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 2B,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 2B,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 2B,UP_SEQ_FEATURE[850012629$chain:Coronin-2B, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cortistatin; apoptosis-inducing, TAF9-like domain 1,INTERPRO[450016435$IPR018142:Somatostatin/Cortistatin, C-terminal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,PIR_SUPERFAMILY[630001951$PIRSF001814:somatostatin]
cortistatin; apoptosis-inducing, TAF9-like domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000276$centromere, 790000315$chromosomal protein, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001065$nucleus, 790001363$Secreted, 790001405$signal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,UP_SEQ_FEATURE[850010673$chain:Centromere protein S, 850102883$disulfide bond, 850107247$peptide:Cortistatin-17, 850107248$peptide:Cortistatin-29, 850117814$signal peptide, 850118574$splice variant]
crumbs homolog 3 (Drosophila),KEGG_PATHWAY[470038857$hsa04530:Tight junction]
crumbs homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001528$Tight junction, 790001555$transmembrane]
crumbs homolog 3 (Drosophila),UP_SEQ_FEATURE[850012741$chain:Crumbs protein homolog 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cubilin (intrinsic factor-cobalamin receptor),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450000750$IPR000859:CUB, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
cubilin (intrinsic factor-cobalamin receptor),OMIM_DISEASE[520003120$Megaloblastic anemia-1, Finnish type]
cubilin (intrinsic factor-cobalamin receptor),PIR_SUPERFAMILY[630027753$PIRSF036316:intrinsic factor-B12 receptor cubilin]
cubilin (intrinsic factor-cobalamin receptor),SMART[760000034$SM00042:CUB, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
cubilin (intrinsic factor-cobalamin receptor),SP_PIR_KEYWORDS[790000211$calcium, 790000305$cholesterol metabolism, 790000329$cleavage on pair of basic residues, 790000336$Cobalamin, 790000338$cobalt, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000501$endosome, 790000616$glycoprotein, 790000873$lipid metabolism, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001442$steroid metabolism, 790001558$transport, 790001625$vitamin B12 uptake]
cubilin (intrinsic factor-cobalamin receptor),UP_SEQ_FEATURE[850012808$chain:Cubilin, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103434$domain:CUB 10, 850103435$domain:CUB 11, 850103436$domain:CUB 12, 850103437$domain:CUB 13, 850103438$domain:CUB 14, 850103439$domain:CUB 15, 850103440$domain:CUB 16, 850103441$domain:CUB 17, 850103442$domain:CUB 18, 850103443$domain:CUB 19, 850103444$domain:CUB 2, 850103445$domain:CUB 20, 850103446$domain:CUB 21, 850103447$domain:CUB 22, 850103448$domain:CUB 23, 850103449$domain:CUB 24, 850103450$domain:CUB 25, 850103451$domain:CUB 26, 850103452$domain:CUB 27, 850103453$domain:CUB 3, 850103454$domain:CUB 4, 850103455$domain:CUB 5, 850103456$domain:CUB 6, 850103457$domain:CUB 7, 850103458$domain:CUB 8, 850103459$domain:CUB 9, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103699$domain:EGF-like 7; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118052$site:Cleavage; by furin]
cyclin B1 interacting protein 1,INTERPRO[450016222$IPR017907:Zinc finger, RING-type, conserved site]
cyclin B1 interacting protein 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000859$ligase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
cyclin B1 interacting protein 1,UP_SEQ_FEATURE[850016625$chain:E3 ubiquitin-protein ligase CCNB1IP1, 850106259$mutagenesis site, 850118919$zinc finger region:RING-type; atypical]
cyclin D-type binding-protein 1,BIOCARTA[30000019$h_anthraxPathway:Anthrax Toxin Mechanism of Action]
cyclin D-type binding-protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein]
cyclin D-type binding-protein 1,UP_SEQ_FEATURE[850013054$chain:Cyclin-D1-binding protein 1, 850112793$region of interest:Interaction with RPLP0, 850112909$region of interest:Interaction with TCF3, 850114328$region of interest:Required for interaction with CCND1, 850117294$sequence conflict, 850118574$splice variant]
cyclin J,INTERPRO[450003872$IPR004367:Cyclin, C-terminal, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related]
cyclin J,SMART[760000337$SM00385:CYCLIN]
cyclin J,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000389$cyclin]
cyclin J,UP_SEQ_FEATURE[850013129$chain:Cyclin-J, 850103467$domain:Cyclin N-terminal, 850118574$splice variant]
cyclin-dependent kinase 2 associated protein 2,INTERPRO[450015588$IPR017266:Cyclin-dependent kinase 2-associated protein 2, 450017433$IPR019187:Cyclin-dependent kinase 2-associated protein]
cyclin-dependent kinase 2 associated protein 2,PIR_SUPERFAMILY[630029280$PIRSF037709:CDK2-associated_p2, 630029281$PIRSF037709:cyclin-dependent kinase 2-associated protein 2]
cyclin-dependent kinase 2 associated protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000825$kinase]
cyclin-dependent kinase 2 associated protein 2,UP_SEQ_FEATURE[850013068$chain:Cyclin-dependent kinase 2-associated protein 2]
cyclin-dependent kinase 5,BBID[10000052$26.cyclin-CDK_complexes]
cyclin-dependent kinase 5,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000056$h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway, 30000065$h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors, 30000116$h_fosbPathway:FOSB gene expression and drug abuse, 30000173$h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development, 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000246$h_rac1Pathway:Rac 1 cell motility signaling pathway, 30000258$h_reelinPathway:Reelin Signaling Pathway]
cyclin-dependent kinase 5,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase 5,KEGG_PATHWAY[470038851$hsa04360:Axon guidance, 470038891$hsa05010:Alzheimer's disease]
cyclin-dependent kinase 5,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
cyclin-dependent kinase 5,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
cyclin-dependent kinase 5,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010445$chain:Cell division protein kinase 5, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),BBID[10000001$1.RBphosphoE2F, 10000052$26.cyclin-CDK_complexes, 10000115$94.E2F_transcriptional_activity_cell_cycle]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),BIOCARTA[30000024$h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis, 30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor, 30000119$h_g1Pathway:Cell Cycle: G1/S Check Point ]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),INTERPRO[450001870$IPR002110:Ankyrin, 450009899$IPR010868:Cyclin-dependent kinase inhibitor 2a p19Arf, N-terminal]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer, 470038904$hsa05214:Glioma, 470038908$hsa05218:Melanoma, 470038909$hsa05219:Bladder cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038913$hsa05223:Non-small cell lung cancer]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),OMIM_DISEASE[520000046$A common variant on chromosome 9p21 affects the risk of myocardial infarction, 520000069$A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, 520001994$Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520002893$Li Fraumeni syndrome, 520003125$Melanoma and neural system tumor syndrome, 520003128$Melanoma, cutaneous malignant, 2, 520003247$Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, 520003790$Orolaryngeal cancer, multiple, 520003890$Pancreatic cancer/melanoma syndrome, 520004728$Susceptibility loci for intracranial aneurysm in European and Japanese populations]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),PIR_SUPERFAMILY[630027780$PIRSF036346:cyclin-dependent kinase inhibitor p19]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),SMART[760000220$SM00248:ANK]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000109$Apoptosis, 790000258$cell cycle, 790000259$cell cycle control, 790000356$complete proteome, 790000389$cyclin, 790000407$cytoplasm, 790000446$disease mutation, 790000466$dna-binding, 790000825$kinase, 790000858$Li-Fraumeni syndrome, 790001065$nucleus, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001304$repeat, 790001345$rrna processing, 790001539$Transcription, 790001543$transcription regulation, 790001580$tumor suppressor]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),UP_SEQ_FEATURE[850013103$chain:Cyclin-dependent kinase inhibitor 2A, isoform 4, 850013105$chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3, 850105852$helix, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cysteine and glycine-rich protein 3 (cardiac LIM protein),INTERPRO[450001575$IPR001781:Zinc finger, LIM-type]
cysteine and glycine-rich protein 3 (cardiac LIM protein),OMIM_DISEASE[520000775$Cardiomyopathy, dilated, 1M, 520000799$Cardiomyopathy, familial hypertrophic, 12]
cysteine and glycine-rich protein 3 (cardiac LIM protein),PIR_SUPERFAMILY[630014596$PIRSF017937:cysteine and glycine-rich protein]
cysteine and glycine-rich protein 3 (cardiac LIM protein),SMART[760000114$SM00132:LIM]
cysteine and glycine-rich protein 3 (cardiac LIM protein),SP_PIR_KEYWORDS[790000002$3d-structure, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000864$LIM domain, 790000937$metal-binding, 790001001$myogenesis, 790001065$nucleus, 790001304$repeat, 790001648$zinc]
cysteine and glycine-rich protein 3 (cardiac LIM protein),UP_SEQ_FEATURE[850013239$chain:Cysteine and glycine-rich protein 3, 850102517$compositionally biased region:Gly-rich, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn]
cysteine and histidine-rich domain (CHORD)-containing 1; cysteine and histidine-rich domain (CHORD)-containing 1 pseudogene,INTERPRO[450006445$IPR007051:CHORD, 450006446$IPR007052:CS domain, 450015774$IPR017447:CS]
cysteine and histidine-rich domain (CHORD)-containing 1; cysteine and histidine-rich domain (CHORD)-containing 1 pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
cysteine and histidine-rich domain (CHORD)-containing 1; cysteine and histidine-rich domain (CHORD)-containing 1 pseudogene,UP_SEQ_FEATURE[850013240$chain:Cysteine and histidine-rich domain- containing protein 1, 850103353$domain:CHORD 1, 850103354$domain:CHORD 2, 850103417$domain:CS, 850105852$helix, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106235$metal ion-binding site:Zinc 3, 850106236$metal ion-binding site:Zinc 4, 850106258$modified residue, 850112424$region of interest:Interaction with HSP90AA1 and HSP90AB1, 850112705$region of interest:Interaction with PPP5C, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cysteine-rich with EGF-like domains 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450005638$IPR006212:Furin-like repeat, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
cysteine-rich with EGF-like domains 1,OMIM_DISEASE[520000460$Atrioventricular septal defect, partial, with heterotaxy syndrome, 520000461$Atrioventricular septal defect, susceptibility to, 2]
cysteine-rich with EGF-like domains 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000233$SM00261:FU]
cysteine-rich with EGF-like domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
cysteine-rich with EGF-like domains 1,UP_SEQ_FEATURE[850013392$chain:Cysteine-rich with EGF-like domain protein 1, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850116009$repeat:FU 1, 850116015$repeat:FU 2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cytochrome P450, family 19, subfamily A, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 19, subfamily A, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 19, subfamily A, polypeptide 1,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism]
cytochrome P450, family 19, subfamily A, polypeptide 1,OMIM_DISEASE[520000368$Aromatase deficiency, 520000369$Aromatase excess syndrome, 520004150$Pseudohermaphroditism, female, due to placental aromatase deficiency]
cytochrome P450, family 19, subfamily A, polypeptide 1,PIR_SUPERFAMILY[630000062$PIRSF000049:cytochrome P450 CYP19]
cytochrome P450, family 19, subfamily A, polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001440$Steroid biosynthesis, 790001556$transmembrane protein]
cytochrome P450, family 19, subfamily A, polypeptide 1,UP_SEQ_FEATURE[850013664$chain:Cytochrome P450 19A1, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cytochrome P450, family 27, subfamily B, polypeptide 1,BIOCARTA[30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 27, subfamily B, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 27, subfamily B, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 27, subfamily B, polypeptide 1,KEGG_PATHWAY[470038736$hsa00100:Steroid biosynthesis]
cytochrome P450, family 27, subfamily B, polypeptide 1,OMIM_DISEASE[520005036$vitamin D-dependent rickets type I, 520005037$Vitamin D-dependent rickets, type I]
cytochrome P450, family 27, subfamily B, polypeptide 1,PIR_SUPERFAMILY[630000059$PIRSF000046:cytochrome P450 CYP11B1]
cytochrome P450, family 27, subfamily B, polypeptide 1,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000446$disease mutation, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000969$mitochondrion, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
cytochrome P450, family 27, subfamily B, polypeptide 1,UP_SEQ_FEATURE[850001225$chain:25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
cytochrome P450, family 4, subfamily A, polypeptide 11,BIOCARTA[30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 4, subfamily A, polypeptide 11,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 4, subfamily A, polypeptide 11,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 4, subfamily A, polypeptide 11,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038780$hsa00590:Arachidonic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038821$hsa03320:PPAR signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction]
cytochrome P450, family 4, subfamily A, polypeptide 11,PIR_SUPERFAMILY[630000063$PIRSF000050:cytochrome P450 CYP4B1]
cytochrome P450, family 4, subfamily A, polypeptide 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000544$fatty acid oxidation, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 4, subfamily A, polypeptide 11,UP_SEQ_FEATURE[850000392$binding site:Heme (covalent; via 1 link), 850013783$chain:Cytochrome P450 4A11, 850102576$compositionally biased region:Poly-Leu, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 4, subfamily Z, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 4, subfamily Z, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 4, subfamily Z, polypeptide 1,PIR_SUPERFAMILY[630000063$PIRSF000050:cytochrome P450 CYP4B1]
cytochrome P450, family 4, subfamily Z, polypeptide 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
cytochrome P450, family 4, subfamily Z, polypeptide 1,UP_SEQ_FEATURE[850013817$chain:Cytochrome P450 4Z1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
cytochrome b, ascorbate dependent 3,INTERPRO[450004351$IPR004877:Cytochrome b561, eukaryote, 450006013$IPR006593:Cytochrome b561/ferric reductase transmembrane]
cytochrome b, ascorbate dependent 3,PIR_SUPERFAMILY[630013304$PIRSF016525:cytochrome b561]
cytochrome b, ascorbate dependent 3,SMART[760000578$SM00665:B561]
cytochrome b, ascorbate dependent 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000489$electron transport, 790000501$endosome, 790000616$glycoprotein, 790000652$heme, 790000802$iron, 790000897$lysosome, 790000919$membrane, 790000937$metal-binding, 790001092$oxidoreductase, 790001555$transmembrane, 790001558$transport]
cytochrome b, ascorbate dependent 3,UP_SEQ_FEATURE[850013429$chain:Cytochrome b ascorbate-dependent protein 3, 850103473$domain:Cytochrome b561, 850105770$glycosylation site:N-linked (GlcNAc...), 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850118623$transmembrane region]
cytochrome b5 reductase-like,INTERPRO[450001275$IPR001433:Oxidoreductase FAD/NAD(P)-binding, 450001622$IPR001834:NADH:cytochrome b5 reductase (CBR), 450007611$IPR008333:Oxidoreductase FAD-binding region, 450016241$IPR017927:Ferredoxin reductase-type FAD-binding domain]
cytochrome b5 reductase-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000537$FAD, 790000559$Flavoprotein, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
cytochrome b5 reductase-like,UP_SEQ_FEATURE[850033584$chain:NADH-cytochrome b5 reductase-like, 850103737$domain:FAD-binding FR-type, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118574$splice variant]
cytoskeleton associated protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism]
cytoskeleton associated protein 2,UP_SEQ_FEATURE[850014066$chain:Cytoskeleton-associated protein 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytoskeleton associated protein 5,INTERPRO[450000307$IPR000357:HEAT, 450010814$IPR011989:Armadillo-like helical]
cytoskeleton associated protein 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000973$mitosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
cytoskeleton associated protein 5,UP_SEQ_FEATURE[850014069$chain:Cytoskeleton-associated protein 5, 850106258$modified residue, 850116140$repeat:HEAT 1, 850116141$repeat:HEAT 10, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850116168$repeat:HEAT 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dachsous 1 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 1 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 1 (Drosophila),SP_PIR_KEYWORDS[790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
dachsous 1 (Drosophila),UP_SEQ_FEATURE[850048752$chain:Protocadherin-16, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103226$domain:Cadherin 23, 850103227$domain:Cadherin 24, 850103228$domain:Cadherin 25, 850103229$domain:Cadherin 26, 850103230$domain:Cadherin 27, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
death effector domain containing 2,INTERPRO[450001658$IPR001875:Death effector]
death effector domain containing 2,SMART[760000023$SM00031:DED]
death effector domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
death effector domain containing 2,UP_SEQ_FEATURE[850015883$chain:DNA-binding death effector domain- containing protein 2, 850103511$domain:DED, 850117294$sequence conflict, 850117325$short sequence motif:Bipartite nuclear localization signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
decorin,COG_ONTOLOGY[90000070$Function unknown]
decorin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014674$IPR016352:Small leucine-rich proteoglycan, class I, decorin/asporin/byglycan]
decorin,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
decorin,OMIM_DISEASE[520001209$Corneal dystrophy, congenital stromal]
decorin,PIR_SUPERFAMILY[630002608$PIRSF002490:class I small leucine-rich proteoglycan, decorin/asporin/byglycan types, 630002609$PIRSF002490:SLRP_I]
decorin,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
decorin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000308$chondroitin sulfate proteoglycan, 790000346$collagen binding, 790000356$complete proteome, 790000424$dermatan sulfate, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat]
decorin,UP_SEQ_FEATURE[850014440$chain:Decorin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
dedicator of cytokinesis 8,INTERPRO[450009747$IPR010703:Dedicator of cytokinesis]
dedicator of cytokinesis 8,OMIM_DISEASE[520003160$Mental retardation, autosomal dominant 2]
dedicator of cytokinesis 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
dedicator of cytokinesis 8,UP_SEQ_FEATURE[850014452$chain:Dedicator of cytokinesis protein 8, 850103522$domain:DHR-1, 850103523$domain:DHR-2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dehydrodolichyl diphosphate synthase,INTERPRO[450001283$IPR001441:Di-trans-poly-cis-decaprenylcistransferase-like, 450016792$IPR018520:Di-trans-poly-cis-decaprenylcistransferase-like, conserved site]
dehydrodolichyl diphosphate synthase,KEGG_PATHWAY[470038803$hsa00900:Terpenoid backbone biosynthesis]
dehydrodolichyl diphosphate synthase,PIR_SUPERFAMILY[630005562$PIRSF005638:cis-prenyltransferase, 630030528$PIRSF500283:dehydrodolichyl diphosphate synthase, Fungi/Metazoa type]
dehydrodolichyl diphosphate synthase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001547$transferase]
dehydrodolichyl diphosphate synthase,UP_SEQ_FEATURE[850014707$chain:Dehydrodolichyl diphosphate synthase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dehydrogenase E1 and transketolase domain containing 1,INTERPRO[450000890$IPR001017:Dehydrogenase, E1 component, 450004931$IPR005475:Transketolase, central region, 450010434$IPR011603:2-oxoglutarate dehydrogenase, E1 component]
dehydrogenase E1 and transketolase domain containing 1,PIR_SUPERFAMILY[630000186$PIRSF000157:2-oxoglutarate dehydrogenase, E1 component, 630000187$PIRSF000157:Oxoglu_dh_E1]
dehydrogenase E1 and transketolase domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000615$glycolysis, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001503$thiamine pyrophosphate, 790001550$transit peptide]
dehydrogenase E1 and transketolase domain containing 1,UP_SEQ_FEATURE[850040661$chain:Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
dehydrogenase/reductase (SDR family) member 4 like 2,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
dehydrogenase/reductase (SDR family) member 4 like 2,KEGG_PATHWAY[470038801$hsa00830:Retinol metabolism]
dehydrogenase/reductase (SDR family) member 4 like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
dehydrogenase/reductase (SDR family) member 4 like 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850014723$chain:Dehydrogenase/reductase SDR family member 4-like 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
delta-like 2 homolog (Drosophila),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001280$IPR001438:EGF-like, type 2, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
delta-like 2 homolog (Drosophila),SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
delta-like 2 homolog (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
delta-like 2 homolog (Drosophila),UP_SEQ_FEATURE[850045565$chain:Protein delta homolog 2, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
developmental pluripotency associated 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism]
developmental pluripotency associated 3,UP_SEQ_FEATURE[850014969$chain:Developmental pluripotency-associated protein 3, 850117294$sequence conflict, 850117295$sequence variant]
diablo homolog (Drosophila),BBID[10000023$126.Apoptosis-Bcl-2, 10000024$127.Mito-stress, 10000103$81.Structure_of_Caps_and_SMACs]
diablo homolog (Drosophila),BIOCARTA[30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling]
diablo homolog (Drosophila),INTERPRO[450013589$IPR015142:Second mitochondria-derived activator of caspase/Direct IAP-binding protein with low PI]
diablo homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000969$mitochondrion, 790001550$transit peptide]
diablo homolog (Drosophila),UP_SEQ_FEATURE[850014989$chain:Diablo homolog, mitochondrial, 850105852$helix, 850117294$sequence conflict, 850117494$short sequence motif:IAP-binding, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion]
dickkopf homolog 3 (Xenopus laevis),INTERPRO[450006202$IPR006796:Dickkopf, N-terminal cysteine-rich]
dickkopf homolog 3 (Xenopus laevis),PIR_SUPERFAMILY[630012236$PIRSF015386:Dickkopf-related protein 3 (Dkk-3)]
dickkopf homolog 3 (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001642$wnt signaling pathway]
dickkopf homolog 3 (Xenopus laevis),UP_SEQ_FEATURE[850015042$chain:Dickkopf-related protein 3, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850111450$region of interest:DKK-type Cys-1, 850111451$region of interest:DKK-type Cys-2, 850117295$sequence variant, 850117814$signal peptide]
diencephalon/mesencephalon homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450003200$IPR003654:Paired-like homeodomain protein, OAR, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
diencephalon/mesencephalon homeobox 1,SMART[760000341$SM00389:HOX]
diencephalon/mesencephalon homeobox 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
diencephalon/mesencephalon homeobox 1,UP_SEQ_FEATURE[850015048$chain:Diencephalon/mesencephalon homeobox protein 1, 850102927$DNA-binding region:Homeobox, 850113100$region of interest:Interacts with OXT2 and is required for repressor activity, 850117294$sequence conflict, 850117295$sequence variant, 850117629$short sequence motif:OAR, 850118574$splice variant]
dihydroorotate dehydrogenase,COG_ONTOLOGY[90000090$Nucleotide transport and metabolism]
dihydroorotate dehydrogenase,INTERPRO[450001140$IPR001295:Dihydroorotate dehydrogenase, conserved site, 450005173$IPR005719:Dihydroorotate dehydrogenase, class 2, 450010918$IPR012135:Dihydroorotate dehydrogenase, classes 1 and 2, 450012397$IPR013785:Aldolase-type TIM barrel]
dihydroorotate dehydrogenase,KEGG_PATHWAY[470038744$hsa00240:Pyrimidine metabolism]
dihydroorotate dehydrogenase,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
dihydroorotate dehydrogenase,PIR_SUPERFAMILY[630000197$PIRSF000164:DHO_oxidase, 630000198$PIRSF000164:dihydroorotate oxidase]
dihydroorotate dehydrogenase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000559$Flavoprotein, 790000562$fmn, 790000919$membrane, 790000966$mitochondrial inner membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001092$oxidoreductase, 790001212$polymorphism, 790001285$pyrimidine biosynthesis, 790001287$pyrimidine nucleotide biosynthesis, 790001550$transit peptide, 790001555$transmembrane]
dihydroorotate dehydrogenase,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850015129$chain:Dihydroorotate dehydrogenase, mitochondrial, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region, 850118624$turn]
discs, large (Drosophila) homolog-associated protein 3,INTERPRO[450004495$IPR005026:Guanylate-kinase-associated protein]
discs, large (Drosophila) homolog-associated protein 3,PIR_SUPERFAMILY[630014622$PIRSF017965:disks large-associated protein 1]
discs, large (Drosophila) homolog-associated protein 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse]
discs, large (Drosophila) homolog-associated protein 3,UP_SEQ_FEATURE[850015435$chain:Disks large-associated protein 3, 850102574$compositionally biased region:Poly-His, 850106258$modified residue]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000015$h_alkPathway:ALK in cardiac myocytes, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000137$h_hesPathway:Segmentation Clock, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,INTERPRO[450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450001015$IPR001158:DIX, 450001316$IPR001478:PDZ/DHR/GLGF, 450002925$IPR003351:Dishevelled protein, 450007617$IPR008339:Dishevelled region, 450007618$IPR008340:Dishevelled-1 protein, 450010816$IPR011991:Winged helix repressor DNA-binding, 450013947$IPR015506:Dishevelled related protein]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,SMART[760000014$SM00021:DAX, 760000041$SM00049:DEP, 760000200$SM00228:PDZ]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001162$phosphoprotein, 790001592$ubl conjugation, 790001642$wnt signaling pathway]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,UP_SEQ_FEATURE[850059217$chain:Segment polarity protein dishevelled homolog DVL-1, 850059218$chain:Segment polarity protein dishevelled homolog DVL-1-like, 850102566$compositionally biased region:Poly-Arg, 850103515$domain:DEP, 850103527$domain:DIX, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),INTERPRO[450016755$IPR018481:Glycosyl transferase, family 4, conserved region]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),OMIM_DISEASE[520001181$Congenital disorder of glycosylation, type Ij]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),PIR_SUPERFAMILY[630006312$PIRSF006375:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000359$congenital disorder of glycosylation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),UP_SEQ_FEATURE[850068279$chain:UDP-N-acetylglucosamine--dolichyl- phosphate N- acetylglucosaminephosphotransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117422$short sequence motif:Dolichol recognition, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
downstream neighbor of SON,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein]
downstream neighbor of SON,UP_SEQ_FEATURE[850045640$chain:Protein downstream neighbor of Son, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dual specificity phosphatase 5,INTERPRO[450000291$IPR000340:Dual specificity phosphatase, catalytic domain, 450000292$IPR000340:Protein-tyrosine phosphatase, dual specificity, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450001562$IPR001763:Rhodanese-like, 450007621$IPR008343:MAP kinase phosphatase, 450012969$IPR014393:Dual specificity protein phosphatase (MAP kinase phosphatase), 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
dual specificity phosphatase 5,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
dual specificity phosphatase 5,PIR_SUPERFAMILY[630001087$PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase), 630001088$PIRSF000939:MAPK_Ptase]
dual specificity phosphatase 5,SMART[760000169$SM00195:DSPc, 760000395$SM00450:RHOD]
dual specificity phosphatase 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000743$hydrolase, 790001065$nucleus, 790001212$polymorphism, 790001261$protein phosphatase]
dual specificity phosphatase 5,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850016440$chain:Dual specificity protein phosphatase 5, 850102573$compositionally biased region:Poly-Gly, 850105184$domain:Rhodanese, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand]
dynactin 5 (p25),INTERPRO[450001293$IPR001451:Bacterial transferase hexapeptide repeat]
dynactin 5 (p25),OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
dynactin 5 (p25),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
dynactin 5 (p25),UP_SEQ_FEATURE[850016482$chain:Dynactin subunit 5]
dynamin 1-like,COG_ONTOLOGY[90000073$General function prediction only]
dynamin 1-like,INTERPRO[450000320$IPR000375:Dynamin central region, 450001246$IPR001401:Dynamin, GTPase region, 450002754$IPR003130:Dynamin GTPase effector, 450017997$IPR019762:Dynamin, GTPase region, conserved site]
dynamin 1-like,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038872$hsa04666:Fc gamma R-mediated phagocytosis]
dynamin 1-like,OMIM_DISEASE[520001679$Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission]
dynamin 1-like,PIR_SUPERFAMILY[630005064$PIRSF005108:dynamin-related, VPS1]
dynamin 1-like,SMART[760000045$SM00053:DYNc, 760000272$SM00302:GED]
dynamin 1-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000637$GTP binding, 790000639$gtp-binding, 790000743$hydrolase, 790000919$membrane, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001278$purine nucleotide binding]
dynamin 1-like,UP_SEQ_FEATURE[850016487$chain:Dynamin-1-like protein, 850104046$domain:GED, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850111134$region of interest:C-terminal dimerization domain, 850112379$region of interest:Interaction with GSK3B, 850113522$region of interest:N-terminal dimerization domain, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dynamin binding protein,BIOCARTA[30000194$h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors]
dynamin binding protein,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001294$IPR001452:Src homology-3 domain, 450003659$IPR004148:BAR, 450010373$IPR011511:Variant SH3]
dynamin binding protein,SMART[760000294$SM00325:RhoGEF, 760000295$SM00326:SH3, 760000627$SM00721:BAR]
dynamin binding protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001475$synapse]
dynamin binding protein,UP_SEQ_FEATURE[850016492$chain:Dynamin-binding protein, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850103092$domain:BAR, 850103518$domain:DH, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850105354$domain:SH3 3, 850105355$domain:SH3 4, 850105356$domain:SH3 5, 850105357$domain:SH3 6, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
dynein heavy chain domain 1,INTERPRO[450003782$IPR004273:Dynein heavy chain, 450012226$IPR013602:Dynein heavy chain, N-terminal region 2]
dynein heavy chain domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
dynein heavy chain domain 1,UP_SEQ_FEATURE[850016528$chain:Dynein heavy chain domain 1-like protein, 850016529$chain:Dynein heavy chain domain-containing protein 1, 850072967$chain:Uncharacterized protein C11orf47, 850102576$compositionally biased region:Poly-Leu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
dystonin,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning, 90000057$DNA replication, recombination, and repair]
dystonin,INTERPRO[450000887$IPR001014:Ribosomal protein L23/L25, conserved site, 450000964$IPR001101:Plectin repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450001788$IPR002017:Spectrin repeat, 450001814$IPR002048:Calcium-binding EF-hand, 450002732$IPR003108:Growth-arrest-specific protein 2, 450010817$IPR011992:EF-Hand type, 450016451$IPR018159:Spectrin/alpha-actinin, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
dystonin,PIR_SUPERFAMILY[630002765$PIRSF002662:plectin]
dystonin,SMART[760000025$SM00033:CH, 760000046$SM00054:EFh, 760000132$SM00150:SPEC, 760000215$SM00243:GAS2, 760000222$SM00250:PLEC]
dystonin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000256$cell adhesion, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000530$extracellular matrix, 790000616$glycoprotein, 790000811$isopeptide bond, 790000924$membrane protein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001592$ubl conjugation]
dystonin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850008525$chain:Bullous pemphigoid antigen 1, isoform 7, 850008527$chain:Bullous pemphigoid antigen 1, isoforms 1/2/3/4/5/8, 850008529$chain:Bullous pemphigoid antigen 1, isoforms 6/9/10, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105350$domain:SH3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111230$region of interest:Central fibrous rod domain, 850111755$region of interest:Globular 1, 850111756$region of interest:Globular 2, 850116729$repeat:Plectin 1, 850116730$repeat:Plectin 10, 850116731$repeat:Plectin 11, 850116740$repeat:Plectin 2, 850116751$repeat:Plectin 3, 850116762$repeat:Plectin 4, 850116773$repeat:Plectin 5, 850116784$repeat:Plectin 6, 850116795$repeat:Plectin 7, 850116803$repeat:Plectin 8, 850116804$repeat:Plectin 9, 850117015$repeat:Spectrin 1, 850117016$repeat:Spectrin 10, 850117017$repeat:Spectrin 11, 850117018$repeat:Spectrin 12, 850117019$repeat:Spectrin 13, 850117020$repeat:Spectrin 14, 850117021$repeat:Spectrin 15, 850117022$repeat:Spectrin 16, 850117023$repeat:Spectrin 17, 850117024$repeat:Spectrin 18, 850117025$repeat:Spectrin 19, 850117026$repeat:Spectrin 2, 850117027$repeat:Spectrin 20, 850117028$repeat:Spectrin 21, 850117029$repeat:Spectrin 22, 850117030$repeat:Spectrin 23, 850117031$repeat:Spectrin 24, 850117032$repeat:Spectrin 25, 850117033$repeat:Spectrin 26, 850117034$repeat:Spectrin 27, 850117035$repeat:Spectrin 28, 850117036$repeat:Spectrin 29, 850117037$repeat:Spectrin 3, 850117046$repeat:Spectrin 4, 850117047$repeat:Spectrin 5, 850117048$repeat:Spectrin 6, 850117049$repeat:Spectrin 7, 850117050$repeat:Spectrin 8, 850117051$repeat:Spectrin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dystrobrevin, alpha,INTERPRO[450000371$IPR000433:Zinc finger, ZZ-type, 450010817$IPR011992:EF-Hand type, 450013600$IPR015153:EF-hand, region 1, 450013601$IPR015154:EF-hand, region 2, 450015760$IPR017432:Distrobrevin]
dystrobrevin, alpha,OMIM_DISEASE[520002801$Left ventricular noncompaction with congenital heart defects, 520002802$Left ventricular noncompaction, familial isolated, 1]
dystrobrevin, alpha,PIR_SUPERFAMILY[630029818$PIRSF038204:Distrobrevin]
dystrobrevin, alpha,SMART[760000262$SM00291:ZnF_ZZ]
dystrobrevin, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000937$metal-binding, 790001162$phosphoprotein, 790001475$synapse, 790001648$zinc, 790001651$zinc-finger]
dystrobrevin, alpha,UP_SEQ_FEATURE[850016560$chain:Dystrobrevin alpha, 850105852$helix, 850106258$modified residue, 850114839$region of interest:Syntrophin-binding region, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118951$zinc finger region:ZZ-type]
dystroglycan 1 (dystrophin-associated glycoprotein 1),BBID[10000002$10.Dysdap, 10000084$63.LAT_couples_T-cell_receptor, 10000104$82.TCR_and_Cap_or_SMAC]
dystroglycan 1 (dystrophin-associated glycoprotein 1),BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation]
dystroglycan 1 (dystrophin-associated glycoprotein 1),INTERPRO[450006062$IPR006644:Dystroglycan-type cadherin-like, 450007739$IPR008465:Dystroglycan, 450012396$IPR013783:Immunoglobulin-like fold]
dystroglycan 1 (dystrophin-associated glycoprotein 1),KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy, 470038923$hsa05416:Viral myocarditis]
dystroglycan 1 (dystrophin-associated glycoprotein 1),SMART[760000642$SM00736:CADG]
dystroglycan 1 (dystrophin-associated glycoprotein 1),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
dystroglycan 1 (dystrophin-associated glycoprotein 1),UP_SEQ_FEATURE[850004758$chain:Alpha-dystroglycan, 850007674$chain:Beta-dystroglycan, 850102883$disulfide bond, 850104974$domain:Peptidase S72, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ecotropic viral integration site 5,INTERPRO[450000166$IPR000195:RabGAP/TBC]
ecotropic viral integration site 5,SMART[760000143$SM00164:TBC]
ecotropic viral integration site 5,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ecotropic viral integration site 5,UP_SEQ_FEATURE[850016903$chain:Ecotropic viral integration site 5 protein homolog, 850102597$compositionally biased region:Ser-rich, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850111439$region of interest:Dimerization, 850112071$region of interest:Interaction with alpha-tubulin, gamma- tubulin, BIRC5 and FBXO5, 850112112$region of interest:Interaction with AURKB and INCENP, 850114858$region of interest:Targeting to the centrosomes, 850117294$sequence conflict, 850117295$sequence variant, 850117879$site:Breakpoint for translocation to form EVI5-TRNG10 fusion protein]
ectodermal-neural cortex (with BTB-like domain),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450014333$IPR015916:Galactose oxidase, beta-propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
ectodermal-neural cortex (with BTB-like domain),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
ectodermal-neural cortex (with BTB-like domain),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
ectodermal-neural cortex (with BTB-like domain),SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000819$kelch repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
ectodermal-neural cortex (with BTB-like domain),UP_SEQ_FEATURE[850016911$chain:Ectoderm-neural cortex protein 1, 850103177$domain:BTB, 850106258$modified residue, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117294$sequence conflict, 850117295$sequence variant]
electron-transfer-flavoprotein, alpha polypeptide,COG_ONTOLOGY[90000064$Energy production and conversion]
electron-transfer-flavoprotein, alpha polypeptide,INTERPRO[450001152$IPR001308:Electron transfer flavoprotein, alpha subunit, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450013181$IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal, 450013182$IPR014731:Electron transfer flavoprotein, alpha subunit, C-terminal, 450016493$IPR018206:Electron transfer flavoprotein, alpha subunit, C-terminal, conserved site]
electron-transfer-flavoprotein, alpha polypeptide,OMIM_DISEASE[520002133$Glutaricaciduria, type IIA]
electron-transfer-flavoprotein, alpha polypeptide,PIR_SUPERFAMILY[630000101$PIRSF000089:Electra_flavoP_a, 630000102$PIRSF000089:electron transfer flavoprotein, alpha subunit]
electron-transfer-flavoprotein, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000489$electron transport, 790000537$FAD, 790000559$Flavoprotein, 790000601$Glutaricaciduria, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide, 790001558$transport]
electron-transfer-flavoprotein, alpha polypeptide,UP_SEQ_FEATURE[850017044$chain:Electron transfer flavoprotein subunit alpha, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
enabled homolog (Drosophila),INTERPRO[450000132$IPR000156:Ran Binding Protein 1, 450000597$IPR000697:EVH1, 450010818$IPR011993:Pleckstrin homology-type, 450013334$IPR014885:VASP tetramerisation]
enabled homolog (Drosophila),KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
enabled homolog (Drosophila),SMART[760000141$SM00160:RanBD, 760000406$SM00461:WH1]
enabled homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000263$cell junction, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001399$sh3-binding, 790001475$synapse]
enabled homolog (Drosophila),UP_SEQ_FEATURE[850045744$chain:Protein enabled homolog, 850102586$compositionally biased region:Pro-rich, 850105697$domain:WH1, 850105852$helix, 850106258$modified residue, 850110773$region of interest:9 X 5 AA tandem repeats of [LMQ]-E-[QR]- E-[QR], 850111645$region of interest:EVH2, 850111646$region of interest:EVH2 block A, 850111647$region of interest:EVH2 block B, 850111648$region of interest:EVH2 block C, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117535$short sequence motif:KLKR, 850118574$splice variant, 850118575$strand, 850118624$turn]
endothelin converting enzyme 1,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
endothelin converting enzyme 1,INTERPRO[450000617$IPR000718:Peptidase M13, neprilysin, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008005$IPR008753:Peptidase M13, 450016770$IPR018497:Peptidase M13, neprilysin, C-terminal]
endothelin converting enzyme 1,OMIM_DISEASE[520002339$Hirschsprung disease, cardiac defects, and autonomic dysfunction, 520002479$Hypertension, essential, susceptibility to]
endothelin converting enzyme 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000693$hirschsprung disease, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
endothelin converting enzyme 1,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850017442$chain:Endothelin-converting enzyme 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
enhancer of polycomb homolog 1 (Drosophila),INTERPRO[450008701$IPR009607:Enhancer of polycomb, C-terminal, 450017779$IPR019542:Enhancer of polycomb-like]
enhancer of polycomb homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000445$direct protein sequencing, 790000635$growth regulation, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
enhancer of polycomb homolog 1 (Drosophila),UP_SEQ_FEATURE[850017464$chain:Enhancer of polycomb homolog 1, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
enolase 3 (beta, muscle),INTERPRO[450000822$IPR000941:Enolase]
enolase 3 (beta, muscle),KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038814$hsa03018:RNA degradation]
enolase 3 (beta, muscle),OMIM_DISEASE[520001699$Enolase-beta deficiency]
enolase 3 (beta, muscle),PIR_SUPERFAMILY[630001557$PIRSF001400:Enolase]
enolase 3 (beta, muscle),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000611$glycogen storage disease, 790000615$glycolysis, 790000891$lyase, 790000899$magnesium, 790000937$metal-binding, 790001212$polymorphism]
enolase 3 (beta, muscle),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850007680$chain:Beta-enolase, 850106107$metal ion-binding site:Magnesium, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118574$splice variant]
epithelial splicing regulatory protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
epithelial splicing regulatory protein 1,SMART[760000328$SM00360:RRM]
epithelial splicing regulatory protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
epithelial splicing regulatory protein 1,UP_SEQ_FEATURE[850017707$chain:Epithelial splicing regulatory protein 1, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
erythroid associated factor,BIOCARTA[30000009$h_ahspPathway:Hemoglobin's Chaperone, 30000018$h_amiPathway:Acute Myocardial Infarction]
erythroid associated factor,INTERPRO[450013759$IPR015317:Alpha-haemoglobin stabilising protein]
erythroid associated factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
erythroid associated factor,UP_SEQ_FEATURE[850004799$chain:Alpha-hemoglobin-stabilizing protein, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
essential meiotic endonuclease 1 homolog 1 (S. pombe),INTERPRO[450005598$IPR006166:DNA repair nuclease, XPF-type/Helicase]
essential meiotic endonuclease 1 homolog 1 (S. pombe),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
essential meiotic endonuclease 1 homolog 1 (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
essential meiotic endonuclease 1 homolog 1 (S. pombe),UP_SEQ_FEATURE[850012709$chain:Crossover junction endonuclease EME1, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
etoposide induced 2.4 mRNA,INTERPRO[450008976$IPR009890:Etoposide-induced 2.4]
etoposide induced 2.4 mRNA,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
etoposide induced 2.4 mRNA,PIR_SUPERFAMILY[630029664$PIRSF038080:etoposide-induced protein 2.4]
etoposide induced 2.4 mRNA,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
etoposide induced 2.4 mRNA,UP_SEQ_FEATURE[850018033$chain:Etoposide-induced protein 2.4 homolog, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
eukaryotic translation initiation factor 1A domain containing,INTERPRO[450001105$IPR001253:Translation initiation factor 1A (eIF-1A), 450005623$IPR006196:S1, IF1 type, 450011038$IPR012340:Nucleic acid-binding, OB-fold]
eukaryotic translation initiation factor 1A domain containing,SMART[760000567$SM00652:eIF1a]
eukaryotic translation initiation factor 1A domain containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
eukaryotic translation initiation factor 1A domain containing,UP_SEQ_FEATURE[850043652$chain:Probable RNA-binding protein EIF1AD, 850102572$compositionally biased region:Poly-Glu, 850105242$domain:S1-like, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
eukaryotic translation initiation factor 2-alpha kinase 2,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000250$h_ranklPathway:Bone Remodelling, 30000262$h_rnaPathway:Double Stranded RNA Induced Gene Expression, 30000300$h_tollPathway:Toll-Like Receptor Pathway]
eukaryotic translation initiation factor 2-alpha kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001016$IPR001159:Double-stranded RNA binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450013172$IPR014720:Double-stranded RNA-binding-like, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
eukaryotic translation initiation factor 2-alpha kinase 2,SMART[760000326$SM00358:DSRM]
eukaryotic translation initiation factor 2-alpha kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000104$Antiviral defense, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001388$serine/threonine-protein kinase, 790001547$transferase]
eukaryotic translation initiation factor 2-alpha kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850026469$chain:Interferon-induced, double-stranded RNA- activated protein kinase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850109967$region of interest:2 X 13 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
eukaryotic translation initiation factor 4 gamma, 2,INTERPRO[450002885$IPR003307:eIF4-gamma/eIF5/eIF2-epsilon, 450003415$IPR003890:MIF4G-like, type 3, 450003416$IPR003891:Initiation factor eIF-4 gamma, MA3, 450014420$IPR016021:MIF4-like, type 1/2/3]
eukaryotic translation initiation factor 4 gamma, 2,KEGG_PATHWAY[470038923$hsa05416:Viral myocarditis]
eukaryotic translation initiation factor 4 gamma, 2,SMART[760000457$SM00515:eIF5C, 760000483$SM00543:MIF4G, 760000484$SM00544:MA3]
eukaryotic translation initiation factor 4 gamma, 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000776$Initiation factor, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001307$repressor, 790001551$translation regulation]
eukaryotic translation initiation factor 4 gamma, 2,UP_SEQ_FEATURE[850018126$chain:Eukaryotic translation initiation factor 4 gamma 2, 850104771$domain:MI, 850104778$domain:MIF4G, 850105686$domain:W2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
eukaryotic translation initiation factor 5,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000096$h_eifPathway:Eukaryotic protein translation]
eukaryotic translation initiation factor 5,INTERPRO[450002426$IPR002735:Translation initiation factor IF2/IF5, 450002885$IPR003307:eIF4-gamma/eIF5/eIF2-epsilon]
eukaryotic translation initiation factor 5,SMART[760000457$SM00515:eIF5C, 760000568$SM00653:eIF2B_5]
eukaryotic translation initiation factor 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000639$gtp-binding, 790000776$Initiation factor, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 5,UP_SEQ_FEATURE[850018150$chain:Eukaryotic translation initiation factor 5, 850102459$compositionally biased region:Asp-rich (acidic), 850102468$compositionally biased region:Asp/Glu-rich (highly acidic), 850105686$domain:W2, 850105852$helix, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,INTERPRO[450001666$IPR001884:Eukaryotic initiation factor 5A hypusine (eIF-5A), 450001667$IPR001884:Translation elongation factor, IF5A, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450013174$IPR014722:Translation protein SH3-like, subgroup, 450018003$IPR019769:Eukaryotic initiation factor 5A, hypusine site, 450018004$IPR019769:Translation elongation factor, IF5A, hypusine site]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,PIR_SUPERFAMILY[630003113$PIRSF003025:eIF5A, 630003114$PIRSF003025:translation initiation factor eIF-5A]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000491$elongation factor, 790000499$endoplasmic reticulum, 790000754$hypusine, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001266$protein transport, 790001339$rna-binding, 790001554$translocation, 790001558$transport]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,UP_SEQ_FEATURE[850018152$chain:Eukaryotic translation initiation factor 5A-1, 850018153$chain:Eukaryotic translation initiation factor 5A-1-like, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111472$region of interest:DOHH-binding, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
exocyst complex component 6,INTERPRO[450006595$IPR007225:Exocyst complex subunit Sec15-like]
exocyst complex component 6,PIR_SUPERFAMILY[630019487$PIRSF025007:exocyst complex, component Sec15, 630019488$PIRSF025007:Sec15]
exocyst complex component 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000522$exocytosis, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
exocyst complex component 6,UP_SEQ_FEATURE[850018194$chain:Exocyst complex component 6, 850117294$sequence conflict, 850117295$sequence variant]
exonuclease 3'-5' domain containing 2,INTERPRO[450002278$IPR002562:3'-5' exonuclease]
exonuclease 3'-5' domain containing 2,SMART[760000419$SM00474:35EXOc]
exonuclease 3'-5' domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism]
exonuclease 3'-5' domain containing 2,UP_SEQ_FEATURE[850018235$chain:Exonuclease 3'-5' domain-containing protein 2, 850102974$domain:3'-5' exonuclease, 850117294$sequence conflict, 850117295$sequence variant]
exophilin 5,INTERPRO[450009940$IPR010911:Rab-binding domain]
exophilin 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
exophilin 5,UP_SEQ_FEATURE[850018239$chain:Exophilin-5, 850105137$domain:RabBD, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
exosome component 10,INTERPRO[450001879$IPR002121:Helicase and RNase D C-terminal, HRDC, 450002278$IPR002562:3'-5' exonuclease, 450011268$IPR012588:Exosome-associated factor Rrp6, N-terminal]
exosome component 10,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
exosome component 10,SMART[760000309$SM00341:HRDC, 760000419$SM00474:35EXOc]
exosome component 10,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001043$nonsense-mediated mrna decay, 790001049$nuclease, 790001065$nucleus, 790001339$rna-binding, 790001345$rrna processing]
exosome component 10,UP_SEQ_FEATURE[850018285$chain:Exosome component 10, 850104151$domain:HRDC, 850105852$helix, 850118574$splice variant, 850118575$strand, 850118624$turn]
eyes absent homolog 3 (Drosophila),INTERPRO[450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005968$IPR006545:EYA]
eyes absent homolog 3 (Drosophila),PIR_SUPERFAMILY[630029716$PIRSF038125:eyes absent protein, 630030896$PIRSF500736:eyes absent protein homolog 3]
eyes absent homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000452$DNA damage, 790000459$dna repair, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001261$protein phosphatase, 790001539$Transcription, 790001543$transcription regulation]
eyes absent homolog 3 (Drosophila),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850018454$chain:Eyes absent homolog 3, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 101, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 101, member A,UP_SEQ_FEATURE[850045811$chain:Protein FAM101A, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 116, member A,INTERPRO[450011538$IPR012860:Protein of unknown function DUF1630]
family with sequence similarity 116, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 116, member A,UP_SEQ_FEATURE[850045838$chain:Protein FAM116A, 850106258$modified residue, 850117294$sequence conflict]
family with sequence similarity 131, member C,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 131, member C,UP_SEQ_FEATURE[850045864$chain:Protein FAM131C, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 133, member B pseudogene; similar to FAM133B protein; family with sequence similarity 133, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 133, member B pseudogene; similar to FAM133B protein; family with sequence similarity 133, member B,UP_SEQ_FEATURE[850045869$chain:Protein FAM133B, 850102554$compositionally biased region:Lys-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850118574$splice variant]
family with sequence similarity 134, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001020$neuropathy, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 134, member B,UP_SEQ_FEATURE[850045871$chain:Protein FAM134B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 155, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 155, member A,UP_SEQ_FEATURE[850066307$chain:Transmembrane protein FAM155A, 850102570$compositionally biased region:Poly-Gln, 850102573$compositionally biased region:Poly-Gly, 850105770$glycosylation site:N-linked (GlcNAc...), 850118623$transmembrane region]
family with sequence similarity 160, member B1,INTERPRO[450017622$IPR019384:Retinoic acid induced 16-like protein]
family with sequence similarity 160, member B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 160, member B1,UP_SEQ_FEATURE[850097667$chain:UPF0518 protein FAM160B1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 176, member B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
family with sequence similarity 176, member B,UP_SEQ_FEATURE[850045905$chain:Protein FAM176B, 850106258$modified residue, 850118623$transmembrane region]
family with sequence similarity 177, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 177, member B,UP_SEQ_FEATURE[850045907$chain:Protein FAM177B, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 186, member B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 186, member B,UP_SEQ_FEATURE[850045923$chain:Protein FAM186B, 850117295$sequence variant]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4,UP_SEQ_FEATURE[850045945$chain:Protein FAM19A4, 850117814$signal peptide]
family with sequence similarity 22, member D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 22, member D,UP_SEQ_FEATURE[850045952$chain:Protein FAM22D, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 24, member B,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
family with sequence similarity 24, member B,UP_SEQ_FEATURE[850045959$chain:Protein FAM24B, 850117295$sequence variant, 850117814$signal peptide]
family with sequence similarity 26, member D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 26, member D,UP_SEQ_FEATURE[850045961$chain:Protein FAM26D, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 46, member B,INTERPRO[450011613$IPR012937:Protein of unknown function DUF1693]
family with sequence similarity 46, member B,PIR_SUPERFAMILY[630011340$PIRSF013835:Caenorhabditis elegans hypothetical protein F55A12.9]
family with sequence similarity 46, member B,SP_PIR_KEYWORDS[790000356$complete proteome]
family with sequence similarity 46, member B,UP_SEQ_FEATURE[850045989$chain:Protein FAM46B]
family with sequence similarity 54, member A,INTERPRO[450007315$IPR007972:Protein of unknown function DUF729]
family with sequence similarity 54, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 54, member A,UP_SEQ_FEATURE[850046007$chain:Protein FAM54A, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 55, member B,OMIM_DISEASE[520000048$A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study]
family with sequence similarity 55, member B,PIR_SUPERFAMILY[630010122$PIRSF011875:pirsf011875]
family with sequence similarity 55, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 55, member B,UP_SEQ_FEATURE[850046012$chain:Protein FAM55B, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 71, member F2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 71, member F2,UP_SEQ_FEATURE[850046040$chain:Protein FAM71F2, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 81, member A,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 81, member A,UP_SEQ_FEATURE[850046062$chain:Protein FAM81A]
family with sequence similarity 82, member A2,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical]
family with sequence similarity 82, member A2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000434$differentiation, 790000919$membrane, 790000960$microtubule, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 82, member A2,UP_SEQ_FEATURE[850057060$chain:Regulator of microtubule dynamics protein 3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
fatty acid synthase,INTERPRO[450000688$IPR000794:Beta-ketoacyl synthase, 450000904$IPR001031:Thioesterase, 450001079$IPR001227:Acyl transferase region, 450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450005594$IPR006162:Phosphopantetheine attachment site, 450005595$IPR006163:Phosphopantetheine-binding, 450008211$IPR009081:Acyl carrier protein-like, 450011786$IPR013149:Alcohol dehydrogenase, zinc-binding, 450011854$IPR013217:Methyltransferase type 12, 450012624$IPR014030:Beta-ketoacyl synthase, N-terminal, 450012625$IPR014031:Beta-ketoacyl synthase, C-terminal, 450012635$IPR014043:Acyl transferase, 450014425$IPR016038:Thiolase-like, subgroup, 450014426$IPR016040:NAD(P)-binding domain, 450016488$IPR018201:Beta-ketoacyl synthase, active site]
fatty acid synthase,KEGG_PATHWAY[470038732$hsa00061:Fatty acid biosynthesis, 470038882$hsa04910:Insulin signaling pathway]
fatty acid synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000542$Fatty acid biosynthesis, 790000743$hydrolase, 790000874$lipid synthesis, 790000891$lyase, 790000993$multifunctional enzyme, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001161$Phosphopantetheine, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
fatty acid synthase,UP_SEQ_FEATURE[850000033$active site:For beta-hydroxyacyl dehydratase activity, 850000040$active site:For beta-ketoacyl synthase activity, 850000054$active site:For malonyltransferase activity, 850000083$active site:For thioesterase activity, 850019051$chain:Fatty acid synthase, 850103010$domain:Acyl carrier, 850105852$helix, 850106258$modified residue, 850106308$nucleotide phosphate-binding region:NADP (ER), 850106309$nucleotide phosphate-binding region:NADP (KR), 850110865$region of interest:Acyl and malonyl transferases, 850111013$region of interest:Beta-ketoacyl reductase, 850111016$region of interest:Beta-ketoacyl synthase, 850111587$region of interest:Enoyl reductase, 850114875$region of interest:Thioesterase, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
fibroblast growth factor 14,INTERPRO[450001959$IPR002209:Heparin-binding growth factor/Fibroblast growth factor, 450002089$IPR002348:Interleukin 1/heparin-binding growth factor]
fibroblast growth factor 14,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038908$hsa05218:Melanoma]
fibroblast growth factor 14,OMIM_DISEASE[520004635$Spinocerebellar ataxia-27]
fibroblast growth factor 14,SMART[760000388$SM00442:FGF]
fibroblast growth factor 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000632$growth factor, 790001015$neurodegeneration, 790001065$nucleus, 790001212$polymorphism, 790001431$spinocerebellar ataxia]
fibroblast growth factor 14,UP_SEQ_FEATURE[850019388$chain:Fibroblast growth factor 14, 850117295$sequence variant, 850118574$splice variant]
filaggrin,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450002881$IPR003303:Filaggrin, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
filaggrin,OMIM_DISEASE[520000430$Atopic dermatitis, susceptibility to, 520001459$Dermatitis, atopic 2, 520001461$Dermatitis, atopic, susceptibility to, 520002581$Ichthyosis vulgaris]
filaggrin,SP_PIR_KEYWORDS[790000211$calcium, 790000212$calcium binding, 790000326$citrullination, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000445$direct protein sequencing, 790000480$EF hand, 790000506$epidermis, 790000757$Ichthyosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001484$tandem repeat]
filaggrin,UP_SEQ_FEATURE[850019469$chain:filaggrin, 850102584$compositionally biased region:Poly-Tyr, 850102597$compositionally biased region:Ser-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue, 850115931$repeat:Filaggrin 1, 850115932$repeat:Filaggrin 10, 850115933$repeat:Filaggrin 11, 850115934$repeat:Filaggrin 12, 850115935$repeat:Filaggrin 13, 850115936$repeat:Filaggrin 14, 850115937$repeat:Filaggrin 15, 850115938$repeat:Filaggrin 16, 850115939$repeat:Filaggrin 17, 850115940$repeat:Filaggrin 18, 850115941$repeat:Filaggrin 19, 850115942$repeat:Filaggrin 2, 850115943$repeat:Filaggrin 20, 850115944$repeat:Filaggrin 21, 850115945$repeat:Filaggrin 22, 850115946$repeat:Filaggrin 23, 850115947$repeat:Filaggrin 3, 850115948$repeat:Filaggrin 4, 850115949$repeat:Filaggrin 5, 850115950$repeat:Filaggrin 6, 850115951$repeat:Filaggrin 7, 850115952$repeat:Filaggrin 8, 850115953$repeat:Filaggrin 9, 850117294$sequence conflict, 850117295$sequence variant]
filaggrin family member 2,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450002881$IPR003303:Filaggrin, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2, 450017214$IPR018942:Seminal vesicle protein repeat]
filaggrin family member 2,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
filaggrin family member 2,UP_SEQ_FEATURE[850019470$chain:Filaggrin-2, 850102597$compositionally biased region:Ser-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue, 850114567$region of interest:S-100-like, 850115931$repeat:Filaggrin 1, 850115932$repeat:Filaggrin 10, 850115942$repeat:Filaggrin 2, 850115947$repeat:Filaggrin 3, 850115948$repeat:Filaggrin 4, 850115949$repeat:Filaggrin 5, 850115950$repeat:Filaggrin 6, 850115951$repeat:Filaggrin 7, 850115952$repeat:Filaggrin 8, 850115953$repeat:Filaggrin 9, 850117295$sequence variant]
filamin binding LIM protein 1,INTERPRO[450001575$IPR001781:Zinc finger, LIM-type]
filamin binding LIM protein 1,SMART[760000114$SM00132:LIM]
filamin binding LIM protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000263$cell junction, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000864$LIM domain, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
filamin binding LIM protein 1,UP_SEQ_FEATURE[850019487$chain:Filamin-binding LIM protein 1, 850102586$compositionally biased region:Pro-rich, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850104719$domain:LIM zinc-binding 3, 850106259$mutagenesis site, 850111678$region of interest:Filamin-binding, 850114060$region of interest:PLEKHC1-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
flavin containing monooxygenase 2 (non-functional),INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002000$IPR002254:Flavin-containing monooxygenase (FMO) 2, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 2 (non-functional),KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 2 (non-functional),PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 2 (non-functional),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000899$magnesium, 790000919$membrane, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane]
flavin containing monooxygenase 2 (non-functional),UP_SEQ_FEATURE[850015179$chain:Dimethylaniline monooxygenase [N-oxide- forming] 2, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant]
flavin containing monooxygenase 4,INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002002$IPR002256:Flavin-containing monooxygenase (FMO) 4, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 4,KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 4,PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000919$membrane, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein]
flavin containing monooxygenase 4,UP_SEQ_FEATURE[850015181$chain:Dimethylaniline monooxygenase [N-oxide- forming] 4, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118623$transmembrane region]
flavin containing monooxygenase 5,INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002003$IPR002257:Flavin-containing monooxygenase (FMO) 5, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 5,KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 5,PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000919$membrane, 790000953$methylation, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane]
flavin containing monooxygenase 5,UP_SEQ_FEATURE[850015182$chain:Dimethylaniline monooxygenase [N-oxide- forming] 5, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant]
fms-related tyrosine kinase 3 ligand,INTERPRO[450003721$IPR004213:Flt3 ligand, 450011046$IPR012351:Four-helical cytokine, core]
fms-related tyrosine kinase 3 ligand,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
fms-related tyrosine kinase 3 ligand,PIR_SUPERFAMILY[630012510$PIRSF015744:Fms-related tyrosine kinase 3 ligand/SL cytokine]
fms-related tyrosine kinase 3 ligand,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
fms-related tyrosine kinase 3 ligand,UP_SEQ_FEATURE[850060940$chain:SL cytokine, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
forkhead box J2,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box J2,SMART[760000307$SM00339:FH]
forkhead box J2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
forkhead box J2,UP_SEQ_FEATURE[850019877$chain:Forkhead box protein J2, 850102570$compositionally biased region:Poly-Gln, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102914$DNA-binding region:Fork-head, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
forkhead box P3,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450006475$IPR007087:Zinc finger, C2H2-type, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box P3,OMIM_DISEASE[520001516$Diabetes mellitus, type I, susceptibility to, 520002620$Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked]
forkhead box P3,SMART[760000307$SM00339:FH, 760000323$SM00355:ZnF_C2H2]
forkhead box P3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
forkhead box P3,UP_SEQ_FEATURE[850019897$chain:Forkhead box protein P3, 850102914$DNA-binding region:Fork-head, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),UP_SEQ_FEATURE[850004581$chain:Alpha-(1,3)-fucosyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
gamma-glutamyl cyclotransferase,INTERPRO[450008399$IPR009288:AIG2-like, 450016251$IPR017939:Gamma-glutamylcyclotransferase]
gamma-glutamyl cyclotransferase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
gamma-glutamyl cyclotransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790001547$transferase]
gamma-glutamyl cyclotransferase,UP_SEQ_FEATURE[850020541$chain:Gamma-glutamylcyclotransferase, 850105852$helix, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
gap junction protein, alpha 5, 40kDa,INTERPRO[450000426$IPR000500:Connexins, 450002010$IPR002264:Gap junction alpha-5 protein (Cx40), 450011736$IPR013092:Connexin, N-terminal, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450016300$IPR017992:Gap junction alpha-5 protein (Cx40) region, 450017807$IPR019570:Gap junction protein, cysteine-rich domain]
gap junction protein, alpha 5, 40kDa,OMIM_DISEASE[520000438$Atrial fibrillation, 520000441$Atrial fibrillation, familial 4, 520000454$Atrial standstill]
gap junction protein, alpha 5, 40kDa,PIR_SUPERFAMILY[630002418$PIRSF002292:gap junction protein]
gap junction protein, alpha 5, 40kDa,SMART[760000029$SM00037:CNX]
gap junction protein, alpha 5, 40kDa,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000581$gap junction, 790000919$membrane, 790001555$transmembrane]
gap junction protein, alpha 5, 40kDa,UP_SEQ_FEATURE[850020611$chain:Gap junction alpha-5 protein, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
gastrulation brain homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
gastrulation brain homeobox 1,SMART[760000341$SM00389:HOX]
gastrulation brain homeobox 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
gastrulation brain homeobox 1,UP_SEQ_FEATURE[850024460$chain:Homeobox protein GBX-1, 850102378$compositionally biased region:Ala-rich, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102927$DNA-binding region:Homeobox, 850117295$sequence variant]
general transcription factor IIH, polypeptide 1, 62kDa,INTERPRO[450005056$IPR005607:BSD, 450010818$IPR011993:Pleckstrin homology-type, 450012473$IPR013876:TFIIH p62 subunit, N-terminal]
general transcription factor IIH, polypeptide 1, 62kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors, 470038823$hsa03420:Nucleotide excision repair]
general transcription factor IIH, polypeptide 1, 62kDa,SMART[760000657$SM00751:BSD]
general transcription factor IIH, polypeptide 1, 62kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
general transcription factor IIH, polypeptide 1, 62kDa,UP_SEQ_FEATURE[850021051$chain:General transcription factor IIH subunit 1, 850103175$domain:BSD 1, 850103176$domain:BSD 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
germ cell associated 1,INTERPRO[450011158$IPR012478:GSG1-like]
germ cell associated 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
germ cell associated 1,UP_SEQ_FEATURE[850021091$chain:Germ cell-specific gene 1 protein, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ghrelin/obestatin prepropeptide,BIOCARTA[30000126$h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis]
ghrelin/obestatin prepropeptide,INTERPRO[450004900$IPR005441:Preproghrelin peptide, 450006144$IPR006737:Motilin/ghrelin-associated peptide, 450006145$IPR006738:Motilin/ghrelin]
ghrelin/obestatin prepropeptide,OMIM_DISEASE[520003721$Obesity, susceptibility to]
ghrelin/obestatin prepropeptide,PIR_SUPERFAMILY[630001985$PIRSF001846:motilin]
ghrelin/obestatin prepropeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000060$amidation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000708$hormone, 790000881$lipoprotein, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001447$stomach]
ghrelin/obestatin prepropeptide,UP_SEQ_FEATURE[850105852$helix, 850105876$lipid moiety-binding region:O-decanoyl serine; alternate, 850105879$lipid moiety-binding region:O-octanoyl serine; alternate, 850106258$modified residue, 850107719$peptide:Ghrelin-27, 850107720$peptide:Ghrelin-28, 850108513$peptide:Obestatin, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand]
glucocorticoid modulatory element binding protein 1,INTERPRO[450000665$IPR000770:SAND, 450009947$IPR010919:SAND-like]
glucocorticoid modulatory element binding protein 1,SMART[760000230$SM00258:SAND]
glucocorticoid modulatory element binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
glucocorticoid modulatory element binding protein 1,UP_SEQ_FEATURE[850000333$binding site:DNA, 850021368$chain:Glucocorticoid modulatory element-binding protein 1, 850105253$domain:SAND, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
glucosamine (N-acetyl)-6-sulfatase,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
glucosamine (N-acetyl)-6-sulfatase,INTERPRO[450000800$IPR000917:Sulfatase, 450010976$IPR012251:N-acetylglucosamine-6-sulfatase, 450014386$IPR015981:N-acetylglucosamine-6-sulfatase, eukaryotic, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha]
glucosamine (N-acetyl)-6-sulfatase,KEGG_PATHWAY[470038771$hsa00531:Glycosaminoglycan degradation, 470038840$hsa04142:Lysosome]
glucosamine (N-acetyl)-6-sulfatase,OMIM_DISEASE[520003389$Mucopolysaccharidosis type IIID, 520004371$Sanfilippo disease IIID]
glucosamine (N-acetyl)-6-sulfatase,PIR_SUPERFAMILY[630028150$PIRSF036666:G6S, 630028151$PIRSF036666:N-acetylglucosamine-6-sulfatase]
glucosamine (N-acetyl)-6-sulfatase,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000743$hydrolase, 790000896$lysosomal storage disease, 790000897$lysosome, 790000937$metal-binding, 790000992$Mucopolysaccharidosis, 790001355$Sanfilippo disease, 790001405$signal, 790001465$sulfuric ester hydrolase]
glucosamine (N-acetyl)-6-sulfatase,UP_SEQ_FEATURE[850033188$chain:N-acetylglucosamine-6-sulfatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105909$metal ion-binding site:Calcium, 850105944$metal ion-binding site:Calcium; via 3-oxoalanine, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide]
glucose-6-phosphatase, catalytic subunit,INTERPRO[450000279$IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase, 450014599$IPR016275:Glucose-6-phosphatase]
glucose-6-phosphatase, catalytic subunit,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038730$hsa00052:Galactose metabolism, 470038765$hsa00500:Starch and sucrose metabolism, 470038882$hsa04910:Insulin signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway]
glucose-6-phosphatase, catalytic subunit,OMIM_DISEASE[520002143$Glycogen storage disease I]
glucose-6-phosphatase, catalytic subunit,PIR_SUPERFAMILY[630001047$PIRSF000905:Glucose-6-phosphatase]
glucose-6-phosphatase, catalytic subunit,SMART[760000008$SM00014:acidPPc]
glucose-6-phosphatase, catalytic subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000595$gluconeogenesis, 790000611$glycogen storage disease, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000922$membrane bound, 790001047$nuclear membrane, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein]
glucose-6-phosphatase, catalytic subunit,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850021450$chain:Glucose-6-phosphatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
glutamate receptor, metabotropic 2,INTERPRO[450000138$IPR000162:GPCR, family 3, metabotropic glutamate receptor, 450000290$IPR000337:GPCR, family 3, 450001299$IPR001458:GPCR, family 3, metabotropic glutamate receptor 2, 450001618$IPR001828:Extracellular ligand-binding receptor, 450010362$IPR011500:GPCR, family 3, nine cysteines region, 450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
glutamate receptor, metabotropic 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glutamate receptor, metabotropic 2,PIR_SUPERFAMILY[630005529$PIRSF005608:metabotropic glutamate receptors and related]
glutamate receptor, metabotropic 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
glutamate receptor, metabotropic 2,UP_SEQ_FEATURE[850031237$chain:Metabotropic glutamate receptor 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutamine and serine rich 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
glutamine and serine rich 1,UP_SEQ_FEATURE[850021637$chain:Glutamine and serine-rich protein 1, 850102485$compositionally biased region:Gln-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
glutathione S-transferase mu 1,INTERPRO[450002707$IPR003081:Glutathione S-transferase, Mu class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase mu 1,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase mu 1,PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase mu 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000436$dimer, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase mu 1,UP_SEQ_FEATURE[850021800$chain:Glutathione S-transferase Mu 1, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
glutathione S-transferase mu 2 (muscle),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glutathione S-transferase mu 2 (muscle),INTERPRO[450002707$IPR003081:Glutathione S-transferase, Mu class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase mu 2 (muscle),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase mu 2 (muscle),PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase mu 2 (muscle),SP_PIR_KEYWORDS[790000002$3d-structure, 790000199$brain, 790000244$cardiac muscle, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000646$heart, 790000701$homodimer, 790001212$polymorphism, 790001415$skeletal muscle, 790001547$transferase]
glutathione S-transferase mu 2 (muscle),UP_SEQ_FEATURE[850021801$chain:Glutathione S-transferase Mu 2, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glutathione S-transferase omega 2,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glutathione S-transferase omega 2,INTERPRO[450003562$IPR004045:Glutathione S-transferase, N-terminal, 450004901$IPR005442:Glutathione S-transferase, omega-class, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase omega 2,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase omega 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase omega 2,UP_SEQ_FEATURE[850021808$chain:Glutathione S-transferase omega-2, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850117294$sequence conflict, 850117295$sequence variant]
glutathione reductase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione reductase,INTERPRO[450000708$IPR000815:Mercuric reductase, 450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450005747$IPR006322:Glutathione reductase, animal and bacterial, 450011674$IPR012999:Pyridine nucleotide-disulphide oxidoreductase, class I, active site, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase]
glutathione reductase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione reductase,OMIM_DISEASE[520002265$Hemolytic anemia due to glutathione reductase deficiency]
glutathione reductase,PIR_SUPERFAMILY[630000254$PIRSF000210:dihydrolipoamide dehydrogenase]
glutathione reductase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000050$alternative initiation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000537$FAD, 790000559$Flavoprotein, 790000701$homodimer, 790000969$mitochondrion, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001302$Redox-active center, 790001303$redox-active disulfide, 790001550$transit peptide]
glutathione reductase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850021757$chain:Glutathione reductase, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
glutathione synthetase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione synthetase,INTERPRO[450004360$IPR004887:Glutathione synthase, substrate-binding, eukaryotic, 450005064$IPR005615:Glutathione synthase, eukaryotic, 450012420$IPR013816:ATP-grasp fold, subdomain 2, 450012634$IPR014042:Glutathione synthase, alpha-helical, eukaryotic, 450012641$IPR014049:Glutathione synthase, N-terminal, eukaryotic]
glutathione synthetase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione synthetase,OMIM_DISEASE[520002136$Glutathione synthetase deficiency, 520002266$Hemolytic anemia due to glutathione synthetase deficiency]
glutathione synthetase,PIR_SUPERFAMILY[630001728$PIRSF001558:glutathione synthase, 630001729$PIRSF001558:GSHase]
glutathione synthetase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000603$glutathione biosynthesis, 790000672$hereditary hemolytic anemia, 790000859$ligase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
glutathione synthetase,UP_SEQ_FEATURE[850000242$binding site:ATP, 850000249$binding site:ATP; via carbonyl oxygen, 850000555$binding site:Substrate, 850021826$chain:Glutathione synthetase, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
growth arrest-specific 2,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ]
growth arrest-specific 2,INTERPRO[450001520$IPR001715:Calponin-like actin-binding, 450002732$IPR003108:Growth-arrest-specific protein 2]
growth arrest-specific 2,PIR_SUPERFAMILY[630021016$PIRSF027832:PIRSF027832]
growth arrest-specific 2,SMART[760000025$SM00033:CH, 760000215$SM00243:GAS2]
growth arrest-specific 2,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000258$cell cycle, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000631$growth arrest, 790000919$membrane, 790001162$phosphoprotein]
growth arrest-specific 2,UP_SEQ_FEATURE[850022453$chain:Growth arrest-specific protein 2, 850103317$domain:CH, 850106258$modified residue, 850117989$site:Cleavage; by a caspase during apoptosis]
growth differentiation factor 15,INTERPRO[450001626$IPR001839:Transforming growth factor beta, 450016259$IPR017948:Transforming growth factor beta, conserved site]
growth differentiation factor 15,SMART[760000177$SM00204:TGFB]
growth differentiation factor 15,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth differentiation factor 15,UP_SEQ_FEATURE[850022489$chain:Growth/differentiation factor 15, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
